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Abstract 
Background 
Heart failure is one of the principal causes of death and disability. The causes of heart failure 
are many, and a number of technologies have been developed to address this issue by 
providing support to the failing heart, both as a permanent solution and as a bridge to 
recovery. These options are called Mechanical Circulatory Support Devices, a particular 
branch of these devices is the Ventricular Assist Devices, which have been under intense 
development over the recent years offering a promising solution for this major problem.  
However, these devices are still bulky, and heavy designed to support failing hearts in the 
adult population.  On the other hand, little has been done in recent times on the development 
of implantable solutions for heart failure or insufficiency in children. There are many reasons 
for this, but primarily the relatively small number of children requiring these procedures, the 
challenges associated with growth, and the lack of physical space for such implantable 
circulatory support technologies in children are fundamental limitations to the development 
and deployment of these technologies.  
Aims of the project 
The primary purpose of this project was to investigate the development of a new miniaturised 
self-power VAD that is suitable for paediatrics implantation. This project suggested the use of 
the newly developed Artificial Muscles to create a mesh that envelops the heart and works as 
an external assisting circulation mechanism. The same materials could be used to generate 
electricity when deformed, which can be used to power the proposed device. Critically, the 
project was to focus on optimising the materials with regard to their operating efficiency to 
ascertain whether they represent a viable option for VAD production.  
Materials and Methods 
A full review of the current available Artificial Muscles was performed to choose the most 
suitable type for this project. Then different fabrication protocols were developed to make 
IPMC Artificial Muscles using platinum and palladium coatings. A series of characterization 
tests were conducted on the fabricated Ionic Polymeric Metal Composites (IPMC) to ensure 
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their quality. Finally, the mechanical and electrical properties were tested and compared with 
the proposed device requirements. 
Results 
The review of Artificial Muscles showed that IPMC would be the best candidate to use in this 
application. The characterisation tests showed as well that the produced IPMC Artificial 
Muscles were fabricated to the same standards as those commercially available, and the 
reported by other investigators. However, these materials showed very low mechanical 
output with high electrical power consumption, which made them far from practical and not 
suitable for the proposed application. On the other hand, IPMCs showed promising results as 
an option to generate electricity to power low consumption implantable devices. 
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Thesis Outline 
Chapter 1 introduces the anatomy of the heart, coronary arteries, and the blood circulation 
system in general. Then it moves to describe the cardiovascular diseases that affect the heart 
and lead to end stage heart failure. The final part of this chapter describes the available 
options of Mechanical Circulatory Support Devices. 
Chapter 2 details the objectives and the concept of the project. Then it explains the history, 
types, and properties of Artificial Muscles. Finally, it lists the proposed solutions and 
hypothesis to create a VAD from Artificial Muscles. 
Chapter 3 starts with determining the requirements of proposed devices. Then explains the 
primary investigation phase of IPMC Artificial Muscles.  After that, it moves to detail the 
process of making IPMC samples and their electrical driver.  
Chapter 4 lists all the tests conducted on IPMC Artificial Muscles to evaluate their properties. 
These tests are surface scanning, measuring thickness, measuring water uptake, measuring 
surface resistance, electrical power consumption, displacement, and blocking force.  
Chapter 5 describes the use of IPMC for power harvesting and sensing. 
Chapter 6 discusses and explains the results of the proposed device. 
Chapter 7 concludes finding of the project.  
Chapter 8 describes the limitations that were faced during the project. 
Chapter 9 lists the future development of the proposed device.   
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Chapter 1 
Background 
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 Physiological Background 
  Introduction 
Heart transplantation is still the gold standard for patients suffering from end-stage heart 
failure. According to the World Health Organization, one in 33 infants born has one or more 
congenital anomaly, some of these patients require surgical intervention in their first month 
of life (Hines 2013). In the USA alone, more than 9,000 infants are born with congenital heart 
problems annually, just 400 of them will have their chance to get a new heart (Fynn-
Thompson and Almond 2007). The cost of cardiovascular diseases and stroke in the United 
States is estimated at more than $300 billion a year (Shahinpoor 2010). Due to the shortage 
of donors (Mitamura 2015), and the high risk of rejection of the donated heart, Mechanical 
Circulatory Support Devices (MCSD) are used to support the patient’s heart while a long-term 
solution is considered. In the last three decades, mechanical support devices have been the 
focus of considerable development activity, offering a broad range of solutions for patients 
with end-stage heart failure  as a bridge to decision (BTD),  bridge to transplant (BTT), bridge 
to recovery (BTR), or finally as a destination therapy (DT) for the whole life (Timms 2011, 
Sabashnikov, Mohite et al. 2014). 
Until recently, the most popular and reliable solution for this problem was using venoarterial 
Extracorporeal Membrane Oxygenation (ECMO). ECMO can offer full cardiac support that can 
be applied rapidly. On the other hand, it can be implemented only for a short time, over a few 
days in most cases, with a few weeks being the extreme range of deployment (Fynn-
Thompson and Almond 2007). Centrifugal pumps are also used as an extracorporeal circuit in 
infants and children, supporting them from a few days to a few weeks. Under both treatment 
modalities, patients are confined to the Intensive Care Unit (ICU) setting (Potapov, Stiller et 
al. 2007). 
More advanced mechanical support devices are the Ventricular Assist Devices (VAD), which 
can help the patient’s heart longer than ECMO. VADs can be divided into several categories 
depending on the flow, place of implantation and the supporting system that can offer to the 
heart (Potapov, Stiller et al. 2007). 
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 Anatomy of the Heart 
 The Heart 
The heart is the most important working muscular organ in all living creatures, playing a 
significant role in providing oxygenated blood and nutrients to all of the living cells. In 
humans, the heart is located in the anterior chest wall directly posterior to the sternum. 
Connected to it are the great blood vessels, the aorta, the vena cava, the pulmonary arteries, 
and pulmonary veins, as shown in Figure 1.1 and Figure 1.2. The healthy adult’s heart 
measures around 12.5 cm in length, and it has a mass between 250 g and 350 g. The adult's 
heart usually beats between 60 and 100 times a minute, while the baby's heart may beat up 
to 190 times a minute. During an average lifetime, the human heart will beat more than three 
billion times, pumping more than 160 million litres of blood (Martini F. 2011). On average, 
each day the human’s heart pumps 7,500 litres of blood and beats 100,000 times (Shahinpoor 
2010). 
 
Figure 1.1 The Heart (Martini F. 2011) 
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The wall of the heart consists of three primary layers, the Epicardium, the Myocardium, and 
the Endocardium. The first layer covering the outer surface of the heart is the Epicardium; 
this layer consists of an exposed mesothelium and an underlying layer of loose areolar 
connective tissue, which is connected with the second layer. The second layer is the 
Myocardium, which is the primary muscular layer forming the atria and ventricles. This layer 
consists of concentric layers of cardiac muscle tissue; it also contains blood vessels and 
nerves. The third layer is the Endocardium, which covers all the inner surfaces of the heart 
including the valves. The thickness of the heart wall is not equal in all heart chambers; the left 
ventricle has a thicker wall which enables it to pump the large systemic circuit through the 
body at a high arterial pressure (Martini F. 2011).      
 
Figure 1.2 The Heart (Martini F. 2011) 
The heart consists of four main chambers: two ventricles and two atria, as shown in Figure 
1.3. The right atrium is located on the top right side of the heart, receives the deoxygenated 
blood from all parts of the body through the Superior Vena Cava (SVC) and the Inferior Vena 
Cava (IVC), and is connected to the right ventricle through the tricuspid valve. The left atrium 
is located on the top left side of the heart, receives all oxygenated blood from the left and 
right lungs through the pulmonary veins and delivers this blood to the left ventricle through 
the mitral valve. The right ventricle is located on the right bottom side of the heart, receives 
the deoxygenated blood from the right atrium and pumps it to the left and right pulmonary 
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arteries through the pulmonary valve to the left and right lungs. The left ventricle, which is 
normally the largest chamber of the heart, is located on the left bottom side of the heart, 
receives the oxygenated blood from the left atrium and pumps it to the whole body 
throughout the aortic valve and the aorta. The aorta is then divided into several branches to 
cover all parts of the human body. A thick muscular wall called the septum separates the right 
side and the left side of the heart. In each heartbeat, the right side of the heart pumps the 
same amount of blood into the lungs and the left side of the heart into the body. Commonly, 
physicians refer to the right atrium and right ventricle as the right heart, and the left atrium 
and the left ventricle as the left heart (Martini F. 2011). 
 
Figure 1.3 Heart Valves (Martini F. 2011) 
  The Coronary Circulation 
Since the heart is a continuously working pump, it requires a constant energy supply. The 
coronary circulation, which supplies the heart and its muscular cells with the oxygen, provides 
this energy and nutrients needed and removes all the waste products. Interestingly, the first 
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function of the heart is to supply nutrients to itself. The coronary circulation, shown in Figure 
1.4, consists of the left and right coronary arteries, which are branched from the ascending 
aorta. Also the cardiac veins, which are connected to the right atrium near the base of the 
inferior vena cava. The coronary circulation is crucial; any blockage to this circulation, even 
partially blockage, will cause a reduction in the cardiac performance and can result in a heart 
attack. This blockage in the coronary circulation system is called a Coronary Artery Disease 
(CAD)(Martini F. 2011).   
 
Figure 1.4 The Coronary Circulation (Martini F. 2011) 
 The Blood Circulatory System  
The blood circulatory system, shown in Figure 1.5, consists of the heart and two blood circuits 
connected with it: the pulmonary circuit, and the systemic circuit. In the pulmonary circuit, 
the deoxygenated blood from all parts of the body is collected in the right side of the heart 
and then pumped to the lungs, where gaseous exchange occurs, deoxygenated blood is 
converted to oxygenated blood, and redirected to the left side of the heart. In the systemic 
circuit, the oxygenated blood is pumped from the left side of the heart to all parts of the body 
to supply the tissues with oxygen and nutrients needed for their various functions, and to 
collect the metabolic waste products from all living cells. Following this, the deoxygenated 
blood is returned to the right side of the heart to complete the circuit(Martini F. 2011).         
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Figure 1.5 The Blood Circulatory System (Martini F. 2011) 
 The Embryonic Heart 
There are several phases of fetal heart development. The first phase is Tube Formation, 
between 15 and 20 days, where the heart has a shape of two bent tubes and begins to beat. 
The second phase is Looping, between 21 and 28 days. In this stage, distinct chambers start 
to appear, the left and right ventricles became more evident. The third phase is Atrial 
Septation, between 34 and 50 days. Here, the septum grows from the ventral wall of the 
atrium and forms a ridge on the posterior wall of the atria. The fourth phase is Outflow Tract 
Septation between 35 and 56 days. In this stage, the outflow tract begins as a single tube 
connected with the ventricles, by the end of this stage the aorta and the pulmonary outflow 
are separated and attached to the left and right ventricles respectively. The fifth phase is 
Ventricular Septation, between 38 and 45 days, in this phase, the separation between the 
ventricles is completed (Yeung 2007). Development of an embryonic heart is a very 
complicated process, any small change during this process can cause congenital heart disease 
of the fetus. 
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 Paediatric Cardiovascular System: 
Paediatric patients fall into the followings categories shown in Table 1.1: 
Neonates A baby within 44 weeks of age from the date of conception 
Infants A child of up to 12 months of age 
Child 1 to 12 years 
Adolescent 13 to 16 years 
Table 1.1 Paediatric age range (Macfarlane 2006) 
In neonates, the myocardium is less contractile, causing the ventricle to be less compliant and 
less able to generate tension during contraction. That is why they have a higher heart rate 
compared to the other groups (Macfarlane 2006). Table 1.2 shows the changes in heart rate 
and blood pressure in the paediatric range.  
Age Heart rate (BPM) Blood Pressure (mm Hg) 
Preterm 130 120-170 
Newborn 120 100-170 
1-11 months 120 80-160 
2 years 110 80-130 
4 years 100 80-120 
6 years 100 75-115 
8 years 90 70-110 
10 years 90 70-110 
14 years boy 80 60-100 
14 years girl 85 65-105 
16 years boy 75 55-95 
16 years girl 80 60-100 
Table 1.2 Heart rate and blood pressure in the paediatric range (Macfarlane 2006) 
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 Cardiovascular Diseases 
 Congenital Heart Disease 
Congenital Heart Disease (CHD) is any defect or change in the structure of the healthy heart 
and the primary vessels connected with it, which appears directly after birth. The chance of 
having congenital heart disease is 6 in 1000 births and occurs in similar frequencies in each 
part of the world within all ethnic groups (Kenny and Stuart 2009).  
Depending on the direction of blood flow through intracardiac shunts, congenital heart 
disease can be classified into different types. Blood flowing from left side to the right side of 
the heart is called acyanotic defect. Arterial Septal Defect (ASD) is an example of the acyanotic 
defect, where the blood flows from the left atrium to the right atrium. The oxygenated blood 
in the left atrium is mixed with the deoxygenated blood in the right atrium, which causes an 
increased volume load on the right atrium. The other case when the blood is flowing from the 
right side to the left side of the heart is called a cyanotic defect. The most common example 
is Tetralogy of Fallot (TOF), where the right ventricle outflow tract is narrowed. In TOF, the 
deoxygenated blood in the right ventricle faces a significant resistance to flow into the 
pulmonary artery, and as a result, blood then follows the lower resistance path which is the 
Ventricular Septal Defect (VSD) and flows to the aorta without undergoing gaseous exchange 
in the lungs. Some children may suffer from both cases together; this case is called mixed 
lesion CHD or complex CHD (Woodward 2011). 
Infants with complex CHD may suffer from poor nutrition due to their poor appetites, which 
can have a substantial effect on their healthy growth. Unrepaired CHD in the early stages of 
life increases the risk of morbidity and mortality due to underlying cardiopulmonary 
compromises (Woodward 2011). 
 Myocardial Dysfunction 
Children suffering from myocardial dysfunction can be streamed into one of two clinical 
approaches; a bridge to recovery in reversible dysfunction cases, and a bridge to heart 
transplantation in more severe cases. Paediatric patients suffering from reversible myocardial 
dysfunction can be treated with a Mechanical Circulatory Support Device (MCSD) as a bridge 
to recovery. Reversible myocardial dysfunction includes postcardiotomy myocardial 
dysfunction, acute myocarditis, or acute post-transplant rejection. Children with end-stage 
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congenital heart disease and prolonged graft rejection after heart transplantation are 
candidates for long-term support with MCSDs as a bridge to transplantation or in other cases 
as a destination therapy (Chang and McKenzie 2005).    
 Cardiopulmonary Resuscitation 
MCSDs are used to rescue the patient’s heart after the failure of conventional resuscitation. 
All cardiac intensive care units should be able to support the patient with an MCSD, in this 
case, in a matter of a few minutes (Chang and McKenzie 2005).    
 Preoperative Stabilisation 
MCSDs are used to support paediatric patients with cardiovascular collapse, or severe 
hypoxemia before any surgical intervention is undertaken. Some cases that are considered 
under this situation are pulmonary hypertensive crises, total anomalous pulmonary venous 
connection, tetralogy of Fallot with the absence of pulmonary valve, or Ebstein’s anomaly 
(Chang and McKenzie 2005).     
 Acute Respiratory Distress Syndrome 
Extracorporeal Membrane Oxygenation (ECMO) is the primary option for parenchymal lung 
disease in paediatrics.  Patients with congenital heart disease are more prone to develop 
parenchymal lung disease before or after their cardiac surgery. ECMO is used for a few weeks 
to support patients suffering from parenchymal lung disease, allowing more time for the lungs 
to recover (Chang and McKenzie 2005).   
 Malignant Dysrhythmias 
In some rare cases, patients who fail conventional aggressive medical therapy for continuous 
tachydysrhythmias may be suitable for a short-term support with MCSDs. Patients in this case, 
may suffer from lethal arrhythmias associated with myocardial disease, supraventricular 
tachycardia, ventricular tachycardia, or junctional ectopic tachycardia (Chang and McKenzie 
2005).    
 Profound Cyanosis 
Paediatric patients diagnosed with cyanosis need to be corrected. MCSDs can be used to 
support these patients on a case-by-case basis. Some alternative options could be possible to 
help patients with cyanosis, but MCSDs are used if all the previous options fail (Chang and 
McKenzie 2005). 
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 Dilated Cardiomyopathy 
Cardiomyopathy disease is a disease that affects the heart’s muscle or in other words the wall 
of the heart. Cardiomyopathy includes abnormal changes in the size of the heart chambers, 
the wall thickness, or abnormalities in heart functions such as systolic or diastolic 
dysfunctions. Dilated cardiomyopathy is the most common type of cardiomyopathy in the 
world, in this case, the left ventricle or the ventricles are enlarged and contract very weakly 
(Jefferies and Towbin 2010).     
 Mechanical Circulatory Support Device (MCSD)  
The first report of MCSD use was in 1967 when Dr Debakey used a left atrial- axillary artery 
ventricular assist device in a teenager's heart to recover him from postcardiotomy failure 
after mitral valve replacement. This was the first successful use of MCSD and the patient 
recovered after six months (Fynn-Thompson and Almond 2007). 
The use of centrifugal pump systems started in the 1970s, supporting infants and children in 
their early age (<6 kg). This type of treatment had excellent reports at that time, but also it 
has the same problems with as ECMO, such as non-pulsatile blood flow and a short support 
time (Fynn-Thompson and Almond 2007).  
During the early 1990s, VAD systems emerged in greater numbers and configurations. 
Extracorporeal systems have been used in medium size children, and the results were 
generally encouraging. Some problems arose with the use of VAD systems, including those 
associated with thrombogenicity. However, the development of VADs advanced and had 
been developed to the degree of use in infants and small children, offering both pulsatile and 
continuous blood flow modalities. Despite the huge advancement achieved in this field, there 
remains a compromise between clinical need and safety in the use of VADs in the paediatric 
domain with none yet meeting the ideal criteria (Fynn-Thompson and Almond 2007, Timms 
2011).   
The fundamental purpose of MCSD is to save the patient’s life in emergency cases. They are 
primarily used to support the patient’s heart for short periods, but the following devices have 
been developed to help the patient for longer periods. 
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MCSDs are divided into three main groups 
 Extracorporeal Membrane Oxygenation (ECMO). 
 Centrifugal Pumps. 
 Ventricular Assist Devices (VADs).  
 Extracorporeal Membrane Oxygenation (ECMO)  
ECMO is the first solution used to support children suffering from heart failure. Lack of 
alternatives and the long time experience in applying ECMO as a treatment for respiratory 
and heart failure make ECMO the leading approach at present. The first child to have ECMO 
support was a nine years old boy in the late 1980s, reported by   Dr Denton Cooley. This boy 
was supported for 12 hours until a suitable donor was found. This case was the beginning of 
the use of MCSDs in paediatric patients and has opened all the options for researchers in this 
field (Frazier, Bricker et al. 1989). 
The ECMO circuit as shown in Figure 1.6 below consists of the following components:   
 
Figure 1.6 ECMO circuit (Lodge, Antunez et al. 2012) 
40 
 
 Blood Pump: Gravity drainage is responsible for flowing the blood from the patient’s 
Right Atrium (RA) to a blood reservoir before the pump, the pump then pumps the 
blood from the reservoir to the other components. It could be a centrifugal pump or 
roller head pump (Palanzo, El-Banayosy et al. 2013). 
 Oxygenator: or the artificial lung, where the blood status will change from 
deoxygenated into oxygenated blood. This oxygenator is connected to an external 
oxygen gas source to keep the gaseous exchange running. 
 Heat Exchanger: is applied to maintain the blood temperature at a fixed point.  
 Tubing Set: a set of tubes and cannulas that are used to connect the patient’s heart 
with the other components. Special cannulas are used depending on the type of 
support applied on the patient. Some cannulas are directly applied to the heart while 
others are applied peripherally. 
 Monitoring System: control and monitor all the components and the parameters, 
such as blood flow and temperature. Provide the user also with the appropriate 
alarms.  
Due to the presence of the oxygenator, it can also offer support for the lungs when the heart 
disease is associated with hypoxia or pulmonary hypertension. ECMO is an option that can 
offer a cardiac support alone, pulmonary support only, or a combination of both.  In children, 
the primary cause of using ECMO is a failure to recover from cardiopulmonary bypass (CPB) 
after cardiac surgery or in the case of fulminant myocarditis (Amodeo, Brancaccio et al. 2010).    
ECMO is associated with several complications due to the large artificial surface area of 
contact between the circuit and patient’s blood, which requires a high level of 
anticoagulation. Some of these complications are thromboembolic and bleeding. Using 
cannulas can also cause some problems, such as infection due to the open chest, and 
immobilisation. The continuous non-pulsatile flow could also be a possible cause of end-organ 
failures, such as kidneys and liver, besides the neurological complications. Short term support 
could be considered as one of the limitations in using ECMO, where it can be applied just for 
few weeks maximum (Fynn-Thompson and Almond 2007). These problems caused ECMO 
patients to have a high mortality, with a 50% chance of survival and discharge from the 
hospital (Jeewa, Manlhiot et al. 2010). On the other hand, ECMO still has some advantages, 
such as supporting both heart and lung at the same time, biventricular support, quick and 
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easy installation, accommodation of neonatal size limitations, inexpensive compared to the 
other solutions, and the large international neonatal and paediatric experience (Lodge, 
Antunez et al. 2012).  
 Centrifugal Pumps 
This system is very similar to ECMO, but without the oxygenator and heat exchanger, it is also 
used for a short-term support. The system consists of a centrifugal pump, control console, 
and a set of tubes that connect the patient’s heart with the pump. A non-pulsatile flow is 
provided by a vortex technology, where an impeller rotates at speeds between 1,000 and 
4,000 RPM to create a flow of 5 - 6 L/min (Potapov, Stiller et al. 2007). Blood enters from the 
centre of the pump and leaves from the side; blood path is shown in Figure 1.7. 
 
Figure 1.7 Centrifugal Pump (Adachi and Fraser 2011) 
The main advantage of this system is the low priming volume of the pump and short length 
of the tubing system, which allows its use in small patients <10kg (Del Nido, Duncan et al. 
1999). Centrifugal pumps also show lower rates of haemolysis compared with other types of 
MCSDs (Kosaka, Yada et al. 2013, Yasui, Kosaka et al. 2013), and their design is still under 
development to improve the haemocompatibility level (Amaral, Gross-Hardt et al. 2013). 
Several reports have described the successful use of centrifugal pumps in supporting a broad 
range of paediatric cardiac diseases(Inoue, Nishimura et al. 2011). It is also a relatively 
inexpensive choice, and much easier for transporting the patient compared to 
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ECMO(Potapov, Stiller et al. 2007). However, the cannulation system is not very stable and 
this could be considered as a problem by not allowing the patient to move. The patient’s 
movement is restricted unlike the VAD, which offers some degree of freedom. Infection still 
exists in this system but to a lesser extent than ECMO. Anticoagulation substances are needed 
due to the contact between the blood and the artificial surface of the pump and tubes(Lodge, 
Antunez et al. 2012).  
 
Figure 1.8 Bio Medicus Centrifugal Pump (Adachi and Fraser 2011) 
Several products have been used in practice, such as Bio-Pump (Medtronic Bio-Medicus, 
Minneapolis, MN), as shown in Figure 1.8, Capiox (Terumo, Ann Arbor, MI, USA) and Rotaflow 
(Maquet, Rastatt, Germany). The pump chamber is available with a variety of different sizes 
to cover a broad spectrum of patients; small priming volume pumps are specially produced 
for infants (Baldwin and Duncan 2006).   
 Ventricular Assist Device (VAD)  
 Introduction to VADs 
The third option available for children with heart failure is using VAD. These devices have 
been in use since the 1990s. For adult patients, VADs are very successful with BTT, BTR, and 
DT. In contrast, for paediatric patients, VADs are still behind, and new technologies are still 
under research to develop a suitable paediatric VAD (Fumoto, Shiose et al. 2014, Padalino, 
Bottio et al. 2014). VADs have several advantages over ECMO, such as pulsatile flow, which 
leads to a better tissue perfusion, and patients do not need to be totally paralysed. Also, VADs 
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can offer some degree of freedom for the patient where he/she can move and allow physical 
rehabilitation(Gandhi 2009). Figure 1.9 shows an example of an adult VAD. 
 
Figure 1.9 HeartMate XVE (Thunberg, Gaitan et al. 2010) 
VADs can be divided into several categories depending on their outflow pattern, duration of 
support, the mechanism of the pump, and the connection between the device and the 
patient. 
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According to the outflow pattern, VADs can be divided into a pulsatile flow and a continuous 
flow: 
 Pulsatile Flow: the blood flows in series of pulses, like the blood flow produced by a 
normal heart. Figure 1.10 shows an example of a pulsatile flow VAD driven by 
compressed air. 
 
Figure 1.10 Berlin Heart EXCOR (Potapov, Stiller et al. 2007) 
 Continuous Flow: the blood flows continuously in this type of VAD using axial flow 
pumps or centrifugal pumps, as shown in Figure 1.11. This type has several 
advantages, such as a small size pump, no need for a compliance chamber, no need 
for valves, low power consumption, and much quieter than the pulsatile flow pumps.   
 
Figure 1.11 HeartMate II (John 2008) 
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According to the duration of support, VADs can be divided into short-term support and long-
term support: 
 Short Term Support: In this category, the devices are used to support the heart for a 
few days, usually less than 30 days. They are applied until the decision is made, 
transplantation is ready, or heart is recovered. Mainly, those devices are placed 
outside the patient’s body.   
 Long Term Support: these devices can be used for months or even years, mostly 
applied as a destination therapy and are entirely implantable inside the patient’s body.   
According to the mechanism of the pump, VADs can be divided into positive displacement 
pumps, axial flow pumps, and centrifugal pumps (Garbade, Bittner et al. 2011): 
 Positive Displacement Pumps: they are also called the first generation VADs, these 
pumps have a pulsatile outflow. The pump is driven either pneumatically by 
compressed air, or electrically by an electric motor.  Figure 1.12 shows an example of 
the pulsatile VAD. 
 
Figure 1.12 Thoratec IVAD (Timms 2011) 
 Axial Pumps: also called the second generation VADs. These pumps have a continuous 
outflow, as shown in Figure 1.13. 
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Figure 1.13 HeartMate II (John 2008) 
 Centrifugal Pumps: the new generation of VADs are using magnetically levitated 
impellers with centrifugal pumps, as shown in Figure 1.14. This type is still under 
development.  
 
Figure 1.14 HVAD (Garbade, Bittner et al. 2011) 
According to the support system applied on the heart, VADs can be divided into RVAD, LVAD, 
and BiVAD: 
 Right Ventricular Assist Device (RVAD): support the right ventricle. 
 Left Ventricular Assist Device (LVAD): support the left ventricle. 
 Bi-Ventricular Assist Device (BiVAD): support both left and right ventricles, it could 
be called a total artificial heart, as shown in Figure 1.15. 
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Figure 1.15 PediPump (Baldwin and Duncan 2006) 
According to the connection between the device and the patient, VADs can be divided into 
extracorporeal (paracorporeal) devices and intracorporeal devices: 
 Extracorporeal Devices: those VADs are placed outside the patient’s body. They need 
special care, and the patient should stay in the ICU all the time. Mainly used as a short 
term support systems. Figure 1.16 shows an Extracorporeal VAD placed outside the 
patient’s body. 
 
Figure 1.16 Toyobo LVAS (Masuoka, Katogi et al. 2008) 
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 Intracorporeal Devices: those VADs are entirely implantable inside the patient’s body, 
apart from the external power source and the controller connected to the patient 
through a percutaneous cable, as shown in Figure 1.17.  
 
Figure 1.17 PediaFlow (Noh, Antaki et al. 2008) 
The last classification is the most important one in many ways as it represents the ideal VAD 
solution, the one which is in-dwelling and renders the patient independent of the ICU setting 
over prolonged periods of time.  
 VADs Classifications 
 VADs Generations 
1.5.2.2.1.1  First Generation VADs 
The first-generation design is based on a pulsatile positive displacement pump. This 
engineering design consists of an internal blood chamber, two mechanical or biological valves 
to maintain unidirectional blood flow, and two grafts for inflow and outflow. The pump is 
either driven pneumatically by an external compressed air source, or by an electric 
mechanical actuator driven by an internal electric motor. These following devices are big, 
heavy, noisy, and they need large percutaneous cables, which incorporates an air vent line to 
equalise the atmospheric pressure in the motor chamber. There is also a high incidence of 
mechanical failure associated with long-term support. All these limitations restrict the use of 
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the first generation VADs for young children and are not suitable for paediatric patients 
(Pagani 2008, Jaquiss and Imamura 2011).  
1.5.2.2.1.2  Second Generation VADs 
The second-generation design is based on continuous flow rotary pumps, which are 
suspended on contact bearings. These VADs contain two main parts, the rotor and the stator, 
beside two grafts for inflow and outflow. The rotor is pivoted on two mechanical bearings at 
each end of the rotor spindle, with the spinning of the rotor achieved by magnetic coupling 
with the motor placed in the stator part (Stanfield and Selzman 2013). A thin percutaneous 
cable exits the body and connects the device to an external electrical power source and a 
system controller. The second generation VADs are much smaller, lighter, and quieter than 
the first generation. This allows them to be implantable in small size patients and adults, and 
suitable for medium and long term support (Pagani 2008).         
1.5.2.2.1.3  Third Generation VADs     
The third-generation design is based on continuous flow rotary pumps, which are suspended 
on noncontact bearings system. This design is very similar to the second-generation devices, 
except for the bearing mechanism. The pump consists of two parts (the stator and the rotor), 
the latter part being suspended magnetically within the stator part. This levitation force could 
be either passive (depending on permanent magnets), or active (generated by an electrical 
current passing through a coil). In both cases, this technique helps in reducing the power 
consumption. These noncontact bearings mitigate the risk of flow stagnation, thrombus 
formation, heat generated by friction, and mechanical wear (Pagani 2008, Miera, Potapov et 
al. 2011, Boehning, Timms et al. 2013, Kim, Ishiyama et al. 2013). 
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The first, second, and third generation VADs are listed in Table 1.3 below:   
First Generation Second Generation Third Generation 
HeartMate I HeartMate II HeartMate III 
Thoratec Implantable VAD 
(IVAD) 
Micromed DeBakey VAD 
Child/ Heart Assist 5 
Berlin Heart Incor 
 
Thoratec  PVAD 
 
Infant and Child Size Jarvik 
2000 VAD 
PediaFlow 
 
Berlin Heart EXCOR Circulite Micro VAD PediPump 
MEDOS HIA-VAD Abiomed Impella cVAD 
Tandem Heart 
Toddler VAD 
Novacor LVAS Pediatric pVAD CorAide 
Abiomed Biventricular 
Support 5000 
Pediatric Cardiac Assist 
System pCAS 
Levacor VAD 
Abiomed AB 5000 Cardio Flow PQ Dura Heart 
Penn State PVAD  VentrAssist 
Toyobo NCVC LVAS  Heart Ware Ventricular Assist 
Device HVAD 
  Levitronix  PediVAS 
  Tiny Pump 
  Levitronix CentriMag Blood 
Pumping System 
Table 1.3 VADs Generations 
 Intracorporeal and Extracorporeal VADs  
Extracorporeal pumps are the first VADs used to support paediatric patients, offering less 
mobility restriction than ECMO, and longer time than previous options. This type of VAD is 
used for short to medium term support until heart recovery or transplantation (Jaquiss and 
Imamura 2011). The patient with extracorporeal VAD should stay at the hospital all the time 
for monitoring. The location of the VAD outside the body allows easy monitoring of the blood 
flow and helps in observing any thrombus formation; any mechanical failure could be directly 
noticed and solved immediately. The main disadvantage is the high risk of infection due to 
the large tubes needed to connect the pump with the patient’s heart; two tubes for single 
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ventricular support, and four tubes for biventricular support. Particular care is required to 
keep these tubes clean and sterile at the skin entry sites.  
The other type of VAD is the intracorporeal VAD, where the pump is fully implanted inside 
the patient’s body, either intraventricular or extraventricular, depending on the size of the 
pump and the patient. This type can provide both short-term or long-term support. Unlike 
the extracorporeal VADs, there is no need for any external motor or air compressor; the 
intracorporeal pump is just connected to a small controller and a set of rechargeable batteries 
through a thin percutaneous cable. This small percutaneous cable helps to reduce the risk of 
infection. Patients with intracorporeal VADs are mobile and tend to leave the hospital after 
implantation.  Intracorporeal and Extracorporeal VADs are listed in Table 1.4 below: 
Intracorporeal VADs Extracorporeal VADs 
HeartMate I Thoratec  PVAD 
HeartMate II Berlin Heart EXCOR 
HeartMate III MEDOS HIA-VAD 
Berlin Heart Incor Abiomed Biventricular Support 5000 
Thoratec Implantable VAD (IVAD) Abiomed AB 5000 
PediaFlow Penn State PVAD 
Micromed DeBakey VAD Child/ Heart Assist 
5 
Levitronix CentriMag Blood Pumping 
System 
Infant and Child Size Jarvik 2000 VAD Levitronix  PediVAS 
PediPump Tandem Heart 
Toddler VAD Pediatric pVAD 
CorAide Pediatric Cardiac Assist System pCAS 
Levacor VAD Cardio Flow PQ 
CircuLite Micro VAD Toyobo NCVC LVAS 
Dura Heart Tiny Pump 
VentrAssist  
Novacor LVAS  
Heart Ware Ventricular Assist Device HVAD  
Abiomed Impella cVAD  
Table 1.4 Intracorporeal and Extracorporeal VADs 
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 Continuous Flow and Pulsatile Flow 
Pulsatile flow or positive displacement pumps are the first generation VAD’s pumps. Pulsatile 
flow pumps are either pneumatically or electrically driven pumps. Pneumatic pumps need an 
external compressed air source to push the diaphragm, while the electrical pumps have an 
electrical motor to drive the pusher plate (Huang, Yang et al. 2013). Those pumps are 
enormous, which make them unsuitable for small patient sizes. They need a large vent line 
for the pusher plate chamber, which increases the risk of infection. On the other hand, this 
type of pump has a simple control system and can be adjusted very easily to accommodate 
the patient’s need for everyday activities (Fukamachi and Smedira 2005).    
The vast majority of VADs available for paediatric patients are continuous flow pumps; there 
are two types as previously described, the axial pumps and the centrifugal pumps. Both axial 
and centrifugal pumps have almost the same design; a rotor impeller is generating the flow. 
In the axial flow, the impeller is in the same line of the inflow and outflow tubes, whereas in 
the centrifugal pump the inflow cannula is in the top of the pump and the outflow one is 
coming from the side of the pump. Centrifugal pumps have the advantage of less ventricular 
suction which reduces the risk of left ventricular collapse(Fukamachi and Smedira 2005).  
In general, continuous flow pumps have the following benefits: small, quiet, no need for 
valves, no need for vent lines, a thin driveline or percutaneous cable, and very low power 
consumption. The very complicated control mechanism, inability to respond to the flow rate 
needed by the patient and the unknown outcomes of non-pulsatile flow are the main 
disadvantages of continuous flow pumps(Fukamachi and Smedira 2005). In another study, 
patients with continuous flow pumps showed lower Pulmonary Artery Pressure (PAP) than 
the patients with pulsatile flow pumps (Ozturk, Engin et al. 2013). 
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Continuous flow and pulsatile flow VADs are listed in Table 1.5 below: 
Continuous Blood Flow VADs Pulsatile Blood Flow VADs 
HeartMate II HeartMate I 
HeartMate II Thoratec  PVAD 
Berlin Heart Incor Berlin Heart EXCOR 
PediaFlow MEDOS HIA-VAD 
Micromed DeBakey VAD Child/ Heart 
Assist 5 
Abiomed Biventricular Support 5000 
Levitronix CentriMag Blood Pumping 
System 
Abiomed AB 5000 
Infant and Child Size Jarvik 2000 VAD Thoratec Implantable VAD (IVAD) 
Levitronix  PediVAS Penn State PVAD 
PediPump Novacor LVAS 
Tandem Heart Toyobo NCVC LVAS 
Toddler VAD Paediatric Cardiac Assist System pCAS 
Paediatric pVAD Cardio Flow PQ 
Abiomed Impella cVAD  
Heart Ware Ventricular Assist Device 
HVAD 
 
VentrAssist  
Dura Heart  
Tiny Pump  
CircuLite Micro VAD  
Levacor VAD  
CorAide  
Table 1.5 Continuous Flow and Pulsatile Flow VADs 
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 VAD Limitations for Children 
 Size 
The anatomical space available for VAD implantation in paediatric patients is one of the 
greatest challenges. Firstly, this area is tiny at the time of birth, so the VAD should be a 
miniature pump that can fit into this small volume. Secondly, this small space is not fixed in 
size. The infant will start to grow up and the previous miniature pump will not be suitable, 
and VAD replacement surgery is associated with high risk of mortality.  Therefore, a miniature 
modular system could be the best possible solution for paediatric patients. 
 Power 
All implantable paediatric VADs, which are available now, need power to run the pump; this 
power is provided by rechargeable batteries connected to the pump through a percutaneous 
cable. This cable is associated with a high risk of infection and limits the ability of the patients 
to move and practice their usual daily activities (Schima, Stoiber et al. 2013). One elegant 
solution to VAD power is to receive power inductively from an external power source and 
store it in a battery inside the body or ideally to generate its power from a source inside the 
patient’s body. 
 Mechanism of Control 
The most advanced generation of VAD’s is based on continuous blood flow design, using 
either axial flow or centrifugal pumps. In both cases, blood flow is not measured directly but 
is estimated from the operating parameters of the pump, such as the pump speed and 
pressure drop. The absence of this kind of blood flow monitor makes the control of the pump 
very complicated, especially when the body requires various amounts of cardiac output due 
to the different daily activities. The available techniques are expensive and very complex, and 
only a few VADs have a flow probe to measure the exact blood flow, and very few VADs have 
the ability to remotely monitor the patients (Pektok, Demirozu et al. 2013). Therefore, a 
secure, remote, cheap and accurate technique is required to monitor the blood flow and to 
control the pump performance.      
 Haemocompatibility and Infections 
Infection is a clinically adverse effect associated with the patient with VADs. This could 
happen for several reasons, such as reduced immune response caused by the damage of 
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leukocytes during VAD support (Chan, Hilton et al. 2013). The blood contacting side of the 
VAD is made of artificial materials, which are considered as foreign material for the blood 
cells. This will increase the risk of bleeding when patients are taking anticoagulation (Pieri, 
Agracheva et al. 2014), or in other cases thrombus formation (Capoccia, Bowles et al. 2013, 
Egger, Maas et al. 2013). 
 Price 
The cost of implanting a paediatric VAD is around $150,000 including the surgery and hospital 
accommodation. This huge sum of money is due to the expensive extra costs in developing 
and manufacturing paediatric VADs, but is also due to the small quantity of paediatric patients 
compared with the adults. A novel affordable material could be the possible solution to 
overcome this problem (Mulloy, Bhamidipati et al. 2013). 
 The Ideal VAD for Paediatric Applications 
The primary purpose of current VAD research is to develop a fully implantable independent 
that fulfils the following criteria: 
 Durable: this VAD should stay for the whole life with the patient. 
 Reliable: since the device is implanted inside the patient’s chest, there should be 
minimal chance of any type mechanical failure. 
 Adequate flow: VAD should provide enough cardiac output to keep organs functioning 
perfectly.  
 Quiet: VAD should be completely silent while running.  
 Small and lightweight: since this VAD is designed for small children, size and weight 
are the major parameters, which should be noticed carefully. 
 Modular system: the system should be capable of providing cardiac support across a 
wide range of patient sizes, ranging from neonates to young adults. 
 Immunologically inert: should not cause any type of immunological complications, 
which may affect other organs.  
 Resistant to infection:  should be totally sterile. 
 Resistant to thrombosis: thrombus formation is very dangerous and could cause 
problems for other organs. 
 No need for anticoagulation: no bleeding problems in future.  
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 Fully implantable: no need for a percutaneous power cable or vent line. 
 No external power source: no need to carry sets of batteries all the time, the new 
power supply could be inside the body. 
 Easy to operate: easy in implantation, does not need complicated equipment in 
implanting or running. 
 Cost effective and affordable: all patients could afford it, by using cheap materials. 
 Forgettable: patient should not notice that he/she is connected to a VAD. 
 Future VADs 
 Minimally Invasive VAD 
The improved technologies in developing new VADs have made it possible to reduce the size 
of the current VADs compared with the first generation ones. These developments result in 
the possibility of using minimally invasive surgeries for the implantation, explantation, and 
exchange of VADs. Minimally invasive surgeries reduce the risk of postoperative 
complications after full sternotomy, such as bleeding, sternal instability, wound infections, 
and right heart failure (Rojas, Avsar et al. 2015).  
 Integrated Power Source for VAD 
All implantable VADs have an external power source system placed outside the patient’s 
body, connected with the implantable pump through a small percutaneous cable. This 
technique has solved some problems but not all of them, with infection remaining the primary 
cause of morbidity and mortality for patients with implantable VADs. The restriction of 
movement with this type of power system prohibits some activities, such as swimming 
(Trumble 2011). Therefore, there is a need to look for an integrated power source, which 
either can be totally implanted inside the patient’s body, such as nuclear power, or can be 
generated inside the body from the muscles or the metabolic activities. 
 Muscle Power Source 
Using muscle to produce power is one of the earliest methods used to generate power inside 
the human body. Several muscles have been studied for this cause; the most appropriate 
muscle for generating power is the Latissimus Dorsi (LD). This muscle is moving continuously 
with breathing, so it is considered as the non-stopping muscle. A unique device called Muscle 
Energy Converter (MEC) is connected with the muscle and used to convert the contractile 
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energy of the muscle into hydraulic power. This type of integrated power source VAD is called 
Muscle Powered Cardiac Assist Device (MCAD). Muscle power was found to be able to 
produce energy up to 1.37 J, which is enough to run a VAD at a 60 BPM heart rate or below 
(Trumble, Melvin et al. 2008, Trumble 2011). The diaphragm could also be used to generate 
power during breathing. The flat sheet of transducers can be placed on the diaphragm, and 
its continuous movement could be converted to an electric current that can run the VAD. A 
similar approach is the use of a Skeletal Muscle Ventricle (SMV), which can be configured to 
assist the heart by filling during systole phase, and ejecting during diastole phase. The method 
provides counterpulsation support same as Intra Aortic Balloon Pump (IABP) (Ramnarine, 
Capoccia et al. 2006). 
 Piezoelectric Source 
Piezoelectric crystals are used to convert the mechanical power to electrical power, or vice 
versa. This technique is very well known in the medical field especially for ultrasound and 
physiotherapy. Stress applied on the moving bones can be implemented to a piezoelectric 
crystal to generate electric power. This requires the continuous moving of the bones, which 
is not achieved during sleeping or resting. This source could be used to partially power the 
VAD (Ming, Zhu et al. 2005, Lewandowski, Kilgore et al. 2009). 
 Thermal Gradient Source 
The thermal gradient between the internal body temperature and the surface temperature 
could also be a possible source of electric power. This power source has been used previously 
to power a wristwatch. The main problem with this type is that the thermal gradient is not 
stable. This changes between summer and winter and it is suitable just for cold countries not 
for hot countries (Lewandowski, Kilgore et al. 2009).  
 Internal Fuel (metabolic) Source 
The primary source of energy for all muscles is glucose, where the body is using this substance 
to store the energy (Martini F. 2011). This source can be used to generate power by using 
special sensors inside the body. This will require the patients to be more careful about their 
diet. More studies are needed to focus on this technique and decide if this source is sufficient 
to run an implantable blood pump.  
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 Nuclear Power Source 
Nuclear power is a small, continuous, durable, and clean source of energy. On the other hand, 
it needs continuous cooling and a thick housing for shielding, which make it hefty and not 
suitable for portable applications. Some early studies used nuclear power to operate a total 
artificial heart and failed for the earlier reasons.  A small, lightweight, and self-cooled nuclear 
reactor could be the future option for implantable devices.   
 Soft Robotic Sleeve Supports Heart Function 
Soft robotics are constructed from a combination of elastomers, fibres, and other filler 
materials, which make them suitable for human interaction. By combining the soft robotics 
design with a simple controlling mechanism, they can achieve complex motions, mimicking 
the motion of the heart. (Roche, Horvath et al. 2017) Reported creating an implantable soft 
robotic sleeve to provide circulatory support for a patient with a failing heart. This design is 
implanted around the heart, offering support for the cardiac muscle instead of replacing it, 
without getting in contact with the blood, which will eliminate the risk of blood clotting or 
infection.  
This robot mimics the motion of the cardiac muscle by providing twisting and compression 
motions as shown in Figure 1.18. An ECG signal or pacemaker from the patient’s heart is used 
to trigger the soft Pneumatic Artificial Muscles (PAM). During systolic phase, PAMs will be 
pressurised causing them to contract. While in the diastolic phase, they will be decompressed 
causing them to extend. The device monitors and records heart rate, pulmonary artery 
pressure, flow rate, and ascending aortic pressure. Ecoflex 00-30 silicone is used to fabricate 
the soft robotic actuators because of their large strains and elastic modulus values, which are 
very close to the heart muscle. A hydrogel cushion between the device and the heart is used 
to reduce friction and minimise inflammation. 
 
Figure 1.18 Soft Robotic Sleeve (Roche, Horvath et al. 2017) 
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In vitro, the device was tested using a simplified synthetic silicone heart, showing 68 ml 
volumetric displacement under twisting motion, and 84 ml under circumferential. The next 
stage of testing was in vivo, where it was implanted inside a pig with a heart failure.  The soft 
robotic showed 88% restoration of cardiac output when 21 PSI pressure was applied at 80 
BPM for 200 mSec per cycle. The device is still under improvement, and there are still many 
aspects of developing, such as biocompatibility, long-term mechanical properties, controlling, 
sensors, and miniaturising the system.  
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Chapter 2 
Device Concept 
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 Device Concept 
 Introduction 
This chapter explains the theory behind the device concept, starting with objectives of the 
proposed device, and its concept. Then, explaining in details the theory of Artificial Muscles, 
their properties, types, limitations, and applications. Finally, this chapter will detail the three 
proposed solutions and the hypothesis.  
 Objectives 
This thesis will explain the process of the development of a Ventricular Assist Device using 
Electro Active Polymers for paediatric use.  
The objectives of this project are: 
 Review the IPMC actuators and decide which one is suitable for creating a VAD. 
 Make IPMC materials in the lab.  
 Test the mechanical properties of the IPMC. 
 Test the electrical properties of IPMC. 
 Verify the ability of IPMC to generate electricity. 
 Design and build a VAD made from IPMC. 
 Test the performance of the VAD. 
 Concept 
The new proposed device is based on the idea of creating a thin elastic membrane around the 
heart, which is custom formed to match the epicardium shape of the heart for each patient. 
This proposed device will completely envelop the heart, without any direct contact with the 
patient’s blood, generating a compression force to support the failing heart. This device will 
be powered by an internal power source inside the patient’s body. 
 Artificial Muscle 
Actuators that are responsive to an external stimulus and have several characteristics in 
common with natural muscles are called Artificial Muscles. Their ability to generate motions 
is used in many application, such as mechatronics, robotics, automation, biomedical 
engineering, haptics, biotechnology, fluidics, optics, and acoustics (Carpi, Kornbluh et al. 
2011).    
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 History of the Material 
Polymeric materials have many attractive properties, such as lightweight, easy to 
manufacture, cheap, fracture tolerance, thin, can take different shapes, soft, and pliable. 
These features make polymeric materials suitable for various applications (Bar-Cohen 2004, 
Biddiss and Chau 2006, Madden 2006).  
Since the early discovery of polymeric materials, it has been known that certain types of 
polymers could change shape in response to an external stimulant, inducing a slight strain. 
The early discovery of this reaction could be tracked back to 1880 when Roentgen conducted 
an experiment on a strip of natural rubber (Roentgen 1880). Roentgen recognised the volume 
change of the dielectric material when an electric field is applied.  
Polymeric materials were considered as passive materials, but later on, more stimulus 
methods were applied and tested. Polymeric materials could be stimulated using electrical, 
chemical, thermal, pneumatic or magnetic stimulations. This discovery changes the face of 
polymeric materials from passive elements into smart structures that could be utilised in 
many applications such as actuation and sensing (Bar-Cohen 2004, Mirfakhrai, Madden et al. 
2007).   
Further studies and tests were carried on these polymer sheets; the main focus was to 
investigate the response of these sheets to an electrical stimulus. From the beginning of the 
1990s, these polymer sheets were found to be able to change their shape and size if an electric 
current is applied, they can induce strains exceeding 100%. On the other hand, if a mechanical 
deformation is applied then they can produce an electrical output. This type of material is 
called Electro-Active Polymer (EAP). EAP is the material that undergoes shape change in 
response to electric stimulation and acts rather like natural muscles (Sareh and Rossiter 
2013). Polymers responding to electric fields, and reactive (faradic) conducting polymers are 
collectively known as electroactive polymers since annual SPIE conferences in 1999 (Otero, 
Martinez et al. 2012). 
Those properties attracted the scientists to study them and discover more about EAP. Since 
EAP was very close to human muscles, they were called Artificial Muscles. EAP can be used in 
many fields such as biomimetic, robotics and other biomedical applications (Bar-Cohen 2004, 
Bar-Cohen and Zhang 2008).  
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 Biological Muscles 
To understand and model EAP properly, we need to compare it with natural human muscles. 
Natural muscles are biological organs that have been developed to transform chemical energy 
into mechanical energy and heat (Otero, Martinez et al. 2012). They are made from a series 
of muscle cells that are specialised for contraction. Biological muscles can be divided into 
three main categories; skeletal muscles, cardiac muscles, and smooth muscles. Skeletal 
muscles are organs made from skeletal muscle tissues, connective tissues, nerves, and blood 
vessels. Their main task is to move our bodies by pulling bones, based on a controlling nerve 
signal, making it possible for humans to walk. Cardiovascular muscles are found in the heart; 
their job is to push the blood into the cardiovascular system. While the smooth muscles are 
found in the digestive system, their job is to push food into the digestive tract and regulate 
the diameter of small arteries (Martini F. 2011).   
Muscle cells are composed of a series of fascicles (bundles of fibres) covered by a dense 
collagen layer called epimysium. These bundles are separated by connective tissues fibres 
called the perimysium. Each bundle is made of a series of cylindrical shape muscle fibres, or 
muscle cells. Each muscular cell measures between 10 and 100 µm in diameter, and a few cm 
lengthwise, as shown in Figure 2.1. Human muscles are designed to change length; extend 
and contract. The movement mechanism is driven by a reversible hydrogen bonding between 
two proteins; actin and myosin. These muscles can produce a huge lifting force in a concise 
period (Martini F. 2011). 
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Figure 2.1 The organisation of skeletal muscle (Martini F. 2011) 
 Non-Electrically Deformable Polymers 
Polymers can be activated by different kinds of stimulus, other than an electric field. They 
have the ability to memorise a shape or deformation and to return to their original shape 
when appropriately stimulated. This stimulus could be chemical, photovoltaic, or thermal 
changes in the surrounding environment of the polymers, which will trigger a response in the 
polymeric materials and cause them to change their shape or properties (Rossiter, Takashima 
et al. 2012).  
 Chemically Activated Polymers 
Chemo-mechanical behaviour in polymers can be traced back in the late 1940s when 
(Katchalsky 1949) discovered a contractile polymeric gel. Certain polymers are very sensitive 
to the pH level in their solution, and they can expand or contract in response to the change 
of the pH. Increasing the acidity level of the solution will cause the polymer gel to contract 
because of the increase of the hydrogen ion concentration. While in alkaline solutions, the 
polymer gel will expand due to the decrease of the hydrogen ions (Bar-Cohen 2004).  
65 
 
 Light Activated Polymers 
Researchers in polymers that respond to change in the light density reported in the 1970s.  
(Aviram 1978) Indicated that a polymeric gel made of poly (N, N-dimethyl glutamanilide) could 
expand up to 35% under UV illumination (Bar-Cohen 2004).  
 Magnetically Activated Polymers 
Magnetically activated polymeric gels, which are also called ferrogels, are chemically cross-
linked polymer networks. These gels will swell under the effect of a magnetic field due to the 
movement of their particles in the direction of the magnetic field (Bar-Cohen 2004).  
 Thermally Activated Polymers 
It has been proven that heat is the most widely used stimulus in environmental polymer 
actuator systems, as it can be applied directly and efficiently on materials without energy 
conversion. Certain polymer gels response to the change in the temperature by changing their 
volume (Hu and Chen 2011). Hirokawa and Tanaka first reported this experiment in 1984 
(Hirokawa, Tanaka et al. 1984). The gels went through a phase transition in the range of 20oC 
to 40oC, causing the gel to contract and produce a force up to 100 kPa in a very short period 
of 20-90 Sec (Bar-Cohen 2004). 
 Properties of EAPs 
EAP can generate more than 300% strain, which is much higher than the rigid, fragile 
Electroactive Ceramics (EAC). Compared with Shape Memory Alloy (SMA), EAP has a higher 
response time, lower density, and better resilience. Also, EAP consumes less power than the 
other rivals do. On the other hand, EAP has limitations in mechanical force and robustness 
compared with SMA and EAC (Yambe, Amae et al. 2001, Bar-Cohen 2004). 
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Table 2.1 shows a comparison between EAP, SMA, and EAC.  
Property EAP SMA EAC 
Actuation strain Over 300% <8% short fatigue 
life 
Typically 0.1-0.3% 
Force (MPa) 0.1-40 200 30-40 
Reaction Speed µsec to min msec to min µsec to sec 
Density 1-2.5 g/cc 5-6 g/cc 6-8 g/cc 
Drive Voltage 1-7 v for ionic EAP 
and 10-150 v/µm for 
electric EAP 
5 V 50-800 V 
Consumed Power m-watt watt watt 
Fracture Behaviour Resilient, elastic Resilient, elastic Fragile 
Table 2.1 Comparison between EAP, SMA and EAC (Bar-Cohen 2004) 
EAPs, are resilient, fracture tolerant, noiseless actuators that can be made miniature, low 
mass, inexpensive and consume low power. Many characteristics of soft EAPs including 
pliability, scalability, low weight, silent operation and relatively large actuation strain, make 
them well suited for robotic applications (Sareh and Rossiter 2013).  
 Types of EAPs 
EAP can be divided into two main groups based on the type of electrical stimulation: Electric 
and Ionic. Electric EAP includes Ferroelectric, Electrostrictive Graft, and Liquid Crystalline 
polymers. The electric field (Coulomb Force) drives this group, they require a high voltage 
>150 V/µm close to the breakdown level, and they can hold their displacement under a DC 
voltage (Bar-Cohen, Bao et al. 2002). Ionic EAP includes Gels, Polymeric Metal Composites, 
Conductive Polymers, Carbon Nanotubes. These polymers are driven by the mobility or 
diffusion of ions, they require a low driving voltage as 1-5 V. However, they need to be kept 
wet, and it is challenging to maintain their displacement under a DC voltage (De Luca, 
Digiamberardino et al. 2013).  
 Electric EAPs 
Electric EAPs are driven by an electric field, or a Coulomb Force, also known as dry EAP or field 
activated EAP. This type has several advantages, such as holding the induced displacement 
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under activation of a DC voltage, achieving high actuation strains and stresses, fast response, 
and has a long lifetime (Carpi, Kornbluh et al. 2011). Also, this type has a greater mechanical 
energy density, and they can be operated in air with no major constraints. On the other hand, 
they require a high activation field, typically up to the order of 100 V/µm (Bar-Cohen 2004, 
De Luca, Digiamberardino et al. 2013).  
Table 2.2 shows the advantages and disadvantages of the Electric EAP:  
Advantages Disadvantages 
 Exhibits high mechanical energy 
density. 
 Induces relatively large actuation 
forces. 
 Can operate for a long time in room 
conditions. 
 Exhibits rapid response (mSec) 
 Can hold strain under DC Activation. 
 Independent of the voltage polarity, 
it produces mostly monopolar 
actuation due to associated 
electrostriction effect. 
 Requires high voltages (~100 MV/m). 
Recent development allowed for a 
fraction of the field in the 
Ferroelectric EAP. 
Table 2.2 Advantages and Disadvantages of Electric EAP (Bar-Cohen 2004) 
Electric EAPs are listed below: 
 Ferroelectric Polymers 
Piezoelectric effects were discovered in 1880 by Pierre and Paul-Jacques Curie when they 
found that applying a force at certain axes on a certain crystal a voltage could be recorded on 
the surface of the crystal. On the other hand, if an electric current is applied to these crystals, 
then they will sustain an elongation (Madden, Vandesteeg et al. 2004). 
This phenomenon is called Ferroelectricity and is found in non-centre symmetric materials 
only. In other words, Ferroelectrics are non-conducting crystals or dielectric materials that 
exhibit a spontaneous electric polarisation (Bar-Cohen 2004). These polymers have a high 
Young’s modulus in the range of 1-10 GPa, which makes them offer high mechanical energy 
density. On the other hand, these polymers need a high-applied AC field (~200 MV/m) which 
can be very dangerous, and it is very close to the dielectric breakdown (Bauer, Fousson et al. 
2002, Bar-Cohen 2004). 
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 Electrets 
Electrets are the materials that retain their electrical polarisation after being subjected to a 
strong electrical field. The positive charges within the materials will be permanently oriented 
alongside the electric field, while the negative charges will be oriented on the opposite side. 
These electrets can be made from polymers, ceramics, or wax, where the molecules will be 
randomly distributed at the beginning, and then an electric field is applied which will cause 
the molecules to hold a permanent polarisation(Bar-Cohen 2004, Marchese, Katzschmann et 
al. 2015). 
  Dielectric Elastomers (DEs) 
Dielectric Elastomers are a particular class of non-conductive rubber-like solids that have a 
low elastic stiffness and dielectric constants; they were first developed in the early 1990s 
(Vertechy, Frisoli et al. 2012, Carpi, Anderson et al. 2015). These Dielectric Elastomers can 
produce a large actuation strain under the effect of an electrostatic field (Bar-Cohen 2004, 
Brochu and Pei 2010). Because of their performance, simplicity, and easy availability, the 
interest in developing DEs has continued to grow, which makes them suitable for a range of 
applications from haptic devices to energy harvesting (McKay, O’Brien et al. 2010, Wang, Cai 
et al. 2012). 
 Electrostrictive Graft Polymers 
First developed in NASA Langley Research Centre in 1998, which shows a considerable strain 
when subjected to an electric field. This material consists of two components; a flexible 
backbone macromolecule, and a grafted polymer that forms a crystalline structure. The main 
advantage is the ability to produce a relatively high electromechanical power density, and 
high processability (Cheng, Xu et al. 2002, Bar-Cohen 2004). 
 Electrostrictive Papers 
Papers are made from a group of fibres that are connected with each other to make a single 
sheet. This passive sheet of paper could be converted into a smart material if it could be 
combined with electroactive properties. Such as EAP has been produced by (Kim and Seo 
2002) where two silver laminated sheets of paper were bonded with a silver electrode placed 
on the outside surface. Upon applying a voltage to the electrode surface, the paper produced 
a bending motion, depending on the level of voltage applied, the frequency, and the shape of 
69 
 
the voltage wave. This new material has many applications, such as active sound absorbing 
material, flexible speakers, and smart shape control devices (Bar-Cohen 2004).  
 Liquid Crystal Elastomer (LCE) Materials 
These materials were first developed at Albert-Ludwigs University in Germany. They have the 
properties of piezoelectric materials and can be activated by inducing Joule heating 
(Finkelmann, Kock et al. 1981). The actuation procedure of the material requires phase 
change between nematic and isotropic phase during a very short period, in less than a second. 
The reverse process takes a long time, around 10 seconds, and requires cooling for the 
material to expand to its initial shape.  The mechanical properties of the LCE can be controlled 
by the liquid crystalline phase selection, density of crosslinking, the flexibility of the polymer 
backbone, the coupling between the backbone and liquid crystal group, and the external 
stimuli. The main advantage of the LCE lies in its uniaxial response to an external activation, 
such as temperature, light or electric fields (Bar-Cohen 2004, Madden, Vandesteeg et al. 
2004). 
 Ionic EAPs 
Ionic EAPs (Gels, Polymer Metal Composites, Conductive Polymers, and Carbon Nanotubes) 
involve mobility or diffusion of ions. This type is driven by diffusion of ions, and they require 
an electrolyte for the actuation mechanism. The main advantage is that they require low 
voltage for activation around 1-2 Volts (Carpi, Kornbluh et al. 2011). On the other hand, they 
are slower and produce smaller energy density compared with Electric (De Luca, 
Digiamberardino et al. 2013).   
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Table 2.3 shows the advantages and disadvantages of Ionic EAP:  
Advantages Disadvantages 
 Natural bi-directional actuation that 
depends on the voltage polarity. 
 Some ionic EAP like Conducting 
Polymers have a unique capability of 
biostability. 
 Requires low voltage. 
 Requires using an electrolyte. 
 Electrolysis occurs in aqueous 
systems at >1.23 V. 
 Require encapsulation or 
protective layer to operate in open 
air conditions. 
 Low electromechanical coupling 
efficiency. 
 Except for CPs and NTs, ionic EAPs 
do not hold strain under DC voltage. 
 Slow response (fraction of a 
second). 
 Bending EAPs induce a relatively 
low actuation force. 
 High currents require rare earth 
electrodes such as gold or platinum. 
 Except for CPs, it is difficult to 
produce a consistent material 
(particularly IPMC). 
Table 2.3 Advantages and disadvantages of Ionic EAP (Bar-Cohen 2004) 
 Ionic Polymeric Gels (IPG) 
Ionic Polymeric Gels are crosslinked polymers, that have been developed in the late 1980s 
and early 1990s in the USA, Japan, and Italy (Carpi, Kornbluh et al. 2011). These polymeric 
gels are activated by changing the environmental parameters, such as temperature, or pH 
level. They will swell in alkaline solutions and get denser in acidic solutions. This change in the 
pH level can be controlled electrically, which will make IPG behave and look like Artificial 
Muscles. They can produce a strong actuation force that could match the force generated 
from a biological muscle (Schreyer, Gebhart et al. 2000, Bar-Cohen 2004, Choe, Kim et al. 
2006).  
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During activation, the IPG will bend, as the cathode side becomes more alkaline, while the 
anode side becomes more acidic. This movement happens as a result of ion diffusion through 
the multilayered gel, which means the response will be very slow. For example, expanding 
and shrinking an IPG from 6x6 to 3x3 occurred over a period of 20 minutes, which make these 
gels very slow for many functions and far away from practical applications. Besides that, the 
large actuation caused the electrodes to damage, which results in a failure of the actuator 
after 2 or 3 cycles (Schreyer, Gebhart et al. 2000, Bar-Cohen 2004). 
 Conductive Polymers (CP) 
Conductive Polymers are made from two layers of polymers, such as polypyrrole or 
polyaniline, with an electrolyte in between them. The actuation mechanism functions via the 
revisable counter-on insertion and expulsion during redox cycling. When a voltage is applied 
to both polymers, oxidation occurs at the anode side, and reduction occurs at the cathode 
side. This will cause the H+ ions to move from the anode to the cathode through the 
electrolyte to balance the electric charge that is applied. The increased concentration of H+ 
ions will cause the cathode to swell, while the decreased concentration of H+ will cause the 
anode side to shrink. This will result in the CP sandwich bending towards the anode side. The 
thickness of the polymers plays an important role in controlling the speed of actuation; the 
thinner the layers, the faster the response, but on the other hand, the CP will produce lower 
force. The CP requires low voltage to be activated (in the range of 1-5 V), speed and force 
density both increase with increasing the voltage (Bar-Cohen 2004, Madden, Vandesteeg et 
al. 2004, Fang, Tan et al. 2008). 
 Carbon NanoTube (CNT) 
(Baughman, Cui et al. 1999) First introduces Carbon Nanotubes with diamondlike mechanical 
properties as a form of EAP in 1999. The carbon- carbon bond between the carbon atoms are 
suspended in the electrolyte, and the change in the bond length is responsible for the 
actuation mechanism. The electrolytes form an electric double layer surrounding the carbon 
nanotubes and play a major role in injecting significant charges that affect the balance of the 
carbon-carbon bonds and cause these bonds to change their length. These small changes in 
carbon-carbon bond levels are rendered into macroscopic movements and results in CNT 
extensions (Bar-Cohen 2004, Kosidlo, Omastova et al. 2013). The CNT can produce a higher 
mechanical stress and a higher work per cycle than any other previous EAP. Since carbon 
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offers a high thermal stability, CNT can be used in applications at a high temperature that 
could reach up to 1000oC. The main disadvantages facing CNT are the high production cost 
and the difficulty in mass production (Bar-Cohen 2004, Hu, Chen et al. 2010). 
 Electrorheological Fluids (ERF) 
Electrorheological Fluids experience a large change in their viscosity levels when subjected to 
electricity. These fluids are made from two components; a suspension base fluid and small 
particles size 0.1-100 µm. Winslow first reported ERF in 1949, and the electrorheological 
effect is called the Winslow effect (Winslow 1949). The change in ERF viscosity is believed to 
happen because of the difference in dielectric constant between the base fluid and the 
particles. When an electric field is applied, the particles will form a chain in the same direction 
of the field because of the dipole moment. This chain will change the properties of the ERF, 
such as the viscosity and the yield stress, allowing the ERF to change its appearance from a 
liquid state into a more viscoelastic like a gel. The response time is very short between these 
two states, in the range of milliseconds. These properties make the ERF suitable for many 
hydraulic applications, such as shock absorber, active damper clutches, adaptive gripping 
devices, and variable flow pumps (Bar-Cohen 2004, Glaser, Caccese et al. 2011, Must, Vunder 
et al. 2014). 
 Ionic Polymer Metal Composites (IPMC) 
IPMC is an EAP that bends in response to an electric stimulus, because of the movement of 
the cations in the polymer network. They were first reported in the early 90s when different 
groups of researchers in Japan and the United States started testing the electroactive 
characteristics of the IPMC (Bar-Cohen 2004, De Luca, Digiamberardino et al. 2013).  
IPMC is the product of combining ionic polymer with a conductive medium such as a metal. It 
can produce a significant mechanical deformation when an electric current is applied; it has 
been reported that IPMC could generate a blocking force in the range 1 mN/V to 10 mN/V 
(De Luca, Digiamberardino et al. 2013). As well, it can produce an electrical output when a 
dynamic mechanical deformation is applied. It can be used both as an actuator and as a sensor 
at the same time (Shahinpoor and Kim 2001, Kruusamäe, Brunetto et al. 2011). IPMC can 
generally produce a bending motion towards one side. Recently, some new techniques can 
produce more complexed deformations, where different sections of IPMC are controlled 
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separately to produce such a complicated motion (Chen and Tan 2010, Riddle, Jung et al. 
2010, Feng and Liu 2014).  
There are several types of polymer base used to make IPMC; the most famous ones are Nafion 
(perfluorosulfonate, made by DuPont), and Felmion (perfluorocarboxylate, made by Asahi 
Glass, Japan). Both membranes provide channels for the movement of the positive ions when 
the voltage is applied, which will result in the bending action (Shahinpoor 2003, Bar-Cohen 
2004). Figure 2.2 shows a schematic structure of IPMC.  
 
Figure 2.2 Schematic Diagram of IPMC (De Luca, Digiamberardino et al. 2013) 
IPMC displacement depends on the chemical composition and structure of the backbone of 
ionic membrane. The morphology of the metal electrodes, the nature of the cations, the level 
of hydration (Nemat-Nasser 2002, Kikuchi, Sakamoto et al. 2011), and the surrounding 
environmental conditions affect the actuation performance of the  IPMC (Punning, Must et 
al. 2015). The movement of water molecules inside the membrane matrix is believed to be 
the main driver of the actuation mechanism, where water appears on the surface of the 
expansion side and disappears on the surface of the contraction side. The electrophoresis -
like internal ion- water movement is responsible for creating effective strain for actuation. 
Water leakage through the porous platinum electrode reduces the electromechanical 
conversion efficiency, similar to a leaky hydraulic jack (Shahinpoor and Kim 2001, Kim and 
Shahinpoor 2003, Park, Kim et al. 2010).  Figure 2.3 shows an explanation of how IPMC 
actuates.     
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Figure 2.3  Schematic diagram of how IPMC actuates (Shahinpoor and Kim 2001) 
Manufacturing of an IPMC starts with an ionic polymer with ion exchanging capability, which 
is then chemically treated with an ionic salt solution of a metal (gold, platinum, palladium, or 
others) and then chemically reduced to yield ionic polymer metal composites (Shahinpoor 
and Kim 2001, Shahinpoor 2005). The type of metal used in making IPMC will play an 
important role in the electromechanical properties of the IPMC actuator.  IPMC requires low 
voltage to be active, in the range of 1-10 V, as shown in Figure 2.4. Previous tests found that 
IPMC will provide a large actuation at low frequencies lower than 1 Hz, and their response 
will decrease by increasing the frequency (Bar-Cohen 2004, Brufau-Penella, Puig-Vidal et al. 
2007).    
 
Figure 2.4 Deformation of IPMC strip ( 10x 80x0.34 mm) under 4 V DC (Shahinpoor 2010) 
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IPMC advantages can be summarised as the following (Lumia and Shahinpoor 2008): 
 Low actuating voltage. 
 Flexible and compliant material (Young’s Modulus 200 MPa). 
 It can be cut to micro size without loss in actuation and sensing properties. 
 Fast response (microseconds to seconds). 
 Lightweight. 
 Ability to actuate at sub-zero temperatures (Paquette, Kim et al. 2005).  
 EAP Limitation 
 Mechanical Power Generated 
Mechanical power generated from EAP is linked to different factors, such as the thickness of 
the actuator, the voltage applied and the frequency. The surrounding environment also plays 
a major role in the EAP behaviour. Some EAP performs better in wet conditions, such as Ionic 
EAP.  
 Lifespan 
EAPs have different lifespans depending on the type and the applications. Electric EAP has a 
longer lifespan compared with Ionic, as the Ionic EAPs need to be hydrated to function 
properly.  
 Reaction Time 
Not all EAPs react at the same rate. The actuation mechanism of some EAPs depends on ion 
movement, which needs some time for the ion to move between the electrodes. Usually the 
reaction time is in the range of few seconds. This has a significant effect on the response time.  
 Cost 
EAPs are still in the development stage and at the moment only a handful of companies are 
producing them. They are not fully commercialised yet, as many types of EAPs are still under 
tests and developments at research centres. These make the materials difficult to source and 
very expensive to be used in many applications. 
 Fabrication Procedure 
EAPs are still in their early stage of research and development. This means EAPs are custom 
made, which will take a long time to order some samples from the current EAPs providers. 
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Some fabrication procedures might take weeks to reach the desired thickness of EAP. Also, 
any small mistake during this procedure will have an effect on the final product.   
 Applications of EAP 
Since the early discovery of EAPs, they have been used in many fields as actuators and 
sensors, from basic robotic applications to more advanced medical devices. Here are some of 
these applications: 
 Wearable Haptic Interface 
Body worn systems have been under investigation recently. They enable the possibility of 
monitoring people anywhere and anytime and provide feedback as well as to the person using 
them. Their applications vary from healthcare, well-being, lifestyle, protection, and safety. 
(De Rossi, Carpi et al. 2011, Carpi, Frediani et al. 2012) Developed a new textile integrated 
glove, which can provide sensing and feedback at the same time. This glove is made from two 
types of electroactive polymers; the actuator part is made from piezoresistive rubber, while 
the sensing part is made from a dielectric elastomer.  This glove will be able to monitor, 
classify hand gestures, and provide vibration feedback for the user.  
 Tunable Lens 
Different applications require the use of one lens with the ability to change focus, such as 
consumer electronics (cameras, mobile phones, and surveillance systems), medical devices 
(video endoscopy), and optical communication systems (optical fibre components) (Hanley, 
Gun'ko et al. 2014). Many techniques have been used to develop such a lens, where a lens 
made from smart material could respond to mechanical, electrical, thermal and chemical 
stimulation. (Carpi, Frediani et al. 2011) Reported the use of dielectric elastomer to create a 
tunable lens. This new lens is made of a fluid-filled elastomeric lens integrated with an annular 
elastomeric actuator working as artificial muscle-like the human eye, Figure 2.5 shows a 
comparison between the natural human eye and the new tunable lens. When electrically 
activated, the Artificial Muscle (elastomeric actuator) deforms the lens and changes the focal 
length resulting in changing the focus of the lens. This new design is small in size, light, silent, 
does not overheat, and has low power consumption (Carpi, Frediani et al. 2012).  
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Figure 2.5 Comparison between the human lens and the bio-inspired lens (Carpi, Frediani et al. 2011) 
 Braille Display 
Previously, piezoelectric ceramics were used in refreshable Braille display pages, where a 
group of actuators will push the Braille dots to create a word. The big size, the fragility of the 
piezoelectric ceramics, plus the high cost of the actuators make it very limited to develop a 
cheap and small refreshable Braille display system. One solution to this problem is the use of 
EAP instead of piezoelectric ceramics. (Ren, Liu et al. 2008) Reported using Ferroelectric EAP 
to create a refreshable Braille display. The design is shown in Figure 2.6, where the EAP 
actuators are connected to the Braille pins and pushed up based on a word to display. The 
new model is more compact, light, cheaper to manufacture, and able to produce a full page 
of refreshable Braille display.   
 
Figure 2.6 Schematic diagram of the proposed EAP Braille cell using the compact (Ren, Liu et al. 2008) 
 Robotic Micro-Gripper 
Micro-grippers can be found in many fields, such as handling small components precisely or 
moving fragile living cells. EAPs offer the best solution to create a gripper that can handle 
both rigid and flexible objects, and move them precisely to the required position (McDaid, Aw 
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et al. 2011). (Alici and Huynh 2006) Used conducting polymers to create a three fingers gripper 
(10x1x0.2 mm). The gripper was able to lift a 30 mg object under 1 V of activation as shown 
in Figure 2.7. The main drawback of this design was the low speed of response and 
nonlinearity of the actuation. (Deole, Lumia et al. 2008) Used IPMC as well to create a 
microgripper, finger size were 5x1x0.2 mm. This design was able to lift objects up to 16 mg.  
 
Figure 2.7 Conducting Polymer Gripper (Alici and Huynh 2006) 
To obtain a faster response (Lumia and Shahinpoor 2008), used IPMC to create their version 
of a two fingers micro-gripper, measuring 5x1x0.2 mm. The shape of the design has a large 
base leading to the micro-gripper finger. The large base was designed for a better electrical 
conductivity, which leads to a more powerful and faster response. This micro-gripper was able 
to lift a 15 mg solder ball under a 2V signal. (Jain, Datta et al. 2010, Jain, Datta et al. 2011) 
Also reported using IPMC to make a two fingers micro-gripper, 30x6x0.2 mm. The IPMC 
fingers were able to move 14 mm and creating a force of 10 mN, which make them able to lift 
a weight up to 10 mg. More advanced tasks can also be produced by a multi fingers IPMC 
micro-gripper, like moving objects in large surface areas and placing them accurately (Jain, 
Majumder et al. 2013, Jain, Datta et al. 2014)  
 Micropumps 
Micropumps are essential parts in any microfluidic system and lap on chip technologies. The 
need for a controlled micro flow of gases or liquids has led to the use of EAPs as a heart of 
micropumps (Simon, Jager et al. 2009, Santos, Lopes et al. 2010). (Nguyen, Goo et al. 2008) 
Used IPMC actuators in their flap valve micropump design. This design is based on a flexible 
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IPMC supported diaphragm as shown in Figure 2.8, which gave the actuator a large 
displacement and improve the pump performance. The pump was able to produce a 
760µl/min flow, and maximum back pressure of 1.5 kPa when a 3 V driving signal was applied 
at 3 Hz.  
 
Figure 2.8 The IPMC micropump with a flexible support design: (a) structure of the micropump with six stacked layers and (b) 
photograph of the fabricated micropump (Nguyen, Goo et al. 2008) 
 Jellyfish Robot 
Currently, many biomimetic robotics have the ability to move, fly, or walk based on motors. 
With the recent developments of EAPs, they could replace the motors and build an EAP-based 
robot. (Yeom and Oh 2009) Developed a new jellyfish robot based on using curved strips of 
Ionic Polymer Metal Composite. This study focused on making curved non-electric plating 
IPMC, building a Jellyfish robot, and then test this robot in water. The robot consists of 
Jellyfish legs, which are the IPMC actuators, and electrical connection components. Figure 2.9 
shows the final design of multi strips of IPMC connected in a shape of Jellyfish. This Jellyfish 
robot could travel upward with a velocity of 0.057 mm/s and 0.045 mm/s under 1 Hz and 2Hz 
signal respectively. The thrust force was also measured under the same frequencies, 0.87 gf 
and 0.544 gf respectively.  
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Figure 2.9 Jellyfish Robot (Yeom and Oh 2009) 
 Artificial Cilia 
A more advanced movement could also be produced by EAPs. (Sareh, Rossiter et al. 2012) 
Demonstrated how to build a cilium using IPMC and produce a very complexed actuating. In 
simple IPMC, the actuator bends towards the negative electrode producing a curved shape 
actuator, while a cilium produces a more complexed curvature with multiple curving points. 
In this study, a low voltage-based actuator was developed from IPMC to replicate the 
movement of a biological Cilium. Figure 2.10 shows the artificial IPMC cilium with its multiple 
twisting points; the arrows refer to the electrical contacts points. 
 
Figure 2.10 Artificial IPMC  Cilium (Sareh, Rossiter et al. 2012) 
81 
 
 Hand Prosthesis 
Recently, there have been lots of research on using robots for limbs rehabilitation, making 
assistive devices for arms, hands, and legs. Most of these devices are using heavy mechanical 
components, like motors with complicated electronics. However, these assistive devices are 
very bulky, heavy and expensive, which make them unsuitable for many situations. Therefore, 
Artificial Muscles could be used as the main actuator in these devices (Biddiss and Chau 2006, 
Jain, Datta et al. 2010, Jain, Datta et al. 2014). (Lee, Jung et al. 2006) Used IPMC Artificial 
Muscle to create an artificial hand prosthesis which was controlled by the human muscle 
signal Electromyography (EMG). Four strips of IPMC were made of different thickness 
between 178 µm and 800 µm and then placed on a holder similar to the hand’s shape. The 
EMG signal was receded from flexor carpi ulnaris and the extensor carpi ulnaris muscles, then 
used as a guide to change the driving voltage of the IPMC strips. Figure 2.11 shows the layout 
of the IPMC hand prosthesis and how it could move based on the hand movement. On the 
left side the hand is in none state, while the right side the hand is in flexion state. 
 
Figure 2.11 IPMC Hand Prosthesis (Lee, Jung et al. 2006) 
 Medical Devices 
There is a continuous need to improve new technologies for minimally invasive therapies, 
where tiny and accurate movements are necessary for robotic surgeries, or scanning 
endoscope (Yoon, Reinhall et al. 2007). The use of EAPs has increased recently in this field, 
due to their interesting properties. Conducting Polymers (CP) are perfect candidates, they can 
be used in various applications, such as micro-anastomosis connector, steerable guide wires 
and catheters, and balloon catheter (Jager 2013).  
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In teleoperation surgeries, the key parameter is how to measure the force applied on the 
object accurately, and how to gauge the softness of that object. IPMC is an excellent martial 
for this application, as it could be used for actuation and sensing at the same time. (Bonomo, 
Brunetto et al. 2008) Designed a new small tactile sensor that can measure the softness of an 
object. This design can be applied in both medical surgeries, and in aerospace as well. The 
prototype as shown in Figure 2.12 consists of two IPMC strips. The first one is the actuator, 
and the second one is the sensor. When sinusoidal voltage is applied to the actuator, it will 
vibrate, and it will push the sensor towards the object under testing. The sensor will deform 
and generate a voltage, which is reordered and then used to measure the object’s stiffness.  
 
 
Figure 2.12 IPMC Tactile Sensor (Bonomo, Brunetto et al. 2008) 
(Li, Kim et al. 2011, Moeinkhah, Rezaeepazhand et al. 2014) Reported using IPMCs in a helical 
shape to create an active biomedical stent. The stent was fabricated through thermal 
treatment of an IPMC strip helical coiled on a glass rod and then put in 90oC water for 1 hour. 
This IPMC helical stent could show not only bending motions but also torsional and 
longitudinal motions as well. The movement of the stent can be controlled by changing the 
pitch, the diameter, the width of the stent, as well as the voltage applied, and the frequency. 
Figure 2.13 shows the stent in (a) expanding state, (b) neutral state, and (c) contracting state.     
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Figure 2.13 IPMC Helical Stent (Li, Kim et al. 2011) 
(Liu, Wang et al. 2014) Used a new approach to create a silicone tube with four IPMC actuators 
that have a multi-degree of freedom, as shown in Figure 2.14. This new design was prepared 
for use in minimally invasive surgeries.  
 
Figure 2.14 Fabricated IPMC-embedded tube showing four embedded IPMC biaxial bending actuators (Liu, Wang et al. 
2014) 
(HEGDE, BUCH et al. 2004) Explained the use of EAP to create a cardiac supporting apparatus 
in their patent. The proposed apparatus is based on two heart’s coverings made from 
biologically compatible materials, covering the heart partially and connected with each other 
through EAP actuators. The actuators are oriented in a way that upon activation they will pull 
the two covering towards each other and create an assistive force for the heart to push the 
blood. The design is shown in Figure 2.15 where 100 is the apparatus, 104 the patient’s body, 
108 the heart, 106 constraint device, 110 the heart’s coverings, 112 the size adjustment 
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mechanism, 114 and 116 the EAPs actuators, 118 the controller, 120 and 122 sensors, 124 
power source, 126 transducer.  
 
Figure 2.15 EAP Cardiac Apparatus (HEGDE, BUCH et al. 2004) 
(Shahinpoor and Kim 2005, Shahinpoor 2009, Shahinpoor 2010) Suggested using IPMC to 
make a heart compression/assist device. This device was based on three IPMC fingers, each 
with 2 mm thickness and plated with 24-carat gold, mounted on a base and surrounding the 
heart. Upon activation, these IPMC fingers will contract and apply a gentle force on the outer 
wall of the heart, enhancing the blood circulation and assisting the weak heart. The design is 
shown in Figure 2.16, where 42 is the patient’s body, 5 the heart, 3 IPMC fingers, 30 the base 
of the device, 10 a wire, 46 the rib cage, 12 power supply, and 44 abdomen. IPMCs were 
chosen because of their flexibility, and softness, which can apply enough gentle force to the 
heart without damaging the ventricle.  
 
Figure 2.16 Three Fingers IPMC VAD (Shahinpoor 2010) 
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 Proposed Solutions 
Most of the available devices in the VAD field focus on creating a pump, either internal or 
external, and using it parallel to the heart. These devices are big bulky and not suitable for all 
patients. In addition, they are in direct contact with the blood, which causes blood cell 
damage, blood clots, and leads to more serious risks of thromboembolism in the circulatory 
system. Several studies focused on improving the biocompatibility of the material in contact 
with blood to minimise the mentioned risks (Kobayashi, Ohuchi et al. 2005).  
 In this thesis, a new approach is suggested, where this method will help the heart in its job, 
and assist the heart during the contraction phase. The proposed device is based on a thin 
mesh made from a smart material that fits around the patient’s heart. This structure can 
change its shape; contracts and expands based on a controlling signal. The movement of the 
device will produce a mechanical force to assist the heart to contract, which will generate 
enough pressure inside the heart’s chambers, and will lead to a normal blood flow in the body. 
The main advantage of this newly proposed device is that the blood will not be in contact with 
any foreign surface, unlike any other previous VADs, where blood will be exposed to a high 
risk of coagulation, and patients should use anticoagulations for their whole life (Lowe, 
Hughes et al. 1999). This proposed device will eliminate this risk by keeping the blood 
circulating inside the normal blood vessels without contacting any artificial surface.   
Our approach is to use Electro-Active Polymer (EAP) as a smart material, in particular, IPMC, 
to design and test this new VAD. IPMCs have unique characteristics making them the ideal 
solution for this design, such as their excellent chemical stability, good mechanical strength, 
remarkable thermal stability, and very high electrical conductivity. This new device has a 
unique shape that can fit around the wall of the heart, and occupy a minimum space around 
the heart; all the other components will be installed in the rib cage and the abdomen area. 
By using smart materials, like EAP, this device can expand and suits the different sizes of the 
heart. Additionally, this new VAD has a very low power consumption; this will allow us to 
apply some techniques to harvest energy from inside the patient’s body, eliminating the need 
to use a percutaneous power cable. 
Here in this thesis, three solutions are suggested to solve this problem: 
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 VAD powered directly from IPMC placed on the diaphragm 
The first solution suggests creating a VAD made from IPMC actuators and power this VAD 
directly from another sheet of IPMC that is placed on the diaphragm. The continuous 
movement of the diaphragm will constantly activate the IPMC actuator, which will produce 
electrical power that is used to run the VAD. Figure 2.17 shows the proposed option where 1 
is the patient, 2 the heart, 3 the IPMC mesh around the heart, 4 the controlling device, 5 the 
wires, 6 the diaphragm, and 7 IPMC sheets to harvest electrical power. 
 
Figure 2.17 Proposed solution option 1 
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 VAD powered from a battery charged from IPMC placed on the diaphragm 
If the first solution is not producing sufficient electrical energy directly to run the VAD, then 
we can use an internal battery to run the VAD and use the sheet of IPMC placed on the 
diaphragm to charge the battery. Figure 2.18 shows the proposed option where 1 is the 
patient, 2 the heart, 3 the IPMC mesh around the heart, 4 the controlling device, 5 the wires, 
6 the battery, 7 IPMC sheets to harvest electrical power, and 8 the diaphragm. 
 
Figure 2.18 Proposed solution option 2 
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 VAD powered from a battery charger transcutaneously 
The final option is to use an internal battery to run the VAD that can charge transcutaneously 
without any cable connection. Figure 2.19 shows the proposed option where 1 is the patient, 
2 the heart, 3 the coil, 4 the wires, 5 the battery, 6 the controlling device, and 7 IPMC mesh 
around the heart. 
 
Figure 2.19 Proposed solution option 3 
  Properties of the Proposed Device 
 Self-Powered 
All previous VADs require an external power source to keep the VAD running; this requires 
having a percutaneous cable to connect the VAD with the external power supply. Therefore, 
the proposed device should be self-powered from an internal power supply that can generate 
power from inside the patient’s body, or to transfer the power wirelessly and store it in an 
internal battery inside the patient’s body without any need for cables coming out of the 
patient’s skin. 
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 Small Size 
In paediatrics, their heart is very small, and there is not enough room around the heart to 
insert any implants. For this reason, the proposed device should be as small as possible to fit 
in this space without affecting the other organs. 
 Ability to Grow 
The heart’s size is not fixed; it changes its size over the growing period from infancy to 
adulthood. The proposed device should fit the heart during the growth stage without any 
need to replace the VAD with a bigger size one. 
 Control the Rhythm 
The heart contraction cycle consists of different phases, where each part of the heart 
contracts at a specific time. The proposed device should follow the same heart contraction 
cycle to produce the same blood flow pattern. 
 Hypothesis 
In this thesis, two main hypotheses are suggested: 
We can use IPMC to generate enough mechanical power to force the heart to contract. 
We can use IPMC to generate electricity to charge a battery. 
 Summary 
This chapter explained the theory behind the proposed device, and the listed the proposed 
solution with the hypothesis. The next chapter will account for the development of the 
proposed device and explains all the experiments.  
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Chapter 3 
Device Development  
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 Device Development 
 Introduction 
This chapter will discuss the requirements of the proposed device regarding force, 
displacement, and frequency. Then it will explain step by step the development of the IPMC 
actuators that are used to make the proposed device.  
 Device Requirements 
The idea of applying external mechanical force on the heart has been under research for a 
few decades, mainly using pneumatic power (Lowe, Hughes et al. 1999). While this has been 
the most common approach, some challenges are associated with it. Principally, related to 
the need for an external driving mechanism that is both bulky and represents an infection 
hazard. The solution proposed in this present work suggests a more miniaturised solution 
with no major concerns to the external environment. The proposition is to employ IPMC 
actuator to apply a mechanical force on the wall of the heart, which will maintain the pulsatile 
blood flow without the use of an air compressor. 
 Compressing Force 
The first criterion in the design is to know how much compression force this proposed device 
needs to generate to facilitate the compression of the heart. Assuming the left ventricle has 
a conical shape, and the applied force is uniform on the surface, then the pressure inside the 
ventricle can be calculated using equation (3.1), where P is the pressure in (Pa), F is the force 
in (N), and A is the surface area in (m2)  
𝑃 =
𝐹 
𝐴 
 (3.1) 
 Size of the Left Ventricle 
Assuming the left ventricle has a conical shape as shown in Figure 3.1.  
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Figure 3.1 Anatomy of the Left Ventricle (HUB 2017) 
The lateral surface area can be calculated using the following equation:  
𝐴 =  𝜋 × 𝑟 × √𝑟2 + ℎ2 (3.2) 
Where r is the radius of the base of the cone, and h is the height of the cone, as shown in 
Figure 3.2. 
 
Figure 3.2 Lateral surface area of a cone 
The base of the cone represents the width of the left ventricle, which varies between diastole 
and systole, and also changes a lot depending on the age of the patient. The maximum width 
of the left ventricle will be at the end of the diastole phase when the heart is fully expanded. 
Therefore, it will be considered as the width where the proposed device is applying the 
compressing force.  
93 
 
In the paediatric domain, the width of the left ventricle at the end of the diastole phase is 
D=1.425 cm, and the length is h=2.6 cm when accurate measurements are taken at birth 
(Sharland and Allan 1992). 
While in the adult domain, the left ventricle measures D=5 cm in width at the end of the 
diastole phase (Gibson, Becher et al. 2014), and h=9.5 cm in length (Støylen, Mølmen et al. 
2016). 
From equation (3.2): 
Lateral surface area of a paediatric= 6 cm2 = 6x10-4 m2 
Lateral surface area of an adult = 29.4 cm2 = 29.4x10-4 m2 
 Pressure Inside the Left Ventricle 
For a healthy heart stroke, the pressure inside the ventricle needs to reach a certain level; this 
pressure level is linked to the patient’s size, age, and physical requirements. The adult blood 
pressure inside the left ventricle will oscillate between 0 and 120 mm Hg during each cardiac 
cycle, as shown in Figure 3.3 (Martini F. 2011). The heart beats around 60-70 BPM, and the 
left ventricle pumps around 70 ml of blood each beat (Shahinpoor 2010). While in paediatrics, 
the left ventricle blood pressure could reach a maximum of 170 mm Hg and then gradually 
decreases to 100 mm Hg at the age of 16 years (Macfarlane 2006). 
To use the pressure values in equation (3.1), they should be converted to Pa:  
Paediatric maximum left ventricle blood pressure= 170 mm Hg = 22664.8 Pa 
Adults maximum left ventricle blood pressure= 120 mm Hg = 15998.7 Pa 
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Figure 3.3 Ventricular Blood Pressure in Adults (Martini F. 2011) 
 Force 
This force represents the approximate external force needed to get a healthy heart stroke. In 
other words, the proposed device should at least match this force to get the desired blood 
pressure inside the ventricle and maintain a healthy blood flow. 
Then, from equation (3.1), the force can be calculated for both paediatrics and adults: 
𝐹 = 𝑃 × 𝐴 (3.3) 
For paediatrics:  
F= 22664.8 x 6 x 10-4 = 13.6 N 
For adults 
F= 15998.7 x 29.4 x 10-4 = 47 N 
The previous values give an idea of the minimum approximate external mechanical force that 
should be applied to the heart to maintain a healthy pulsatile blood flow.  
Heart’s wall elasticity and the ventricle thickness are also other aspects that should be 
considered when finalising the design. These parameters should be included in the design to 
determine the exact amount of force needed for each patient. In this study, the focus is on 
the main parameters, which are the size of the ventricle and the ventricle pressure. 
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 Displacement 
In systolic phase the heart contracts, which makes the left ventricular diameter smaller than 
the diastolic phase. Therefore, the proposed device should contract to the same diameter.  
In adults, the left ventricle end systolic diameter varies between 2 cm to 4 cm depending on 
the physical requirements of the body (Talley and O'Connor 2009), which means the proposed 
device should be able to shrink its dimension by 20% to 50% from its original form. 
 Frequency 
Normal heart rate represents the working frequency of the proposed device. The paediatric 
heart pumps at a rate of 130 BPM at birth and decreases towards 60 BPM with growth. 
Therefore, the proposed device should cover a range from 130 BPM to 60 BPM, which means 
roughly the range between 1 Hz to 2 Hz. 
 Summary 
Table 3.1 summarises all the required parameter of the proposed device: 
Parameter Range 
Compressing force 13.6 N to 47 N 
Displacement 20% to 50% 
Frequency 1 Hz to 2 Hz 
Table 3.1 Device requirements 
 Primary Investigation Phase  
The practical phase of the project started by looking at the current suppliers of IPMC Artificial 
Muscles to evaluate their mechanical and electrical properties. As this type of material is still 
in its infancy stage, and they are not available commercially, the search moved towards 
research centres and universities that have experience with EAP. Four pieces of platinum 
coated IPMC Artificial Muscles were bought from Environmental Robots Incorporated 
(Bangor, Maine, USA), measuring (0.5x3 cm) and thickness of 0.2 mm on 15/3/2013. To drive 
the IPMC, they came with a variable voltage/frequency power supply and dynamic signal 
generator, which is powered by a 9 V battery. This signal generator generates a square wave 
and can change the output frequency from (0-20 Hz), and the output voltage from (0-8 V), as 
shown in Figure 3.4. 
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Figure 3.4 IPMC Artificial Muscles from (Bangor, Maine, USA) 1- signal generator, 2-alligator clip, 3- IPMC strips. 
Towards the end of the project for further comparison, two samples were bought on 
27/4/2016. The first was Gold plated IPMC measuring 35x42x2 mm, and the other was 
5x30x0.2 mm platinum plated. 
 Primary Bench Test 
IPMCs showed a noticeable mechanical response when an electric current was applied to the 
strips, under both dry and wet conditions. In the dry conditions, where the samples were left 
to dry for a few hours on the bench, IPMCs showed a short time of actuation before it 
stopped, around 56 seconds. While in the wet conditions, where they were soaked in water 
for a couple of minutes before testing. IPMCs showed a longer duration of actuation than in 
the dry conditions. Higher voltages, more than 7 volts, caused the materials to heat up and 
left some burn marks on both sides of the strip under the alligator clip. IPMCs showed a 
shorter duration of actuation at high frequencies in both wet and dry conditions; Figure 3.5 
below shows IPMC in the bending stage.  
 
Figure 3.5 IPMC bending 
1 3 
2 
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The materials showed promising responses to an electric stimulus under different voltages, 
frequencies and testing conditions. Therefore, they have the potential for further studies to 
quantify their mechanical and electrical properties. 
 Challenges 
To quantify the mechanical and electrical properties of IPMC, more samples were needed 
with a variety of shapes, thicknesses, and coating metals. As these IPMCs were still produced 
in research centres and universities, the cost of buying them was extremely expensive. The 
cost of the previous beginner kit was $584. To make things more complicated, most of the 
IPMCs are custom made, and they have to be pre-ordered weeks in advance. For those 
reasons, the project focus moved to the next step, which is to fabricate IPMC in the lab.  
 Fabrication of IPMC 
Ionic Polymer Metal Composites (IPMC) are currently the best-known type of EAPs, and they 
have the largest spectrum of applications, especially in biomimetic robotics (Must, Kaasik et 
al. 2015). It is now well known and documented that ionic polymers with a conductive metal 
can exhibit a significant deformation when electrically activated. Conversely, a dynamic strain 
of IPMC produces a dynamic voltage across the polymeric membrane (Shahinpoor and Kim 
2001). When IPMC is hydrated, the positive ions can move freely inside the polymeric matrix, 
while the negative ions are fixed with the carbon chain of the polymer. When an electric field 
is applied, the positive ions will move towards the cathode side, while the negative ions will 
stay fixed in place. This will cause the membrane to expand at the cathode side and contract 
at the anode side, which will lead the membrane to bend to the anode side (Chen, Um et al. 
2011).  
The fabrication method of IPMCs starts with a polymeric membrane with an ion exchange 
capability (often called ionomers), which is then coated with a metallic layer on both sides, as 
shown in Figure 3.6 (Shahinpoor and Kim 2000). Mechanical and electrical properties of IPMC 
are determined by the type of polymer, thickness of polymer, the metal particles, and the 
fabrication method (Kim and Shahinpoor 2003). For example, a thin IPMC creates a larger 
displacement, while a thick one produces a larger blocking force (Trabia, Hwang et al. 2016).   
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Figure 3.6 Schematic diagram of IPMC Artificial Muscle (Shahinpoor and Kim 2001) 
 Ion Exchange Membranes 
Ion exchange membranes are designed and synthesised to selectively pass ions of single or 
multiple charges, which means ions are mobile within the materials of the membrane. There 
are several commercial ion exchange membrane manufacturers, including Aqualitics, Asahi 
Chemicals, Asahi Glass, DuPont, W L Gore, Ionics, Solvay, Sybron, Tokuyama, Membranes 
Internationals Inc., and fuMA Tech (Park, Palmre et al. 2014). The most common used ion 
exchange membranes to make IPMC are Nafion from DuPont, Neosepta from Tokuyama, 
Aciplex from Asahi Chemicals, and Flemion from Asahi Glass. (Kim and Shahinpoor 2003). In 
this project, Nafion from DuPont is considered as the base polymer for IPMC. 
Nafion from DuPont (perfluorinated membrane) is one of the most common used ion 
exchange material, the chemical structure of Nafion is shown in Figure 3.7. Developed in the 
1960s by DuPont and commercialised in the 1970s, Nafion is widely used for Proton Exchange 
Membrane (PEM) fuel cells and water electrolysers. The membrane performs as a separator 
and solid electrolyte in a variety of electrochemical cells that requires the membrane to 
selectively transport cations across the cell junction (DuPont 2009, Bahramzadeh and 
Shahinpoor 2014).  
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Table 3.2 list all the properties of Nafion 117 
Property Value 
Thickness 170 µm 
Water uptake capacity Up to 30% at room temperature 
Volume expansion 12-15% 
Table 3.2 Representative properties of Nafion 117 (Kim and Shahinpoor 2003) 
 
 
Figure 3.7 Chemical Structure of Nafion (DuPont 2009) 
Polymeric membrane preparation methods: 
Readymade: this method is considered the easiest one to make IPMC, where the polymer is 
bought in sheets, and ready to start the plating process directly. This approach is suitable to 
create regular shapes. On the other hand, this option is associated with a high cost. For 
example, buying 8×10 inches Nafion membrane would cost £429. 
Hot Pressing: this method starts with single sheets of Nafion membrane and stacks them on 
top of each other to achieve a thicker membrane. The main advantage of this approach is that 
it can control the thickness of the final membrane by changing the number of layers stacked 
on top of each other. The membranes will be placed between two hot press plates, heated 
up to 180oC for 20 minutes,  and then pressed with a medium pressure 50 MPa for 10 minutes 
(Lee, Han et al. 2006). 
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Electrospinning: this method is used to manufacture very thin large-scale membranes. 
Polymer pellets are dissolved in appropriate solution to prepare the desired Nafion mixture  
(Põldsalu, Mändmaa et al. 2015). The electrospinning system consists of a high voltage 
generator, a micro syringe pump, a stainless steel collecting roller wrapped with aluminium 
foil, and a plastic syringe with a stainless steel needle. The syringe is filled with a Nafion 
solution, and then the needle is connected to the high voltage generator, while the collecting 
roller is attached to the ground. The voltage applied between the needle and the roller is 
between 10-13.5kV, and the distance between them is 10 cm. This procedure can produce a 
very thin membrane in the range of 20 µm (Lee and Yoo 2011) 
Spraying: Nafion is available in different forms; one of them is water dispersion, which gives 
the opportunity to make IPMC in unique shapes. Water dispersion also allows mixing Nafion 
with other polymers for various reasons.  (Trabia, Hwang et al. 2016) Reported creating IPMC 
actuators from water dispersion Nafion using an airbrush, and then chemically coat with 
platinum, as shown in Figure 3.8. The Nafion spray membrane has a thickness of 300 µm, and 
the final actuator showed almost identical characteristics to the commercial IPMC. 
 
Figure 3.8 Water dispersion Nafion (Trabia, Hwang et al. 2016) 
Casting: this method is used to obtain certain shapes of IPMC. The membrane is prepared 
from blended polymers, depending on the application, and then dissolved in 
Dimethylformamide (DMF) to form a polymeric solution. This solution is then poured into the 
mould to get the desired shape. After a curing process, the membrane will be ready for the 
plating process. The main disadvantage of this method is producing many micro and macro 
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cracks in the membrane during drying. On the other hand, this approach is suitable for 
producing very thick membranes, up to 2 mm (Panwar, Cha et al. 2012, De Luca, 
Digiamberardino et al. 2013, Panwar, Ko et al. 2013, Hwang, Palmre et al. 2015, Zhao, Wang 
et al. 2015). Also, this technique could be used to cast multi-layers of Nafion on top of each 
other, which is a handy tool to produce a layer by layer configurations (Lee, Yoo et al. 2014). 
Membranes with different properties could be cast separately and then combined by hot 
pressing to produce one thick membrane with multi-layers (Liu, Ghaffari et al. 2012) 
 Non-Electric Plating Protocol 
Many groups have developed their fabrication protocol of IPMC, which produced IPMC 
actuators suitable for different applications (Chen, Um et al. 2011, De Luca, Digiamberardino 
et al. 2013). In general, all these protocols follow almost the same structure, which involves 
two main steps: first is the initial compositing process, and then the surface electroding 
process (Park, Jung et al. 2008). The initial compositing process requires an appropriate metal 
salt such as platinum Pt(NH3)4HCl in the context of chemical reduction processes (Kim and 
Shahinpoor 2002), palladium Pd(NH3)4Cl2 (Kim and Kim 2008, Liu, Wang et al. 2014, Zhao, 
Wang et al. 2015), nickel (Fang, Ju et al. 2007), gold (Zadin, Krasheninnikov et al. 2015), or 
silver AgNO3 (Chung, Fung et al. 2006). Platinum is the preferred metal because it is largely 
immune to corrosion, and allows the use of high driving voltages without causing damage to 
IPMC actuators (Malone and Lipson 2006). Other methods of plating such as electroplating, 
physical deposition, and electrochemical deposition were also reported (Jeon, Yeorn et al. 
2008). 
The principle of the compositing process is to metallise the inner surface of the polymer by a 
chemical reduction means such as LiBH4 or NaBH4. The ionic polymer membrane is soaked in 
a salt solution to allow platinum-containing cations to diffuse through via the ion-exchange 
process. Later, a proper reducing agent, such as LiBH4 or NaBH4, is introduced to metallise the 
polymer.  The primary reaction for the platinum composite is shown in equation (3.4) 
(Shahinpoor, Bar-Cohen et al. 1998)  
NaBH4 + 4[Pt(NH3)4]2+ +8HO-   →   4Pt0 + 16 NH3 + NaBO2 + 6H2O (3.4) 
In this stage, the metallic platinum particles are not homogeneously formed across the 
membrane but concentrate predominantly near the interface boundaries, and only buried 
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few microns deep in the membrane. Therefore, the second step is applied, where multiple 
reducing agents are introduced to continue the reducing process and enhance the surface 
roughness (Shahinpoor and Kim 2001). Figure 3.9 shows the difference between the first and 
the second stage of the IPMC fabrication.   
 
 
Figure 3.9 IPMC preparation process: left after the initial compositing process, right after the surface electroding process 
(Shahinpoor and Kim 2001) 
The first and second steps could be repeated a few times to reach the desired thickness of 
electrodes on the IPMC surface as shown in Figure 3.10 
 
Figure 3.10 Cross section of IPMC showing the two electrodes and the Nafion membrane in the middle (Kim and 
Shahinpoor 2003) 
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All materials used in IPMC fabrications were bought from (Sigma-Aldrich, UK), including the 
Nafion 117 membrane and the chemicals, as shown in Figure 3.11.  
 
Figure 3.11 Chemicals used to make IPMC 
Table 3.3 shows a list of all the materials used during these experiments:  
No Item 
1 Nafion.TM. 117 membrane 0.007 inch thick 
2 HCl (Hydrogen chloride) 
3 (Pt(NH3)4 Cl2) (Tetra-amine platinum chloride hydrate) 
4 Pd(NH3)4Cl2·H2O (Tetra-ammine palladium(II) chloride 
monohydrate) 
5 NH4OH (Ammonium hydroxide) 
6 NaBH4 (Sodium borohydride) 
7 H2NOH.HCl  (Hydroxylamine hydrochloride) 
8 H2NNH2.H2O  (Hydrazine monohydrate) 
9 NaOH (Sodium hydroxide) 
Table 3.3 Materials used to make IPMC samples 
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The method utilised in this project contains the following the major steps, as shown in Figure 
3.12: 
 
Figure 3.12 IPMC Fabrication process 
Pre-treatment: At this step, the surface of the Nafion 117 membrane will be prepared to 
receive the metal ions. The membrane is shown in Figure 3.13. 
 
Figure 3.13 Nafion 117 membrane before surface treatment 
It includes surface treatment of the polymer using sandpaper, which will increase the surface 
area. Very fine sandpaper is used (Norton 600A). Then, the membrane will be cleaned in an 
ultrasound bath (Fisher Scientific, Germany) for 10 minutes to remove any residuals, as shown 
in Figure 3.14. 
Pre-treatment
Ion-exchange 
(Adsorption)
Primary Plating 
(Reduction)
Secondary Plating 
(Developing)
Ion exchange
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Figure 3.14 Ultrasound water bath 
 After that, the membrane will be boiled in 2.4N HCl solution for 30 minutes to remove any 
impurities and ions in the membrane, using a hot water bath (Grant Instruments, Cambridge 
UK) as shown in Figure 3.15.  
 
Figure 3.15 Hot water bath 
Finally, boiled in water to remove acid and to completely swell the membrane.  Figure 3.16 
shows the Nafion 117 membrane at the end of this stage. 
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Figure 3.16 Nafion 117 after the surface preparation 
Ion-exchange (Adsorption): Primary coating includes soaking the membrane in the platinum 
complex ([Pt(NH3)4]Cl2 or [Pt(NH3)6]Cl4) solution or any other metal salt solution, such as 
palladium or gold. The solution should contain more than 3 mg of Pt per cm2 membrane area 
to cover the membrane with Pt completely. An Excess amount of the Pt solution is preferable. 
Then, the membrane is kept in the solution at room temperature for one night, while stirring 
at a low speed. Figure 3.17 shows the Nafion 117 membrane at the end of this stage. 
 
Figure 3.17 Nafion 117 membrane after the Ion-exchange stage. 
Primary Plating (Reduction): Reducing step includes reducing the metal particles placed on 
the surface of the membrane, using some strong reducing agents, such as sodium 
borohydride NaBH4. The amount of the reagent should be proportional to the area of the 
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membrane. In the sequence of addition, the temperature is raised from 40oC to 60oC 
gradually, while stirring at a medium speed. At the end of this stage, a black layer of fine Pt 
particles should be deposited only on both surfaces of the membrane; Figure 3.18 shows the 
membrane at the end of this stage with a black layer covering its surface. 
 
Figure 3.18 Nafion 117 after the Primary Plating stage 
Secondary Plating (Developing): The amount of platinum deposited by the 1st plating 
(reduction process) is only less than 0.9 mg/cm2, which depends on the ion exchange capacity, 
the thickness of the membrane, and the structure of the Pt complex. An additional amount 
of platinum is plated by the developing process on the deposited Pt layer. The Secondary 
coating stage includes soaking the membrane again in Pt solution and adding reducing agents. 
Plating amount is determined by the content of Pt in the solution. Both hydroxylamine 
hydrochloride (NH2OH-HCl) and hydrazine monohydrate (H2NNH2.H2O) are used as reducing 
agents during the developing process, while raising the temperature from 40oC to 60oC 
gradually; Figure 3.19 shows the Nafion 117 membrane at the end of this stage. 
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Figure 3.19 Nafion 117 membrane after the Secondary Plating stage 
Ion exchange: The final stage includes rinsing the membrane with water, and boiling in dilute 
hydrochloric acid to remove the ammonium cation in the membrane. After washing with 
water, H+ in the composite can be exchanged for any cation by immersing in a solution of the 
chloride salt of the cation; the final IPMC is shown in Figure 3.20 
 
Figure 3.20  Final IPMC 
The last setup of the IPMC fabrication is shown in Figure 3.21. 
109 
 
 
Figure 3.21 The full experiment setup 
 
Table 3.4 summarise all the steps in IPMC fabrication: 
1 
 
Pre-treatment 
This is to roughen the surface of Nafion 117 to improve 
the surface adhesion by sandblasting. 
Thermal treatment 
This refers to thermal treatments in the oven for making 
the curved Nafion membrane. 
2 
 
Adsorption  
This is for exchanging the hydrophilic ion clusters (H+) 
with the platinum complex cations overnight. 
3 
 
Reduction (initial compositing) 
This is for making platinum cations penetrate into the 
Nafion film in depth. 
4 
 
Secondary plating (surface electroding) 
This is for developing platinum layers on the primary 
plating surface to improve the electrical conductivity of 
the electrodes by the reduction method. 
5 
 
Ion exchange 
This is to exchange H+ in the IPMC membrane with 
other counter ions such as Li+ or Na+. 
Table 3.4 Fabrication process of curved IPMC actuators (Yeom and Oh 2009) 
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 Protocol Development 
The manufacture of IPMC can be optimised to obtain the maximum force or displacement by 
changing some parameters during the manufacturing process. These parameters are water 
bath temperature, concentration of the metal salt, type of the metal salt, and repetition of 
secondary plating.  
In this study, eight different protocols were used to make IPMC samples; all protocols 
followed almost the same structure which was reported by (Shahinpoor and Mojarrad 2002, 
Kim and Shahinpoor 2003, Yu, Shen et al. 2007, De Luca, Digiamberardino et al. 2013). 
Protocol A used platinum for plating, with two phases of secondary plating. Protocol B also 
used platinum for plating, and two steps of the secondary plating and treated only once with 
NaOH at the end of the process. Protocol C followed the same steps, the only change was 
increasing the temperature very slowly during the primary and secondary plating. Protocol D 
used platinum for plating; the membrane was treated with HCl only once at the end of the 
secondary plating. Protocol E used palladium and platinum both for plating. Protocol F used 
platinum for plating, repeating the primary plating twice before moving to the secondary 
step. Protocol G used palladium only for plating. Protocol H used platinum for plating, 
repeated the primary and secondary plating twice. The detailed protocols are all listed in the 
appendices (section 11.1). Table 3.5 lists all the protocols with the plating metal used. 
Protocol Plating metal 
A platinum 
B platinum 
C platinum 
D platinum 
E palladium and platinum 
F platinum 
G palladium 
H platinum 
Table 3.5 IPMC fabrication protocols with the plating metal type 
 Results 
In this project, 11 IPMC samples were prepared from different protocols. All samples started 
with 2x2 inch of Nafion 117 and then cut into smaller sizes for testing 5x35 mm, (surface area 
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of 1.75 cm2). At the end of this stage, two groups of IPMC were ready for the surface, 
mechanical, and electrical tests. The first group was the commercial samples as shown in 
Table 3.6: 
Sample No Coating 
Commercial 1 platinum 
Commercial 2 platinum 
Commercial 3 platinum 
Commercial 4 platinum 
Commercial 5 platinum 
Commercial 6 gold 
Table 3.6 Commercial IPMC samples 
The second group was the Strathclyde IPMC samples fabricated at the Department of 
Biomedical Engineering, Strathclyde University as shown in Table 3.7: 
Sample No Protocol No Coating 
Strathclyde 1 H platinum 
Strathclyde 2 G palladium 
Strathclyde 3 F platinum 
Strathclyde 4 E platinum + palladium 
Strathclyde 5 E platinum + palladium 
Strathclyde 6 D platinum 
Strathclyde 7 C platinum 
Strathclyde 8 B platinum 
Strathclyde 9 A platinum 
Strathclyde 10 A platinum 
Strathclyde 11 A platinum 
Table 3.7 Strathclyde IPMC samples fabricated at the Department of Biomedical Engineering, Strathclyde University 
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During the different stages of fabrication of Strathclyde sample 1 and 2, small fragments were 
taken from the membrane for further comparison under the SEM, as follows: 
Fragment Stage 
1 Before the first immersion of the membrane in the metallic solution 
(Adsorption). 
2 After the first immersion the membrane in the metallic solution 
(Adsorption). 
3 After the first primary plating (Reduction) 
4 Before the second immersion the membrane in the metallic solution 
(Adsorption). 
5 After the second immersion the membrane in the metallic solution 
(Adsorption). 
6 After the second primary plating (Reduction) 
7 After the first secondary plating (Developing) 
8 After the second secondary plating (Developing) 
Table 3.8 Fragments taken during the fabrication stages 
All samples then were stored in deionised water waiting for the mechanical and electrical 
tests, as shown in Figure 3.22 and Figure 3.23 
 
Figure 3.22 Strathclyde Fabricated IPMC samples 
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Figure 3.23 Commercial IPMC samples 
  Summary 
At the end of this stage, two groups of IPMC samples were ready for characterisations. The 
first was the 11 Strathclyde IPMC samples prepared in the Department of Biomedical 
Engineering, Strathclyde University, and the second was the 6 Commercial IPMC samples 
bought from Environmental Robots Incorporated (Bangor, Maine, USA). Both groups will 
undergo a series of tests to evaluate their properties. 
 IPMC Driver 
The actuation of IPMC depends on the electrical signal applied across the membrane. 
Therefore, the signal’s shape, amplitude, frequency, and current all should be accurately 
controlled to optimise the movement of IPMC actuators.  
The original sample bought from Environment Robotics Inc. (Bangor, Maine, USA) came with 
a basic function generator that can produce a square wave based on a 555 digital timer IC, 
with the ability to control the frequency and the amplitude, as shown in Figure 3.4. This 
function generator ran on a 9 V battery and was not able to provide sufficient current for 
testing. Therefore, it was not suitable for this study, and a new function generator with the 
ability to provide a high current was developed.  
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The ideal IPMC driver should be able to: 
 Generate sine wave, square wave, and triangle wave. 
 Adjust the amplitude between 0-10 V. 
 Adjust the frequency between 0-2 Hz. 
 Provide a driving current up to 2 A. 
The first design was based on a voltage-controlled oscillator IC (XR-2209), which can generate 
triangle and square wave output. Both voltage and frequency of the generated signals were 
controlled by a potentiometer. The output of this IC was linked to an electrical current 
amplifier (OPA548T) (Yu, Shen et al. 2007, Vunder, Itik et al. 2014), which can provide a driving 
current up to 3 A; Figure 3.24 shows the function generator. The main disadvantage of this 
design was the low accuracy in controlling the amplitude and the frequency of the generated 
signal. The output was connected to an oscilloscope to adjust the parameters all the time, so 
this option was abandoned.  
 
Figure 3.24 First design function generator 
The second option was based on a signal generator (TG550, Aim TTi, USA), as shown in Figure 
3.25, and the output was then connected to a current amplifier circuit using OPA548T. This 
option was more accurate than the previous one and was able to provide a sine wave, square 
wave, and tringle wave. This option lacks the ability to record the generated signal for further 
comparisons, so it was also abandoned. 
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Figure 3.25 Second design function generator 
The third option was a computer based function generator, using Lab View 2015, DAQ system 
(NI USB 6225), and a current amplifier (OPA548T). Lab View was used to generate, control the 
signal parameters, and record the generated signal, while the DAQ system (16 bits ADC) was 
used as a Digital to Analogue Converter (DAC) at a rate of 1000 sample per second. Finally, 
the analogue signal was fed to the current amplifier and then applied to the IPMC actuator. 
Figure 3.26 shows the current amplifier and the DAQ system. 
  
Figure 3.26 Current amplifier on the left, DAQ system on the right 
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Based on previous studies, the best signal to drive IPMC and obtain the highest response in 
displacement and blocking force is a square wave (Yu, Shen et al. 2007). Therefore, the square 
wave signal was used to test the IPMC actuators, with the amplitude of 0-10 V, and the 
frequency of 0-2 Hz. Figure 3.27 shows a block diagram of the different stages of the IPMC 
controller. 
 
Figure 3.27 Block diagram of IPMC driver   
 Summary 
This chapter listed the requirements of the proposed device, explained the various stages of 
making the IPMC actuators, and finally showed the development of the IPMC driver electronic 
circuit. The next three chapters will focus on testing the surface topography, mechanical, and 
electrical properties of the IPMC samples.      
Lab View
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system
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amplifier
IPMC 
alligator 
holder
IPMC
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Chapter 4 
IPMC System Characterisation   
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 IPMC System Characterisation 
 Introduction 
This chapter will detail the different tests used to check the characterisation of the IPMC 
samples. The first group of tests (Surface tests, Thickness, Water uptake, and Surface 
Resistance) are used to test the quality of the fabricated Strathclyde IPMC and compare them 
with the Commercial IPMC samples, while the second group (Electrical Power Consumption, 
Displacement, and Blocking Force) are used to evaluate the IPMC as actuators to make the 
proposed device. 
 Surface Tests 
Surface tests focus on the topography of the surfaces of the electrode, and the cross section 
of the actuator. The electrode surface shows an indication of the homogeneity of the metallic 
particles, which relates to the surface resistance, while the cross section test illustrates the 
penetration of the metallic particles inside the structure of the membrane. This is used as an 
indicator of the quality of the tested IPMC samples. 
 Experiment Setup 
In this study, the Hitachi Scanning Electron Microscope (SEM) (tabletop scan 1000, Hitachi, 
Japan) was used to scan the surface of the IPMC actuators.  SEM can scan the surface of a 
sample with a focused beam of electrons and produce an image of the surface’s topography. 
SEM may also provide information about the chemistry and crystalline structure of the 
sample. In most applications, a particular area of the sample will be selected for scanning; this 
area could range from 1 cm to few microns in width. SEM will produce a 2D image of the 
chosen area with a magnification force from 20X up to 30,000X. Figure 4.1 shows the SEM 
used in this study. 
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Figure 4.1 Hitachi tabletop scan 1000 SEM 
To prepare IPMC samples for scanning, a small fragment of the actuator was cut, placed on a 
sample holder and then placed inside the SEM vacuum chamber. Figure 4.2 shows the holder 
on the left and the sample ready for scanning on the right.  
  
Figure 4.2 The sample holder on the left and the sample ready for scanning on the right. 
 Top Surface Test 
This test focuses on the electrode’s surface morphology and the distribution of the deposited 
electrode metal particles on the surface of the membrane. The surface of the IPMC usually 
appears to be rough and cracked with discrete islands. This is believed to happen because of 
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the swelling of the polymeric membrane and bubbles during the reduction processes. This 
has a huge effect on the surface resistance of the IPMC (Park, Kim et al. 2007, Kim and Kim 
2008). To improve the surface morphology, Kim used palladium as a buffer layer between the 
membrane and platinum, which showed a huge difference in the appearance of the surface 
of the electrode, and reduced the surface resistance from 3.3 Ω/□ to 1.2 Ω/□. Figure 4.3 
shows a comparison between two IPMC samples, the left one without Pd where the surface 
appeared cracked, and the sample with Pd on the right, where the surface seemed to be 
smoother and more homogeneous. 
  
Figure 4.3 SEM images of IPMC without Pd on the left and with Pd on the right 
All samples were scanned under different magnifications (200x, 2000x, 3000x, 6000x, 8000x, 
and 1000x) to obtain a clear perspective of the surface morphology. In the next section, a few 
examples are shown, and the rest of the photos can be found in the Appendices section (11.3).  
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 Results 
Figure 4.4 shows all top surface scanning images of the Commercial 5 IPMC under 6 different 
magnifications. 
  
  
  
Figure 4.4 SEM images of the Commercial 5 IPMC 
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Figure 4.5 shows all top surface scanning images of the Strathclyde 3 IPMC under 6 different 
magnifications. 
  
  
  
Figure 4.5 SEM images of the Strathclyde 3 IPMC 
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Figure 4.6 shows all top surface scanning images of the Strathclyde 5 IPMC under 6 different 
magnifications. 
  
  
  
Figure 4.6 SEM images of the Strathclyde 5 IPMC 
  
124 
 
Figure 4.7 shows all top surface scanning images of Strathclyde 11 IPMC under 6 different 
magnifications. 
  
  
  
Figure 4.7 SEM images of the Strathclyde 11 IPMC  
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 Summary  
The SEM images of the surfaces gave a clear indication of the quality of the IPMC fabrication. 
The first fabricated Strathclyde samples (Strathclyde 11, and Strathclyde 5) appeared to have 
a rough surface with clear islands on the electrode surface. This problem has disappeared in 
the most recent Strathclyde samples (Strathclyde 3), which have a smoother surface with no 
sign of cracks or islands on the surface of the electrode, similar to the Commercial 5 images. 
The rest of the top surface images can be found in the Appendices section (11.3).    
 Cross Section Test 
This test focuses on the penetration of the metallic particles inside the matrix of the polymeric 
membrane. The base membrane has a thickness of 170 µm. Usually, the thickness of Pt 
particles deposited on the surface is between 7 and 9 m (Nguyen, Lee et al. 2007, Nguyen 
and Yoo 2007, Yu, Shen et al. 2007). The thickness can be increased by repeating the plating 
process many times. Figure 4.8 shows a scanned image of the IPMC cross section. 
  
  
Figure 4.8 Cross section of IPMC top left (Yu, Shen et al. 2007), top right (Nguyen and Yoo 2007), bottom left (Park, Kim 
et al. 2007), bottom right (Shahinpoor 2003) 
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 Results 
A few examples of the cross section images are shown here, while the rest could be found in 
the Appendices section (11.4). 
Figure 4.9 shows the cross section scanning images of the Commercial 3, 4 and 6 IPMCs under 
2 different magnifications. 
Figure 4.9 Cross Section SEM images of the Commercial IPMCs  
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Figure 4.10 shows the cross section scanning images of the Strathclyde 1, 6, and 11 IPMCs 
under 2 different magnifications. 
Figure 4.10 Cross Section SEM images of the Strathclyde IPMCs  
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Figure 4.11 and Figure 4.12 show the cross section scanning images of the Strathclyde IPMC 
sample 2 at the different stages of fabrication under 2 different magnifications. 
Stage
 3
 
  
Stage
 4
 
  
Stage
 5
 
  
Figure 4.11 Cross Section images of Strathclyde 2 IPMC 
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Stage
 6
 
  
Stage
 7
 
  
Stage
 8
 
  
Figure 4.12 Cross Section images of Strathclyde 2 IPMC 
 Summary 
This test gave an indication of the development of the thickness of the electrode during the 
fabrication of Strathclyde IPMC. These images are used in the next test to measure the 
thickness of the electrode.  
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 IPMC Thickness 
All samples started from the same base membrane (Nafion 117), which has a thickness of 
170µm. During the different plating process, the metal particles were deposited on the 
surface and created the electrode layer. Some particles also penetrated inside the matrix of 
the membrane. The thickness of the electrode and the depth of penetration are critical 
parameters, and they have a huge reflect of the IPMCs behaviour when electrically 
stimulated. 
 Experiment Setup 
 All samples were left to dry for 24 hours before measuring the thickness using an electronic 
micrometer (resolution 1 µm). Three readings were taken from each sample, at different 
places on the surface of the IPMC actuator. After that, the average value and the standard 
error were calculated. Figure 4.13 shows the electronic micrometer. 
 
Figure 4.13 Electronic micrometer 
Since the thickness of the base membrane was known, the thickness of the metal particles 
deposited on top of the membrane on each side could be calculated using equation (4.1).  
Electrode thickness on top of the Nafion =
total IPMC thickness − Nafion thickness 
2
 
  (4.1) 
 
Cross section images from the previous test were analysed using image processing software 
(ImageJ) to measure the total thickness of the electrode. Five readings were taken from each 
image and then the average, and the standard error were calculated. The same method was 
used to measure the development of the total electrode thickness during the different 
fabrication stages of Strathclyde 1 and 2.  
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Finally, the depth of the metal particles inside the membrane can be calculated from equation 
(4.2): 
 
Particles penetration = Total Thickness of the Electrode - Electrode Thickness on top of the 
Nafion (4.2) 
 Results 
Figure 4.14 shows the total thickness of the IPMC measured using the micrometer. The 
thickness of Commercial 6 was 2045 µm, it was removed from the graph to make it easier for 
comapariosn. 
 
Figure 4.14 Total Thickness of the IPMC samples 
Figure 4.15 shows the total electrode thickness measured using the SEM images and ImageJ 
 
Figure 4.15 Total Electrode thickness of IPMC samples 
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Figure 4.16 shows the electrode thickness development of Strathclyde 1 during the 
fabrication stages, measured using the SEM images and ImageJ.  
 
Figure 4.16 Total electrode thickness development of Strathclyde 1 
Figure 4.17 shows the electrode thickness development of Strathclyde 2 during the 
fabrication stages, measured using the SEM images and ImageJ. 
 
Figure 4.17 Total electrode thickness development of Strathclyde 2 
Figure 4.18 shows the metal particle penetration inside the membrane. The values were 
calculated from equation (4.2). 
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Figure 4.18 Metal particles depth inside the membrane 
 
 Summary 
All the results are in the normal range. IPMC total thickness is around 200 µm, metal particles 
penetration is in the range of 5-7 µm, as described in the literature (section 4.22.3). This 
indicated that all IPMC samples were fabricated properly. The changes in the electrode 
thickness of Strathclyde 1 and Strathclyde 2 at the different fabrication stages showed a slight 
increase in thickness in stages 7 and 8 before dropping a little at the final thickness in stage 
8. This could be because of weakly attached particles to the surface, where were lost in the 
last stage. Regarding the depth of the metallic particle penetration inside the membrane, 
Strathclyde Samples showed less penetration than the Commercial Samples, which suggested 
the Commercial sample might have a slightly different fabrication protocol that allowed the 
metal particles to penetrate deep in the membrane. 
 Water Uptake 
The actuation mechanism in IPMC relies on the movement of the water molecules through 
the hydrophilic channels inside the matrix of the polymeric membrane (Gong, Tang et al. 
2009). Therefore, IPMC required being hydrated all the time to keep actuating. Water Uptake 
(WUP) is defined as the water holding capacity of the IPMC, which can be calculated by 
measuring the difference in weight between a dry and wet IPMC (Inamuddin, Khan et al. 
2015). Nafion 117 has a WUP of 48% (Trabia, Hwang et al. 2016), which is one of the reasons 
why it is used in IPMCs. During the fabrication process, the WUP of Nafion decreases because 
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of the electrode layers covering the surface of the membrane.  The final IPMC can reach a 
WUP of 16.7% (Inamuddin, Khan et al. 2015) 
There are three important mechanisms for water loss: water leakage from the surface of the 
electrode, natural evaporation, and water loss due to electrolysis. For example, Nafion IPMC 
lost nearly 70% of its water after 5 minutes of actuation (Nguyen, Lee et al. 2007). 
When an electric field is applied across the membrane, the IPMC will start to actuate, and 
water will be noticed appearing on the cathode side of the electrode, which will lead to some 
water evaporating and the IPMC will dry out and then stop (Shahinpoor and Kim 2002). That 
is why the IPMC should have a high WUP values to keep actuating longer. One solution for 
this issue, is a better platinum particles penetration inside into the ionic polymer membrane 
with a smaller particle size (Shahinpoor and Kim 2002). Another option is using rubber 
coatings to cover the IPMC to prevent water from evaporating (Richardson, Levesley et al. 
2003, Lee, Lee et al. 2005).  
To measure WUP, the samples first were dried for 24 h and weighed. Then, the samples were 
soaked in deionised water for another 24 h at room temperature to completely hydrate. 
Excess water drops were removed and samples were weighed again (Panwar, Lee et al. 2012, 
Park, Palmre et al. 2014)  
 Experiment Setup 
All samples were tested in both dry and wet conditions. For the wet conditions, they were left 
in containers full of deionised water and left for 24 hours at room temperature to hydrate 
fully, while in the dry conditions, they were left for 24 hours on the bench between paper 
towels to dehydrate fully. All tests were carried out using a Lab Balance (Fisher Brand PS-60, 
UK) with a resolution of 0.1 mg, as shown in Figure 4.19. Three measurements were taken 
each time, and then the average and the standard error were calculated.    
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Figure 4.19 Balance used to weigh the IPMC samples 
Both water uptake in mg and percentage were calculated using the following equations: 
𝑊𝑈𝑃 (𝑚𝑔) = 𝑊𝑒𝑡 𝑊𝑒𝑖𝑔ℎ𝑡 − 𝐷𝑟𝑦 𝑊𝑒𝑖𝑔ℎ𝑡 (4.3) 
𝑊𝑈𝑃% =
𝑊𝑒𝑡 𝑊𝑒𝑖𝑔ℎ𝑡 − 𝐷𝑟𝑦 𝑊𝑒𝑖𝑔ℎ𝑡
𝑊𝑒𝑡 𝑊𝑒𝑖𝑔ℎ𝑡
× 100 
(4.4) 
 Results 
Table 4.1 lists all the dry and wet weights of the IPMC samples: 
IPMC Dry (mg) Wet (mg) 
Commercial 1 83.80 97.40 
Commercial 2 90.73 112.10 
Commercial 3 71.63 87.37 
Commercial 4 66.67 80.73 
Commercial 5 85.07 103.00 
Commercial 6 735.10 914.73 
Strathclyde 1 108.10 125.70 
Strathclyde 2 84.97 110.27 
Strathclyde 3 100.67 119.80 
Strathclyde 4 126.80 152.07 
Strathclyde 5 84.20 104.80 
Strathclyde 6 80.47 94.57 
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Strathclyde 7 90.83 110.47 
Strathclyde 8 104.27 126.33 
Strathclyde 9 105.57 126.47 
Strathclyde 10 82.73 97.17 
Strathclyde 11 106.87 126.53 
Nafion 117 82.00 104.57 
Table 4.1 Dry and wet weight of IPMC samples 
Figure 4.20 shows a comparison between dry and wet weight of the IPMC samples in mg, 
Commercial 6 was removed for an easier comparison. 
 
Figure 4.20 Dry and wet weight of IPMC Samples 
 
Figure 4.21 shows the water uptake in mg of the PMC samples in mg, apart from Commercial 
6 which was 179.63 mg.  
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Figure 4.21 Water Uptake in mg of IPMC Samples 
 
 
Figure 4.22 shows the percentage of water uptake of all IPMC samples 
 
 
Figure 4.22 Water Uptake Percentage of IPMC Samples 
  Summary 
This test was conducted to measure the WUP percentage of all fabricated samples, and 
compare it with the results found in the literature. The results were very close between the 
two groups; the Strathclyde IPMCs and the Commercial IPMCs. WUP values were between 
14% and 22%, which match the 16.7% value found in a previous study. This showed again that 
the fabricated samples were fabricated successfully.  
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 Surface Resistance Test 
Sheet resistance is a vital parameter and indicates the quality of the electrodes. The sheet 
resistance Rs is defined as the electrical resistance per a square unit of the membrane 
(Instruments 2001, Panwar, Cha et al. 2012).  
The non-electric plating procedure involves treatment of the membrane at an elevated 
temperature, which causes the membrane to crack and results in increasing the surface 
resistance. To avoid this problem, (Johanson, Punning et al. 2008) used Cu to treat IPMC after 
plating. This method was used to improve the conductivity of the IPMC and prevent the 
surface of the membrane from cracking. Besides that, the relationship between metal 
particles penetration within the polymer and the surface resistance is critical. It is also noticed 
that samples with low surface resistance tend to produce larger blocking force (Kim and 
Shahinpoor 2003).  
There are two main methods to measure the surface resistance or (sheet resistivity). The first 
method used a Four-point surface resistivity device such as Guardian Model SRM-232, (Kim 
and Shahinpoor 2003, Põldsalu, Mändmaa et al. 2015). This device operates by passing a 
calibrated constant current source of 4.53 mA through the two outer tips of the 4-point probe. 
This current develops a voltage across the two inner probe tips, which is directly proportional 
to the surface resistivity. The device shows the results in Ω/□. (Kim and Kim 2008) Used this 
method to measure the surface resistance, 3.3 /□ for the Pt coated IPMC, and 1.2 /□ for 
Pd/Pt coated IPMC. Figure 4.23 shows the principle of the four-point measurement resistance 
device. 
 
Figure 4.23 Four-point surface resistivity device (Punning, Kruusmaa et al. 2007) 
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The other method to measure the resistance used a multimeter, with a distance of 1 cm 
between the probes, as shown in Figure 4.24.  This method is suitable for small samples, and 
present the surface resistance in Ω/cm. (Panwar, Kang et al. 2011) Used this method and 
recorded a surface resistance of 2.5 Ω/cm, (Trabia, Hwang et al. 2016) Recorded 2 Ω/cm, and  
(Hwang, Palmre et al. 2015) also found the surface resistance to be 2 Ω/cm of their samples.  
 
Figure 4.24 Point to point surface resistance (Trabia, Hwang et al. 2016) 
 Experiment Setup 
In this test both methods were used, the square method and the point to point one. The 
square method was used during the fabrication process, as there was enough space to place 
the testing square on top of the membrane and obtain some readings in different locations. 
The testing square was made of a 2x2 cm of polypropylene and had two metal plates on two 
opposite sides only, which were connected to a multimeter. To measure the surface 
resistance, the testing square was placed on top of IPMC surface in different locations to 
obtain the average resistance. Figure 4.25 shows the testing square. 
 
Figure 4.25 Surface resistance testing square 
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The point to point method was used after cutting the IPMC into equal strips. This method 
used a multimeter only with the probes are 1 cm apart from each other. Three reading were 
taken on each side of the IPMC sample, and then the average and the standard error were 
calculated. All surface resistance tests were conducted under dry conditions.  
 Results 
Figure 4.26 shows the surface resistance per cm of the IPMC samples. 
 
Figure 4.26 Surface resistance side A and B of IPMC samples 
Figure 4.27 shows the changes in surface resistance of Strathclyde 1 during fabrication stages. 
 
Figure 4.27 Surface resistance of Strathclyde 1  
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Figure 4.28 shows the changes in surface resistance of Strathclyde 2 during fabrication stages. 
 
Figure 4.28 Surface resistance of Strathclyde 2 
  Summary 
In general, both tests showed low surface resistance per cm and per square. Some samples 
such as Strathclyde 5, and Strathclyde 9 have a different surface resistance on each side. The 
results of the resistance per cm were a little bit over what was found in previous studies, most 
of the values were between 2 Ω/cm and 8 Ω/cm. This was taken in consideration when testing 
the mechanical and electrical properties. 
 Electrical Power Consumption 
One of the most severe drawbacks of IPMC application is their high-current consumption. One 
option to reduce the energy consumption is to improve the properties of the materials, using 
materials that need lower energy to operate. Another option is to enhance the controlling 
signal using a modulated controlling signal (Punning, Anton et al. 2005).  
 Experiment Setup 
This test focused on the electrical power consumed by the IPMC samples, which gave an idea 
of how much power is needed to run the proposed device. As previously explained, the 
proposed device is made of IPMC strips, which should be powered either directly from a 
power-harvesting device or through a battery. In both cases, there is a need to measure and 
decide how much electrical power is required to run the device.  
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Each IPMC sample was placed between an alligator holder, which applied a 6V, square wave 
across the IPMC, as shown in Figure 4.29. 
 
Figure 4.29 IPMC alligator holder 
IPMCs were tested under different frequencies (0.05, 0.5,1, and 2 Hz), using the IPMC driver 
described in (section 3.5). The current passing through the IPMC was measured using a 
multimeter and recorded. Total power consumption was calculated using the equation (4.5) 
𝑃 = 𝑉 × 𝐼 (4.5) 
Where V is the applied voltage (6V), I is the measured current in (A), and P is the consumed 
power in (W). 
To achieve a better understanding of all the samples and for an easier comparison, the 
previous results were used to calculate the current consumption per weight, current 
consumption per surface area, power consumption per surface area, and power consumption 
per weight. 
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 Results 
Figure 4.30, Figure 4.31, Figure 4.32, and Figure 4.33 show the maximum current 
consumption in mA at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively.  
 
Figure 4.30 Maximum current consumption at 0.05 Hz 
 
 
Figure 4.31 Maximum current consumption at 0.5 Hz 
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Figure 4.32 Maximum current consumption at 1 Hz 
 
 
Figure 4.33 Maximum current consumption at 2 Hz 
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Figure 4.34, Figure 4.35, Figure 4.36, and Figure 4.37 show the current consumption per 
weight in mA/mg at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively.  
 
Figure 4.34 Current consumption per weight at 0.05 Hz 
 
 
Figure 4.35 Current consumption per weight at 0.5 Hz 
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Figure 4.36 Current consumption per weight at 1 Hz 
 
 
Figure 4.37 Current consumption per weight at 2 Hz 
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Figure 4.38, Figure 4.39, Figure 4.40, and Figure 4.41 show the current consumption per 
surface area in mA/cm2 at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively. 
 
Figure 4.38 Current consumption per surface area at 0.05 Hz 
 
 
Figure 4.39 Current consumption per surface area at 0.5 Hz 
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Figure 4.40 Current consumption per surface area at 1 Hz 
 
 
Figure 4.41 Current consumption per surface area at 2 Hz 
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Figure 4.42, Figure 4.43, Figure 4.44, and Figure 4.45 show the maximum power consumption 
in mW at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively.  
 
Figure 4.42 Maximum power consumption at 0.05 Hz 
 
 
Figure 4.43 Maximum power consumption at 0.5 Hz 
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Figure 4.44 Maximum power consumption at 1 Hz 
 
 
Figure 4.45 Maximum power consumption at 2 Hz 
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Figure 4.46, Figure 4.47, Figure 4.48, and Figure 4.49 show the power consumption per 
weight in mW/mg at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively.  
 
Figure 4.46 Power consumption per weight at 0.05 Hz 
 
 
Figure 4.47 Power consumption per weight at 0.5 Hz 
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Figure 4.48 Power consumption per weight at 1 Hz 
 
 
Figure 4.49 Power consumption per weight at 2 Hz 
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Figure 4.50, Figure 4.51, Figure 4.52, and Figure 4.53 show the power consumption per 
surface area in mW/cm2 at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively.  
 
Figure 4.50 Power consumption per surface area at 0.05 Hz 
 
 
Figure 4.51 Power consumption per surface area at 0.5 Hz 
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Figure 4.52 Power consumption per surface area at 1 Hz 
 
 
Figure 4.53 Power consumption per surface area at 2 Hz 
 
 Summary 
This test showed the electrical power needed for each IPMC sample to actuate under the 
same conditions. This information will be used to determine which is the best power source 
for the proposed device.  
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 Displacement Test 
The primary mechanism of bending motion of IPMC relies on the imbalance of water density 
inside the membrane (Yu, Shen et al. 2007). When applying an AC voltage, IPMC undergoes a 
swinging motion, and the displacement level is strongly influenced by the voltage amplitude, 
the frequency, and the hydration level. The higher its water content, the larger the 
displacement it undergoes under the same externally applied voltage (Bonomo, Fortuna et al. 
2005). It is also reported that lower frequencies (0.1 to 0.01 Hz) lead to a higher displacement  
(Shahinpoor, Bar-Cohen et al. 1998). 
During displacement tests, It is observed that IPMC reached its maximum tip displacement 
after 20 seconds and then a fast relaxation occurs (Nguyen, Lee et al. 2007). Back relaxation 
is the movement of the IPMC actuator towards the natural state when activated by a low-
frequency signal; it disappears on frequencies higher than 0.5 Hz. 
There are two methods to record the displacement of IPMCs; the first uses a laser position 
sensor such as (BANNER, LG10A65PU) (Chung, Fung et al. 2006, Vunder, Itik et al. 2014). The 
other uses a video camera to record and measure the changes of the tip of the IPMC (Vunder, 
Itik et al. 2014) 
Table 4.2 lists the displacement results of different studies at different testing conditions.  
Study Displacement Size of the sample Testing conditions 
(Chung, Fung et al. 
2006) 
2.1 mm 
4.4 mm 
6.87 mm 
 1V 
2V 
3V 
(Yu, Shen et al. 2007) 4 mm 30x3x0.2 mm square wave, 2.5 V 
and 0.1 Hz 
(Lee, Jung et al. 2006) 3 mm  2V DC 
(Jain, Datta et al. 2010) 14 mm 30x6x0.2 mm 4V 
(Jung, Nam et al. 2003) 0.85 mm 
2 mm 
10x2x0.2 mm 
20x5x0.2 mm 
1.5 V DC 
3V square wave 
(Liu, McDaid et al. 
2011) 
10.27 mm 30x10x0.6 mm 4V 
Table 4.2 Displacement results from previous studies 
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 Experiment Setup 
This test used the video camera method to record the tip displacement of the IPMC. The 
samples were placed in a cantilever position, with one end was connected to the IPMC driver 
using the alligator clip, and the other end was left free to move. The driving signal was 6 V, 
and the frequency range was 0.05, 0.5, 1, 2, DC. This signal was generated by Lab View 2015 
and connected to the IPMC driver through NI 6225 DAQ module.  A graph paper was placed 
behind the IPMC sample, and a Nikon D5300 camera was used to record the displacement. 
Figure 4.54 shows the graph paper and the IPMC holder, Figure 4.55 shows the full 
experiment setup. 
 
Figure 4.54 Graph paper behind the IPMC holder 
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Figure 4.55 The complete experiment setup for displacement test 
Figure 4.56 shows the block diagram of the displacement test. 
 
Figure 4.56 Block Diagram of the displacement test 
All videos were analysed later, and the maximum tip displacement was recorded.   
 
 
 
 
 
 
 
function 
generator
DAQ
NI 6225 
USB
IPMC 
Driver
IPMC
Video 
Camera
158 
 
 Result 
Figure 4.57, Figure 4.58, Figure 4.59, Figure 4.60, and Figure 4.61 show the maximum tip 
displacement in mm of the IPMC actuators at DC, 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively. 
 
Figure 4.57 Maximum tip displacement at DC 
 
 
Figure 4.58 Maximum tip displacement at 0.05 Hz 
0
5
10
15
20
25
D
is
p
la
ce
m
en
t 
m
m
IPMC Samples
Maximum Displacement at DC
0
5
10
15
20
25
D
is
p
la
ce
m
en
t 
m
m
IPMC Samples
Maximum Displacement at 0.05 Hz
159 
 
 
Figure 4.59 Maximum tip displacement at 0.5 Hz 
 
 
Figure 4.60 Maximum tip displacement at 1 Hz 
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Figure 4.61 Maximum tip displacement at 2 Hz 
Figure 4.62, Figure 4.63, Figure 4.64, Figure 4.65, and Figure 4.66 show the maximum tip 
displacement as a percentage of the original length of the IPMC actuators at DC, 0.05 Hz, 0.5 
Hz, 1 Hz, and 2 Hz respectively. 
 
Figure 4.62 Tip displacement % at DC 
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Figure 4.63 Tip displacement % at 0.05 Hz 
 
 
Figure 4.64 Tip displacement % at 0.5 Hz 
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Figure 4.65 Tip displacement % at 1 Hz 
 
 
Figure 4.66 Tip displacement % at 2 Hz 
 
 Summary 
The tip displacement test presented that the IPMC samples showed a larger response when 
stimulated with a DC signal, and the response decreased by increasing the frequency. These 
results from the Commercials and our own Strathclyde materials match what was found in 
the literature previously, and confirm the conformity with other investigators and our own 
materials.  
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 Blocking Force Test 
Blocking force is the force measured at the tip of the IPMC actuator when an electric field is 
applied (Anton, Aabloo et al. 2008).  
To measure the blocking force, the IPMC sample is placed between two electrodes from one 
side, and the other end is positioned opposite to the load cell. Upon activation, the IPMC 
actuator free end will bend towards the load cell, which will generate a voltage output 
proportional to the applied force. By measuring the output voltage of the load cell, the 
blocking force can be calculated using the provided information in the load cell’s datasheet. 
Figure 4.67 shows the experiment setup to measure the blocking force. 
 
Figure 4.67 Blocking force experiment setup (Chen, Um et al. 2011) 
 
Different sensors and load cells were used to measure this force in the literature, Table 4.3 
lists some of the force sensors used to measure the blocking force. 
Study Sensor 
(Chung, Fung et al. 2006) KYOWA, LVS-10GA (Japan) 
(Lee and Yoo 2011) CB-G150,Dacell (Korea) 
(Chen, Um et al. 2011) GS0-10, Transducer Techniques (USA) 
(Vunder, Itik et al. 2014) Millinewton,IPR EPFL (Switzerland) 
(He, Yu et al. 2011) CETR-UMT (USA) 
(Liu, McDaid et al. 2011) SS-2 Precision, Sherborne Sensors Limited (UK) 
Table 4.3 Blocking Force Sensors 
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Figure 4.68 shows a typical blocking force signal generated from 42x9.9x0.5 mm IPMC.  
 
Figure 4.68 IPMC Blocking Force (Trabia, Hwang et al. 2016) 
IPMC can generate a few mN of blocking force. Most of the researchers focused on improving 
the blocking force of IPMC by optimisation and additional treatment of the electrode layer 
during the fabrication process, increasing the thickness of IPMC, or using specific inner 
solution systems based on ionic liquid (Nguyen and Yoo 2007).  
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Table 4.4 lists the blocking force results of different studies at different testing conditions. 
Study Force Size of the sample Testing conditions 
(Malone and Lipson 
2006) 
Max force 0.678 mN 
Average force 0.15 mN 
10x30x0.25 mm  
(Hwang, Palmre et 
al. 2015) 
13.5 mN  3V DC 
(Yu, Shen et al. 
2007) 
1 mN 30x3x0.2 mm square wave, 0.1 
Hz and 2.5 V 
(Jain, Datta et al. 
2010) 
10 mN 30x6x0.2 mm 4V 
(Vunder, Itik et al. 
2014) 
1.2 mN 20x5 mm 2V 
(Han, Park et al. 
2006) 
1.12 gf (10.9 mN) 40x5x0.58 mm 2V DC 
(Chung, Fung et al. 
2006) 
0.114 gf (1.11 mN) 
0.168 gf (1.64 mN) 
0.222 gf (2.17 mN) 
 1V 
2V 
3V 
(Panwar, Kang et al. 
2011) 
2.29 gf (22.44 mN) 
3.59 gf ( 35.18 mN) 
 2.5V 
3 V 
(Shahinpoor and 
Kim 2002) 
1 gf (9.8 mN) 
1.2 gf (11.76 mN) 
20x5x0.2 mm 1V at 0.5 Hz 
1.5V at 0.5 Hz 
(Chen, Um et al. 
2011) 
0.15 gf (1.47 mN)   
(Lee, Jung et al. 
2006) 
0.9 gf (8.82 mN) 
0.95 gf (9.31 mN) 
1 gf (9.8 mN) 
178 µm 2 V 
2.5 V 
3 V 
(Nguyen, Lee et al. 
2007) 
0.6 gf (5.88 mN) 5x20x0.3 mm 3V 
(Liu, McDaid et al. 
2011) 
5.21 gf (51.05 mN) 30x10x0.6 mm 4V 
Table 4.4 Blocking Force results from previous studies 
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 Experiment Setup 
Blocking force was measured using a small force sensor Millinewton-B-1000 (Pewatron 
sensors, Zurich, Switzerland). The force is measured through bending of a cantilever beam, 
which carries a piezoresistive bridge. The electronics on the base carry out the signal 
amplification and deliver a voltage output, which is a linear function of the force. This force 
sensor has three terminals, input 5V DC, output, and ground, as shown in Figure 4.69.   
  
Figure 4.69 Force Sensor 
The force sensor has a linear output voltage, based on the datasheet. The output equation 
(4.6) was: 
𝑌 = 0.003𝑋 + 0.5 (4.6) 
Where Y is the output voltage in mV, and X is the applied force in mN. 
However, upon trying some certified weights and recording the results, some changes were 
found between the measured voltage of the sensor and the results using Equation (11). 
Therefore, a full calibration of the sensor was required, using the certified weights, and the 
new linear equation (4.7) was formed: 
𝑌 = 0.0026𝑋 + 0.5031 (4.7) 
Figure 4.70 shows both set of results, the calculated values using equation (4.7), and the 
actual measured values. 
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Figure 4.70 Calibration graph of the force sensor 
NI 6225 DAQ module was used as an interface between the electronic parts (force sensor, 
and IPMC driver) from one side, and the software (Lab View 2015) from the other side, as 
shown in Figure 4.71. Two analogue output channels and one analogue input were used. The 
output channels were used one for the generated signal for the IPMC driver, and the other to 
power the force sensor, while the input channel was connected to the force sensor’s output. 
  
Figure 4.71 NI 6225 USB DAQ system 
Lab View 2015 was used to generate the driving signal and record the data. Figure 4.72 shows 
the front panel of the code. The testing signal was a 6V square wave, as it has been proven 
before to get the best response to other waves. All samples were tested using different 
frequencies (0.05, 0.5, 1, 2) Hz to match the requirements of the proposed device, see Table 
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3.1. Lab View sent the generated signal to NI 6225 USB DAQ, which was used as a Digital to 
Analogue Converter (DAC), and then connected with the IPMC driver. The other function of 
Lab View was to record the measured data from the sensor. First, the sensor’s output was 
connected to the NI 6225 USB DAQ, which was used as an Analogue to Digital Converter 
(ADC). Then, the digital signal was filtered using a low pass filter to remove any noise. After 
that, equation (4.7) was used to calculate the measured force in mN. Finally, both the 
generated square wave and the measured force signal were saved in an Excel file. Figure 4.73, 
and Figure 4.74 show the block diagram of the Lab View code. 
 
Figure 4.72 Front Panel of Lab View 
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Figure 4.73 Block diagram of Lab View 
 
 
Figure 4.74 Block diagram of the blocking force test 
The complete setup is shown in Figure 4.75.① is the NI 6225 USB DAQ, ②is the IPMC driver, 
③is the power supply, ④is the Force Sensor, ⑤is the IPMC sample, and ⑥is the IPMC 
alligator holder.   
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Figure 4.75 The complete setup of the experiment 
 Results 
In this section, a few examples of the blocking force are shown. The rest of the graphs can be 
found in the Appendices section (11.5). 
Figure 4.76, Figure 4.77, Figure 4.78, and Figure 4.79 show the blocking force of the 
Commercial 6 IPMC sample at different frequencies. 
 
Figure 4.76 Blocking Force of Commercial 6 sample at 0.05 Hz 
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Figure 4.77 Blocking Force of Commercial 6 Sample at 0.5 Hz 
 
 
Figure 4.78 Blocking Force of Commercial 6 Sample at 1 Hz 
 
 
Figure 4.79 Blocking Force of Commercial 6 Sample at 2 Hz 
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Figure 4.80, Figure 4.81, Figure 4.82, and Figure 4.83 show the blocking force of the 
Strathclyde 2 IPMC sample at different frequencies.  
 
Figure 4.80 Blocking Force of Strathclyde 2 Sample at 0.05 Hz 
 
 
Figure 4.81 Blocking Force of Strathclyde 2 Sample at 0.5 Hz 
-8
-6
-4
-2
0
2
4
6
8
0
1
2
3
4
5
6
0 5 10 15 20 25 30 35 40
V
o
lt
ag
e 
(V
)
B
lo
ck
in
g 
Fo
rc
e 
(m
N
)
Time (s)
Blocking Force - Strathclyde 2 at 0.05 Hz
Blocking Force (mN) Voltage (V)
-8
-6
-4
-2
0
2
4
6
8
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 1 2 3 4 5 6 7 8 9 10
V
o
lt
ag
e 
(V
)
B
lo
ck
in
g 
Fo
rc
e 
(m
N
)
Time (s)
Blocking Force - Strathclyde 2 at 0.5 Hz
Blocking Force (mN) Voltage (V)
173 
 
 
Figure 4.82 Blocking Force of Strathclyde 2 Sample at 1 Hz 
 
 
Figure 4.83 Blocking Force of Strathclyde 2 Sample at 2 Hz 
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Figure 4.84, Figure 4.85, Figure 4.86, and Figure 4.87 show the maximum blocking force of all 
IPMC samples in mN at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively. Commercial 6 produced 
74 mN at 0.05 Hz, 32 mN at 0.5 Hz, 25 mN at 1 Hz, and 11 mN at 2 Hz.  
 
Figure 4.84 Maximum blocking force at 0.05 Hz 
 
 
Figure 4.85 Maximum blocking force at 0.5 Hz 
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Figure 4.86 Maximum blocking force at 1 Hz 
 
 
Figure 4.87 Maximum blocking force at 2 Hz 
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Figure 4.88, Figure 4.89, Figure 4.90, and Figure 4.91 show the maximum blocking force per 
weight of all IPMC samples in mN/mg at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively. 
 
 
 
Figure 4.88 Maximum blocking force per weight at 0.05 Hz 
 
 
Figure 4.89 Maximum blocking force per weight at 0.5 Hz 
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Figure 4.90 Maximum blocking force per weight at 1 Hz 
 
 
Figure 4.91 Maximum blocking force per weight at 2 Hz 
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Figure 4.92, Figure 4.93, Figure 4.94, and Figure 4.95 show the maximum blocking force per 
surface area of all IPMC samples in mN/mm2 at 0.05 Hz, 0.5 Hz, 1 Hz, and 2 Hz respectively. 
Commercial 6 showed 43.52 mN/cm2 at 0.05 Hz, 18.82 mN/cm2 at 0.5 Hz, 14.7 mN/cm2 at 1 
Hz, and 6.74 mN/cm2 at 2 Hz.  
 
Figure 4.92 Maximum blocking force per surface area at 0.05 Hz 
 
 
Figure 4.93 Maximum blocking force per surface area at 0.5 Hz 
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Figure 4.94 Maximum blocking force per surface area at 1 Hz 
 
 
 
Figure 4.95 Maximum blocking force per surface area at 2 Hz 
 
 Summary 
Table 3.1, the required force for the proposed device was between 13.6 N and 47N. The 
maximum blocking force recorded out of all IPMC was 74 mN from Commercial 6 at 0.05 Hz. 
This means to generate the required force it needs 183 actuators of Commercial 6 to generate 
13.6 N, and 635 actuators to generate 47 N. In the Strathclyde group, the maximum force 
recorded was from Strathclyde 11 at 1 Hz, measuring only 7 mN. This means, it needs 1943, 
and 6715 actuators, to generate 13.6 N, and 47 N respectively.  
0
1
2
3
4
5
B
lo
ck
in
g 
Fo
rc
e 
m
N
/c
m
2
IPMC Samples
Blocking Force per surface area at 1 Hz
0
1
2
3
4
5
B
lo
ck
in
g 
Fo
rc
e 
m
N
/c
m
2
IPMC Samples
Blocking Force per surface area at 2 Hz
180 
 
 Summary 
This chapter illustrated the characterisation of the Commercial and Strathclyde IPMC 
actuators. These findings will be discussed in more detail in chapter 6 to compare them with 
the requirements of the proposed device. The next chapter will demonstrate the possibility 
of using IPMC to power the proposed device.  
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Chapter 5 
Power Harvesting and Sensing 
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 Power Harvesting and Sensing 
 Introduction  
Power harvesting is the ability of the device to efficiently collect energy from the 
environment. Harvesting systems are defined as systems that can transform dusty 
environmental energy into electrical energy. These systems have aroused considerable 
interest in the last two decades. Researchers focused on transforming mechanical 
environmental vibration into electrical energy (Brufau-Penella, Puig-Vidal et al. 2007). 
Electroactive Polymer (EAP) is a material that exhibits a measurable response to a given 
stimuli, most commonly a change in shape or voltage potential (Biddiss and Chau 2006). When 
the IPMC sheet mechanically deforms (bending, stretching, or mechanically pressing), the 
electrode surface deforms, and the IPMC produces a voltage in the range of millivolts, as 
shown in Figure 5.1.  
 
Figure 5.1 IPMC as a sensor (Shahinpoor 2009) 
Currently, there are a few reasons for this generated voltage; one is based on the movement 
of the electrical charges, and the other is based on the electrical properties of the electrode. 
The first; It is believed that this voltage potential is generated by a shift of mobile charges 
caused by material stresses induced by deformation, resulting in charge imbalance (Biddiss 
and Chau 2006). The second; it is believed the deformations in the electrode surface cause 
proportional changes in the surface resistance. This is most probably caused by the nature of 
the cracked surfaces of metal electrodes to extend cracks when being extended, comparing 
to normal state (Hunt, Punning et al. 2008). Figure 5.2 shows the typical electrical response 
of IPMC under an oscillating excitation.  
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Figure 5.2 Typical voltage response of an IPMC strip ( 10x40x0.2 mm) under oscillating mechanical excitation 
(Shahinpoor 2009) 
(Kim and Shahinpoor 2003, Shahinpoor 2009) Designed Material Testing System (MTS) that 
was used to apply a consistent pure compressive loads of 200 N and 350 N across the surface 
of an IPMC sheet (2x2 cm). The output pressure response for the 200 N load was 80 mV in 
amplitude, and for the 350 N it was 108 mV. This type of power generation may be useful in 
heels of boots and shoes or places where there is a lot of foot or car traffic. 
During bending, IPMCs exhibit as both capacitors and resistors. They are represented as 
distributed RC line model (Punning, Johanson et al. 2009, Moeinkhah, Akbarzadeh et al. 
2014). The cumulated charge depends on the testing conditions, such as temperature and 
humidity (Kruusamäe, Punning et al. 2015). This advantage is very useful in many application, 
such as measuring changes in angles, position sensing, and vibration detection (Punning, 
Kruusmaa et al. 2007). For example, IPMC size 12x6.2 cm generated a 3 nW at an oscillation 
frequency of 7.09 rads-1 (1.12 Hz) (Brufau-Penella, Puig-Vidal et al. 2007). Figure 5.3 shows 
the electrical response of IPMC under different testing conditions. 
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Figure 5.3 IPMC response to (a) 1 Hz, 90o bending stimuli; (b) 0.5 Hz, 90o bending stimuli and (c) an alternating 90o and 
30o stimuli (Biddiss and Chau 2006) 
A Self-sensing piezoelectric actuator was also reported, where an electric charge is used to 
estimate the position and the velocity (Kruusamäe, Punning et al. 2015), a Nafion based 
accelerometer was also reported (Shahinpoor and Kim 2004), and an Ionic actuator used as a 
humidity sensor was demonstrated (Tailoka, Fray et al. 2003, Must, Johanson et al. 2013). 
IPMC are multifunctional materials, can be used as actuators and sensors in the same time, 
where they required working in some environments without a power supply, such as wireless 
sensors. The transduction capabilities of IPMC can be reversible so that they can sense 
external stimuli and react to them (De Luca, Digiamberardino et al. 2013).  
(Kruusamäe, Brunetto et al. 2010) Created self-sensing IPMC actuators by patterning its 
surface and creating separate actuator and sensor. This new IPMC could be used as an 
actuator with sensor providing a feedback for a better control. Figure 5.4 shows the self-
sensing IPMC. 
 
Figure 5.4 Self-sensing IPMC actuator (Kruusamäe, Brunetto et al. 2010) 
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 Experiment Setup 
This test was divided into two experiments; the first one was to measure the voltage 
generated under an oscillating excitation, and the other one was to measure the generated 
electrical current under the same excitation. 
To measure the generated voltage, the IPMC samples were placed in a cantilever 
configuration, where the sample was fixed at one end using the alligator clip, while the other 
end was left free to move. Both ends of the alligator clip were connected to NI 6225 DAQ 
module, which was used as an Analogue to Digital Converter (ADC), and then linked to Lab 
View 2015. The software was used to display, record, and save generated voltage. Later, the 
data were used to calculate the RMS voltage, which is the DC equivalent of the generated AC 
voltage. Figure 5.5, and Figure 5.6 show the front panel and the block diagram of the Lab 
View respectively.  
 
Figure 5.5 Front Panel of Lab View 
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Figure 5.6 Block Diagram of Lab View 
The excitation mechanism used a DC motor with a polypropylene arm to swing the IPMC 
sample. The motor was driven at low-frequency F=0.33 Hz, which is the same as the normal 
breathing frequency. Figure 5.7 shows the DC motor with the polypropylene arm. 
 
Figure 5.7 DC Motor with a polypropylene arm 
Equation (5.1) was used to calculate the RMS voltage 
𝑉𝑅𝑀𝑆 =
𝑉𝑚𝑎𝑥
√2
       (5.1) 
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Figure 5.8 shows the full experiment setup to measure the generated voltage by an 
oscillating excitation. 
 
Figure 5.8 Generated voltage test setup 
To measure the electrical current, a similar setup was used. Both ends of alligator clip were 
connected through an 8 Ω resistor, and a multimeter was used to record the flowing current. 
The same excitation mechanism was used to measure the electric current. Figure 5.9 shows 
the full experiment setup to measure the electrical current by an oscillating excitation. 
 
Figure 5.9 Current test setup 
Finally, equation (9) was used to calculate the maximum power generated from each sample, 
generated power density per weight, and per surface area. 
 Result 
Figure 5.10 shows a comparison of the voltages generated from all IPMC samples. 
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Figure 5.10 IPMC Power Harvesting 
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Table 5.1 shows the values of the generated voltage for all samples. 
 
Current 
(µA) 
Vp-p 
(mV) 
Vrms 
(mV) 
Power 
(mW) 
Power/ Weight 
(µW/mg) 
Power/ Surface area 
(µW/cm2) 
Commercial 1 2 80 56.56 0.113 1.35 66.54 
Commercial 2 5 20 14.14 0.070 0.78 41.59 
Commercial 3 12 2 1.41 0.16 0.24 9.98 
Commercial 4 14 25 17.68 0.247 3.71 145.56 
Commercial 5 56 80 56.56 3.167 37.23 1863.15 
Commercial 6 100 500 353.5 35.35 48.09 20794.12 
Strathclyde 1 15 40 28.28 0.424 3.92 249.53 
Strathclyde 2 65 60 42.42 2.757 32.45 1621.94 
Strathclyde 3 65 70 49.49 3.216 31.96 1892.26 
Strathclyde 4 74 200 141.40 10.46 82.52 6155.06 
Strathclyde 5 72 30 21.21 1.527 18.14 898.31 
Strathclyde 6 32 5 3.54 0.113 1.41 66.54 
Strathclyde 7 20 180 127.26 2.545 28.02 1497.18 
Strathclyde 8 4 3 2.12 0.008 0.08 4.99 
Strathclyde 9 52 15 10.61 0.551 5.22 324.39 
Strathclyde 10 21 2 1.41 0.029 0.36 17.47 
Strathclyde 11 15 2 1.41 0.021 0.2 12.48 
Table 5.1 Voltage, Current, and Power generated from IPMC 
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Figure 5.11 shows the maximum current generated by all IPMC. 
 
Figure 5.11 Current generated from IPMCs 
Figure 5.12 shows the Vp-p generated by all IPMC. 
 
Figure 5.12 Peak to peak voltage generated from all IPMCs 
 
 
 
 
1
10
100
C
u
rr
en
t 
µ
A
IPMC Samples
Current  Generated
1
10
100
V
o
lt
ag
e 
m
V
IPMC Samples
Voltage Generated p-p 
191 
 
 
Figure 5.13 shows the VRMS generated by all IPMC. 
 
Figure 5.13 RMS voltage generated from all IPMCs 
Figure 5.14 shows the maximum power generated by all IPMC. 
 
Figure 5.14 Maximum power generated from all IPMCs 
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Figure 5.15 shows the maximum power generated per weight by all IPMC. 
 
Figure 5.15 Maximum power generated per weight from all IPMCs 
Figure 5.16 shows the maximum power generated per surface area by all IPMC. 
 
Figure 5.16 Maximum power generated per surface area from all IPMCs 
 Summary 
This test presented the electrical power that could be generated by the IPMC if they were 
placed on the diaphragm as proposed earlier. The results showed that IPMC consumed power 
far more that it could generate, for example, sample 2 generated 65 µA, 42.42 mV while 
consumed 100 mA, 6V.  
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Chapter 6 
Discussion  
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 Discussion 
 Introduction 
Heart failure is one of the leading causes of death worldwide; several solutions have been 
developed to provide support for the failing heart over the last few years. These solutions are 
largely suitable for adult patients, leaving paediatrics with a few options other than using 
heavy and bulky devices connected to their tiny bodies. In the recent years, many researchers 
tried to develop a VAD technology for paediatric patients, which are both miniaturised and 
biocompatible. Ideally, such devices should permit mobility in the paediatric patient and 
provide a suitable cardiac support appropriate to their age. 
In this thesis, a novel method was presented to develop a new type of VAD for paediatrics. 
The proposed device benefits from advanced technologies in the field of Artificial Muscles 
developed to deliver VAD solutions for paediatrics. The solution proposed in the thesis 
suggested creating a thin layer of Artificial Muscles that envelop the failing heart and work as 
a contraction mechanism to support the circulation. The main advantage of this new 
approach is that it will not be in contact with the patient’s blood, which will eliminate the risk 
of blood infection, haemolysis, and blood clotting.  
 Device Requirements 
The development of the proposed device started with defining the mechanical demands of 
the new VAD. The first was to estimate the compression force needed to contract the heart. 
A simple analogy was used to calculate the required compression force. The left ventricle was 
assumed to have a conical shape, the applied force is uniform on the surface of the heart, and 
the pressure inside the heart is a known parameter. Then, the compression force applied to 
the wall of the heart can be easily estimated. The results suggested that a compression force 
of 1.36 N for paediatrics and 47 N for adults. 
The second requirement was determining the distance the device needed to travel to match 
the changes in the ventricle diameter. This was measured as a percentage of the difference 
between the end systolic, and the end diastolic diameter of the left ventricle. It was found 
that the proposed device should be able to shrink its diameter by 20% to 50% from its original 
form. 
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The last factor to be determined was the working frequency of the proposed device. This was 
simply estimated from the average heart rate, which was found to be between 60 BPM to 130 
BPM. As a result, the proposed device effective range should be between 1 and 2 Hz. 
 Primary Investigation Phase 
The first phase of the project started by reviewing all IPMC Artificial Muscles available 
commercially, and choosing the most suitable one for the application. As Artificial Muscles 
are still under development, only a few suppliers are available to supply IPMC. An IPMC 
beginner kit was purchased for evaluation, containing four platinum coated IPMCs and an 
IPMC driver. Towards the end of the project, two more samples were bought from the same 
supplier; the first was platinum plated, and the second was gold. 
In the initial bench test, the IPMC showed a clear mechanical response when electrically 
stimulated. The IPMC driver supplied a square wave with a variable frequency and amplitude. 
Different response times were achieved between dry and wet conditions. In the dry 
conditions, the samples were able to actuate for less than a minute before totally drying out 
and freezing, while in the wet conditions, the samples were able to move for a couple of 
minutes before again drying out. It was evident there was a link between the actuation time 
and the hydration level of the samples. Increasing the voltage also resulted in a shorter 
lifespan before drying out. Higher voltages more than 7 V caused the material to overheat 
and left some marks around the retaining interface. IPMC showed a better response at low 
frequencies. By increasing the frequency, the response of the materials dropped very rapidly 
in both wet and dry conditions.  
 After this investigation, it was found that IPMCs have the potential to be used in the proposed 
device. To quantify their mechanical and electrical properties, more samples were needed in 
different thicknesses, shapes, and coating metals. Therefore, the project would move to the 
next phase, which was manufacturing IPMC at the University of Strathclyde for 
characterisation and evaluation.    
 Fabrication of IPMC 
The second phase of the project started by adapting the non-electric protocol to fabricate the 
IPMC Artificial Muscles. Previous researchers (Chen, Um et al. 2011, De Luca, Digiamberardino 
et al. 2013) have described the process extensively, with various approaches adopted, 
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designed for specific applications. The process of making IPMC has different steps, and the 
final result depends on the accuracy of following these measures. The early attempts to make 
IPMC were not successful, as the membrane lacked mechanical integrity, or were not 
structurally complete. To achieve the best results, the temperature was increased very slowly 
to prevent the membrane from curling and breaking. Stirring the solution was also another 
challenge; a rotator blade was used to stir the solution during the different stages of 
fabrication. If the blades were close to the membrane, they would cause some damage to the 
surface and leave some scraping marks which would result in a rejected IPMC. The criticality 
of these process steps illustrates the sensitivity of the complex fabrication process and the 
impact of process control on the final device function. 
As the project progressed, the fabrication of IPMC was also developing. Different changes 
were made to the original fabrication protocol, such as repeating some steps, modifying the 
temperature increments, or using different metal solution. This led to the production of 
different samples from various protocols. Eight different protocols were used to produce 11 
IPMC samples. The complexity of the manufacturing process was a key element of the device 
development and reflects the relative immaturity of this aspect of the material science. 
At the end of this phase of the project, two groups of IPMC were ready for material tests and 
characterization; the first was the commercially purchased IPMC. The second group was the 
IPMC fabricated at the University of Strathclyde.   
 IPMC Driver 
The actuation of IPMC depends on the electrical driving signal’s parameters, such as shape, 
frequency, amplitude, and current. The beginner kit came with a simple driver powered by a 
9V battery. This option was not able to provide sufficient current and was not able to control 
the signal parameters accurately. Therefore, a new IPMC driver was developed to offer the 
ability to adjust the shape of the signal, the frequency, and the amplitude, besides providing 
sufficient current to drive the IPMC actuators.   
The first iteration of the driver developed used a voltage-controlled oscillator IC (XR-2209) to 
generate a square and triangle wave, and IC OPA548T was used as a current amplifier. The 
amplitude and frequency were controlled by potentiometers. This option was similar to the 
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driver in the beginner kit but could provide a higher current. This design suffered from low 
accuracy and the lack of monitoring the parameters of the generated signal. 
The second iteration relied on a signal generator to generate and control the signal 
parameters. The output was connected to a current amplifier. This system was more accurate 
and was able to show the elements of the generated signal for monitoring purposes. The main 
disadvantage of this system was the lack of ability to record the generated signal for further 
comparison. 
The final iteration was based on three main components; LabView software, NI USB 6225 DAQ 
system, and a current amplifier. This option was by far the most appropriate; LabView was 
used to generate, control, monitor, and record the driving signal. The DAQ system was used 
as a connection between LabView and the current amplifier.  
From the literature (Yu, Shen et al. 2007), it was found that a square wave was the best option 
to get the maximum response from IPMC actuators. Therefore, other waves were eliminated, 
and the driver used only square wave for mechanical and electrical characterisation. 
 Quality of IPMC Fabrication 
There are several factors that may be used to determine the quality of the fabricated IPMC. 
These factors include: 
 Surface  
 Thickness  
 Water Uptake 
 Surface Resistance 
At this stage of the project, IPMC samples from both groups, the Commercial and Strathclyde, 
were tested to check the quality of the IPMC fabrication process.  
 Surface Tests 
The surface test is one of the most common and easy methods used to assess the quality of 
the IPMC. Two main approaches were used in this test; the first was to scan the top surface 
of the electrode to give an idea of the consistency of the metal deposition on the polymeric 
membrane. The second test was to examine the cross section of the membrane to have an 
idea of the depth of the metal particles penetration inside the membrane. Both aspects have 
a significant effect on the behaviour of the IPMC actuator.    
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Two issues were considered in the top surface test; the first was a uniform and smooth layer 
of metal particles spread on the membrane surface. The second was a surface with no cracks 
or isolated sections. These two most important aspects have a huge effect on the surface 
resistance and give a clear indication of the quality of the fabrication process.  
The results of the Commercial 5 IPMC showed the top surface has a smooth, consistent layer 
of platinum deposited equally across the surface of the membrane. Also, there are no signs 
of any cracks, islands, or grooves on the electrode surface. Compared with the Strathclyde 11 
IPMCs, the surface looked very rough with multiples grooves appearing under the SEM 
images. Strathclyde 5 IPMC after some modifications to the fabrication protocol, the surface 
looked smoother and more consistent but has many cracks that form isolated sections or 
islands. This has a huge effect on the surface resistance and the performance of the actuator.  
Strathclyde 3 IPMC, one of the most recently manufactured IPMC, has a clear, smooth surface, 
and the islands have almost disappeared.  These images showed a clear indication of the 
improvements of the fabrication process, which suggest that the fabricated IPMCs were made 
successfully through the evolution of our process. 
The cross section test focused on the penetration of the metallic particles inside the polymer. 
This penetration is critical to enhancing the performance of IMPC actuators, which can be 
achieved by repeating the plating process several times. Both groups, Commercial and 
Strathclyde, showed a clear layer of metal deposited on both sides of the membrane with 
different thicknesses depending on the fabrication protocol. Once again, this demonstrated 
adequate fabrication emerging from our development cycle.  
 IPMC Thickness 
The thickness test was used to measure the final thickness of the IPMC actuators and the 
depth of particles penetrations inside the membrane. Both of these measurements were signs 
of the quality of the fabrication process.  
All Strathclyde samples have a total thickness between 180 µm and 195 µm, which is very 
close to the results of the Commercial samples. The electrode thickness results showed a 
range between 7 and 15 µm for the fabricated Strathclyde IPMC, which was less than the 
Commercial IPMC. This suggested that the Commercial samples might have been subjected 
to extra coating steps. On the other hand, the Strathclyde sample results match the results 
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found in the literature (Nguyen, Lee et al. 2007). The thickness of Pt particles deposited on 
the surface of the membrane is between 7 and 9 µm (see section 4.22.3), which again gave 
an indication of healthy fabricated Strathclyde IPMC samples. The difference in depth of the 
metallic particle penetration inside the membrane between Strathclyde samples and 
Commercial samples suggested that the Commercial samples might have a slightly different 
fabrication protocol that allowed the metal particles to penetrate deep in the membrane. 
 Water Uptake 
Water molecules are the primary driving mechanism of actuation inside the IPMC membrane. 
That is why water uptake is a useful parameter to determine the ability of IPMC to actuate 
more efficiently. The test simply compared the different values of the wet and the dry IPMC, 
and the difference will represent the water uptake. 
Both groups showed similar results. They all fall in the range between 14% and 24%, which 
was very close to the 16.7% value found in the literature (Inamuddin, Khan et al. 2015). This 
suggested that the fabricated Strathclyde samples were able to absorb water to the required 
limit.      
 Surface Resistance 
Surface resistance is a significant parameter representing the quality of the electrode. Two 
methods were used to measure the surface resistance; Ω/□, and Ω/cm. 
The results showed different values in resistance in the fabricated group; this could be as a 
result of the isolated sections and grooves on the electrode surface. Some samples showed 
larger values than the ones reported in the literature, (see section 4.5).   
 Electrical Power Consumption 
Measuring power consumption is vital for the design of the proposed device. This will give an 
idea of the essential power source needed to run the proposed VAD. The measurement was 
simply based on recording the current consumption, the voltage applied and then calculating 
the electrical power consumed.  
Most of the samples showed no difference in the current or power consumption under 
different frequencies, apart from Commercial 2, and Strathclyde 2, where they showed a 
decrease in the current and power consumption with increasing the frequency.  
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 Displacement Test 
This test was designed to measure the tip displacement of the IPMC samples under different 
frequencies. When IPMC is activated by a low-frequency signal, it will start to bend and then 
relax back to its neutral state. This phenomenon was reported by (Nguyen, Lee et al. 2007) 
and called Back Relaxation. This happened because of water leaking from the IPMC surface, 
and electrolysis, which results in a dry IPMC. 
It is apparent from the figures that the tip displacement decreased by increasing the 
frequency. At DC the tip displacements for Strathclyde 1, and 2 were around 14 mm, and they 
dropped to less than 1 mm at 2 Hz. This happened because water molecules did not have 
enough time to move inside the membrane when switching the polarity between the 
electrodes. These results match the findings of the previous researchers (Chung, Fung et al. 
2006, Liu, McDaid et al. 2011). 
 Mechanical Blocking Force 
This test was the main core of the project to find out the mechanical power generated from 
the IPMCs. It was found that most IPMC produced a mechanical force in the range of mN, 
depending on the thickness and size of the actuator, as reported previously (Trabia, Hwang 
et al. 2016).  
Commercial 6 produced the highest force at a low frequency, 70 mN at 0.05 Hz, and then the 
mechanical power decreased by increasing the frequencies to 11 mN at 2 Hz. It was also 
noticed that the mechanical response was fading after few cycles, this could be explained by 
water evaporation, and the samples were drying out. Another observation was the time 
difference between the driving signal activating the IPMC, and the IPMC producing the 
mechanical response. This happened at both high and low frequencies due to the time 
needed for the ions to move to the cathode side.     
The mechanical outputs recorded from Strathclyde group were smaller than the Commercial 
samples in general. The shape of the recorded signal was not consistent due to the twisting 
tip of the Strathclyde samples. The delay between the application of the electrical signal and 
the start of the mechanical response was observed as well in all frequencies.   
From the previous figures, it was found that the maximum response recorded was from 
Commercial 6 at 0.05 Hz, recording 74 mN. In the Strathclyde group, Strathclyde 11 produced 
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the highest value, recording 7 mN at 1 Hz. Comparing these findings with the required 
mechanical compression force  (13.6 N for paediatric and 47 N for adults), it was found that 
it needs 183 samples of Commercial 6 (134.6 g, 0.031 m2 ), or 1943 samples of Strathclyde 11 
(206 g, 0.33 m2) to match the 13.6 N required for a paediatric VAD. Also, it needs 635 samples 
of Commercial 6 (465.3 g, 0.108 m2), or 6715 samples of Strathclyde 11 (712 g, 1.14 m2) to 
match the 47 N required for an adult VAD. Power consumption was found to be far from 
practical as well; to power a VAD made from Commercial 6 IPMC it needs (91.5A, 549 W), and 
(317.8 A, 1906.8 W) for paediatric and adult respectively, while Strathclyde 11 needs (582.9 
A, 3294 W), and (2014.5 A, 11440.8 W) for paediatric and adult respectively.   
Although the project used the best commercial IPMC available, it is evident from the results 
that the IPMC actuators are still immature materials, mechanically weak, and consume a 
significant amount of electrical power to generate a tiny mechanical response. It needs to 
combine thousands of IPMC actuators to build the proposed device, which will result in a 
bulky, heavy and high power consumption VAD. This device will be far from practical and, 
does not fit the requirements of a paediatric VAD. IPMC as a science is still developing, and 
step changes in IPMC technology are required to enhance the material before being able to 
achieve such a task. What is needed is a material that is two orders of magnitude stronger 
and consumes electrical power one order lower of magnitude.   
Therefore, it is clear that IPMC is not suitable yet to be used in creating a paediatric VAD. 
However, it was considered that there might be other applications for IPMC technologies 
resulting from this work. In particular, they might be used as electric power generators for 
other implantable devices.   
 Power Harvesting and Sensing 
The second purpose of developing IPMC was to use them for power harvesting inside the 
patient’s body. Interestingly, by reversing the concept explained previously, IPMC could be 
used to generate electrical power when mechanically deformed; this principle was 
investigated to find out if they have the ability to produce enough electrical power to charge 
a battery, or run an implantable device directly.  
A heart powered by the heart, or a heart powered by diaphragm concept could be achieved 
by placing the IPMC on the heart, the diaphragm, or any other continuous moving organ, and 
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then collecting the generated electrical power and use it to run a low power consumption 
VAD or other implantable devices, such as pacemakers, or sensors. This concept could 
contribute towards partially powering an existing VAD, which will offer an extra level of 
independence for the VAD patients. This extra time, offered by the new concept, is not to be 
underestimated, as it could be lifesaving. 
The proposed suggestion was to place the IPMC on top of the patient’s diaphragm, where 
they will generate electricity while the patient is breathing. To illustrate this concept, IPMC 
samples were mechanically deformed at low frequency 0.33 Hz to match the breathing rate, 
the electrical voltage and current were recorded. 
It is obvious there was a huge difference between the generated voltages from the various 
samples. Most of the samples produced a voltage between -50 mV to 150 mV with only a few 
samples below or above that range. Commercial 6 produced the highest voltage and current, 
recording 353.5 mV, and 100 µA respectively, which means it needs 500 mA/100 µA= 5000 
samples of Commercial 6 to provide enough current to drive a VAD. While Strathclyde 4 
produced the highest values from the fabricated Strathclyde group recording 141.40 mV, and 
74 µA for the voltage and current respectively, which meant it needs at least 540 samples of 
Strathclyde 4 to drive a VAD.  
It is evident that the electrical energy level produced from IPMC is still minimal and it needs 
to deform hundreds of IPMCs to generate enough power to run one IPMC. There is a potential 
for developing the material to improve its efficiency in energy harvesting. The focus should 
be on using IPMC to power an implantable device. Therefore, it is evident that IPMC is not 
suitable yet to be used in generating electrical power to run a paediatric VAD, but it has the 
potential to achieve this goal and could produce power for lower consumption devices, such 
as sensors. 
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 Results in the Context of Objectives 
In the context of the present study, a number of objectives were set at the outset of the work. 
These objectives are listed below, with a commentary on the degree to which these were 
met.  
1- Review the IPMC actuators and decide which one is suitable for creating a VAD- 100% 
2- Make IPMC materials in the lab – 100% 
3- Test the mechanical properties of the IPMC – 100% 
4- Test the electrical properties of IPMC – 100% 
5- Test the ability of IPMC to generate electricity – 100% 
6- Design and build a VAD made from IPMC – 0% 
7- Test the performance of the VAD – 0% 
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 Conclusion 
The aim of this project was to explore the development of a new self-powered miniaturised 
VAD for paediatric implantation. The current VADs for paediatrics offer a bulky and heavy 
solution that is associated with a high risk of infection, due to the cables connecting the VAD 
with the external controller. These options immobilise the patients in hospitals, which results 
in an expensive treatment cost.  
To achieve the aim of the project, newly developed Artificial Muscles were utilised. Amongst 
the various categories of Artificial Muscles, IPMC was found to be the best candidate for this 
project. After a successful fabrication of 11 samples of IPMC, a series of characterisation tests 
of the mechanical and electrical properties of the fabricated samples were conducted for 
performance evaluation. The work concluded that the mechanical power generated from the 
IPMC samples was not sufficient to compress the failing heart. Besides that, these samples 
demanded a large electrical current to operate, which made them unsuitable for such an 
implantable device. On the other hand, using IPMC for power harvesting was investigated. 
IPMCs showed promising results as an option to generate electricity that might power low 
demand implants, such as sensors.   
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 Limitation 
There were some limitations, which have impacts on the scope and the quality of the 
presented work including: 
1- Slow production of IPMC: IPMC fabrication is a very long and time-consuming chemical 
coating process; it needs more than a week to produce one sample. It includes various 
precise steps; any small mistake will result in a rejected sample.  
2- Control of IPMC bending motion: the bending motion was not uniform; membranes 
were twisting at different angles. These twisting motions were limiting the ability to 
measure the blocking force. 
3-   Bending Feedback: the system lacks a feedback to measure the IPMC movement 
when electrically stimulated.  
4- Low mechanical power output: Most of the samples produced mechanical responses 
in the range of mN, which is very difficult to detect, and requires a very accurate force 
sensor. It requires considerable attention to the surrounding environment, as any 
change in the testing conditions might affect the results. 
5- High electrical power consumption: connecting few IPMC samples together required 
a high current power source; each sample needs a few hundreds of mA. 
6- Automated testing system: developing an automated system for IPMC 
characterisation would make the testing faster and more efficient. 
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 Future work 
This project represented a proof of concept of developing IPMC Artificial Muscles for a VAD. 
Although the results did not support the proposed idea, there are still areas of improvement 
in the future to achieve that concept. These improvements include: 
1- Trying different metals for plating and coatings. 
2- Improving the force density per weight and surface area. 
3- Reducing electrical power consumption to make it suitable as an implantable device. 
4- Increasing sensing and power harvesting capabilities.    
5- Creating thin threads of IPMC and then weave them together to create a powerful 
structure.   
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 Appendices 
 IPMC Fabrication Protocols: 
 Protocol A 
1. Use sandpaper to rough both sides of the membrane, very gently (such as Norton 600A) 
(2sec/cm2).     
2. Clean the membrane in an ultrasonic water bath cleaner for about 10 minutes.  
3. Rinse the membrane with pure (deionised) water and boil at 80oC in a 2.4N aqueous 
solution of HCl for about 30 minutes. (Gloves must be used; HCl is a highly corrosive acid)  
4. Rinse the membrane again with pure water and boil in pure water for about 30 minutes to 
completely swell the membrane. (Hotplate is used to boil the membrane; carefully deal with 
the boiling water, do not move the plate with hot water, let it cool first and then move it) 
5. platinum-amine complex 
 Prepare 0.2% platinum-amine complex (Pt(NH3)4 Cl2) (tetra-amine platinum chloride 
hydrate, 98%) add 1 ml of NH4OH 30% to equalise the PH. Leave the solution for 3 
hours, preferably for the next day. 
 Immerse the membrane in the solution for 8 hours at room temperature slowly 
stirring the solution. The final amount of platinum deposited on the membrane must 
be about 3.75 mg/cm2 for each face of the membrane surface. This produces a pair of 
porous electrodes on the surface of the membrane. (Gloves must be used) 
6. Rinse the membrane again with pure water and immerse in a reducing solution consisting 
of 180 ml H2O, and 2 ml NaBH4 5% in a water bath at 40 degrees C while stirring at low speed 
(150 RPM). (Gloves must be used; this process must be done in a fume hood) 
 Add 2 ml NaBH4 5% every 30 minutes for about 3 and a half hours while gradually 
increasing the temperature to 60 degrees C 
 At which point add 20 ml NaBH4 5% and stir the mixture for an additional one and a 
half hours.  
 Rinse the membrane with pure water and store in a 0.5% solution of HCl for 1 hour, 
and store it in deionised water for the next day.  
7. Reducing agents: 
 Remove the membrane from the storage.  
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 Immerse the membrane in 0.5% HCl for 1 hour. 
 Rinse the membrane again with pure water and immerse in a solution containing 300 
ml H2O, 0.2 grams Pt(NH3)4Cl2, 6 ml H2NOH.HCl 5% (hydroxylamine hydrochloride, 
99%), 3 ml H2NNH2.H2O 20% (hydrazine monohydrate, 98%), and 0.5 ml NH4OH 30% 
(only NH4OH for the first time of the secondary reduction ) at 40 degrees C while 
stirring at low speed (approximately 60 RPM). (Gloves must be used; this process 
must be done in a fume hood) 
 Add reducing agents consisting of 6 ml H2NOH.HCl 5% and 3 ml H2NNH2.H2O 20% every 
30 minutes for 4 hours while gradually increasing the temperature to 60 degrees C 
(Gloves must be used, Hot plate is used to heat the solution, do not move the plate 
with hot solution, let it cool first and then move it) 
 After the process is over, test the solution containing the membrane for any residual 
Pt by boiling 2 ml of the solution with 2 ml NaBH4 5%. If the colour of the mixture turns 
black, the addition of reducing agents must continue for a longer time. If no colour 
change is visually detected, the process is complete. (Gloves must be used; Hot plate 
is used to heat the solution, do not move the plate with hot solution, let it cool first 
and then move it) 
 Note: Step 7 is part of the developing process to deposit more platinum in the polymer 
matrix.  
8. Rinse the membrane again with pure water and then with 0.1 N NaOH solution to replace 
H+ cations in the membrane with Na+ cations overnight.  
9. Repeat the process: 
 Repeat Steps 7, and 8  
 Rinse with pure water.  
 When reduction is complete, rinse the membrane with pure water and then boil with 
0.1N HCl solution for 30 min to remove any other cations in the membrane. (Gloves 
must be used; HCl is a highly corrosive acid)  
 Store the membrane in pure water at room temperature.  
 Clean the membrane in an ultrasonic cleaner for 5 seconds and removed 
 Note: Step 9 repeats the developing process to increase the amount of platinum 
deposited. If one starts out with a higher concentration of platinum salt in step 7, it is 
possible to deposit sufficient platinum on the membrane on the first pass, thereby 
eliminating the need for step 11. However, this will increase the risk of oxidation as 
well as crowding phenomena on surfaces of the membrane in a short period.  
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 Protocol B 
1. Use sandpaper to rough both sides of the membrane, very gently (such as Norton 600A) 
(2sec/cm2).     
2. Clean the membrane in an ultrasonic water bath cleaner for about 10 minutes.  
3. Rinse the membrane with pure (deionised) water and boil at 80oC in a 2.4N aqueous 
solution of HCl for about 30 minutes. (Gloves must be used; HCl is a highly corrosive acid)  
4. Rinse the membrane again with pure water and boil in pure water for about 30 minutes to 
completely swell the membrane. (Hotplate is used to boil the membrane; carefully deal with 
the boiling water, do not move the plate with hot water, let it cool first and then move it) 
5. platinum-amine complex 
 Prepare 0.2% platinum-amine complex (Pt(NH3)4 Cl2) (tetra-amine platinum chloride 
hydrate, 98%) add 1 ml of NH4OH 30% to equalise the PH. Leave the solution for 3 
hours, preferably for the next day. 
 Immerse the membrane in the solution for 8 hours at room temperature slowly 
stirring the solution. The final amount of platinum deposited on the membrane must 
be about 3.75 mg/cm2 for each face of the membrane surface. This produces a pair of 
porous electrodes on the surface of the membrane. (Gloves must be used) 
6. Rinse the membrane again with pure water and immerse in a reducing solution consisting 
of 180 ml H2O, and 2 ml NaBH4 5% in a water bath at 40 degrees C while stirring at low speed 
(150 RPM). (Gloves must be used; this process must be done in a fume hood) 
 Add 2 ml NaBH4 5% every 30 minutes for about 3 and a half hours while gradually raise 
the temperature to 60 degrees C 
 At which point add 20 ml NaBH4 5% and stir the mixture for an additional one and a 
half hours.  
 Rinse the membrane with pure water and store in a 0.5% solution of HCl for 1 hour, 
and store it in deionised water for the next day.  
7. Reducing agents: 
 Remove the membrane from the storage.  
 Immerse the membrane in 0.5% HCl for 1 hour. 
 Rinse the membrane again with pure water and immerse in a solution containing 300 
ml H2O, 0.2 grams Pt(NH3)4Cl2, 6 ml H2NOH.HCl 5% (hydroxylamine hydrochloride, 
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99%), 3 ml H2NNH2.H2O 20% (hydrazine monohydrate, 98%), and 0.5 ml NH4OH 30% 
(only NH4OH for the first time of the secondary reduction ) at 40 degrees C while 
stirring at low speed (approximately 60 RPM). (Gloves must be used; this process 
must be done in a fume hood) 
 Add reducing agents consisting of 6 ml H2NOH.HCl 5% and 3 ml H2NNH2.H2O 20% every 
30 minutes for 4 hours while gradually increasing the temperature to 60 degrees C 
(Gloves must be used, Hot plate is used to heat the solution, do not move the plate 
with hot solution, let it cool first and then move it) 
 After the process is over, test the solution containing the membrane for any residual 
Pt by boiling 2 ml of the solution with 2 ml NaBH4 5%. If the colour of the mixture turns 
black, the addition of reducing agents must continue for a longer time. If no colour 
change is visually detected, the process is complete. (Gloves must be used; Hot plate 
is used to heat the solution, do not move the plate with hot solution, let it cool first 
and then move it) 
 Note: Step 7 is part of the developing process to deposit more platinum in the polymer 
matrix.  
8. Repeat the process 7 
9. Rinse with pure water 
10. When reduction is complete, rinse the membrane with pure water and then boil with 0.1N 
HCl solution for 30 min to remove any other cations in the membrane. (Gloves must be used; 
HCl is a highly corrosive acid)  
11. Rinse the membrane again with pure water and then with 0.1 N NaOH solution to replace 
H+ cations in the membrane with Na+ cations overnight.  
 Store the membrane in pure water at room temperature.  
 Clean the membrane in an ultrasonic cleaner for 5 seconds and removed 
 Note: Step 8 repeats the developing process to increase the amount of platinum 
deposited. If one starts out with a higher concentration of platinum salt in step 7, it is 
possible to deposit sufficient platinum on the membrane on the first pass, thereby 
eliminating the need for step 11. However, this will increase the risk of oxidation as 
well as crowding phenomena on surfaces of the membrane in a short period.  
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 Protocol C 
1. Use sandpaper to rough both sides of the membrane, very gently (ultrafine 600) (2sec/cm2).     
2. Clean the membrane in an ultrasonic water bath cleaner for about 10 minutes.  
3. Rinse the membrane with pure (deionised) water and boil at 80oC in a 2.4N aqueous 
solution of HCl for about 30 minutes. (Gloves must be used; HCl is a highly corrosive acid)  
4. Rinse the membrane again with pure water and boil in pure water for about 30 minutes to 
completely swell the membrane. (Hotplate is used to boil the membrane; carefully deal with 
the boiling water, do not move the plate with hot water, let it cool first and then move it) 
5. platinum-amine complex 
 Prepare 0.2% platinum-amine complex (Pt(NH3)4 Cl2) (tetra-amine platinum chloride 
hydrate, 98%) add 1 ml of NH4OH 30% to equalise the PH. Leave the solution for 3 
hours, preferably for the next day. 
 Immerse the membrane in the solution for 8 hours at room temperature slowly 
stirring the solution. The final amount of platinum deposited on the membrane must 
be about 3.75 mg/cm2 for each face of the membrane surface. This produces a pair of 
porous electrodes on the surface of the membrane. (Gloves must be used) 
6. Rinse the membrane again with pure water and immerse in a reducing solution consisting 
of 180 ml H2O, 0.5 ml NH4OH 30%, and 2 ml NaBH4 5% in a water bath at 40 degrees C while 
stirring at low speed (150 RPM). (Gloves must be used; this process must be done in a fume 
hood) 
 Add 2 ml NaBH4 5% every 30 minutes for about 3 and a half hours while gradually raise 
the temperature to 60 degrees C 
 At which point add 20 ml NaBH4 5% and stir the mixture for an additional one and a 
half hours.  
 Rinse the membrane with pure water and store in a 0.5% solution of HCl for the next 
day.  
7. Reducing agents: 
 Remove the membrane from the storage.  
 Rinse the membrane again with pure water and immerse in a solution containing 300 
ml H2O, 0.2 grams Pt(NH3)4Cl2, 6 ml H2NOH.HCl 5% (hydroxylamine hydrochloride, 
99%), 3 ml H2NNH2.H2O 20% (hydrazine monohydrate, 98%), and 0.5 ml NH4OH 30% 
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(only NH4OH for the first time of the secondary reduction ) at 40 degrees C while 
stirring at low speed (approximately 60 RPM). (Gloves must be used; this process 
must be done in a fume hood) 
 Add reducing agents consisting of 6 ml H2NOH.HCl 5% and 3 ml H2NNH2.H2O 20% every 
30 minutes for 4 hours while gradually increasing the temperature to 60 degrees C 
(Gloves must be used, Hot plate is used to heat the solution, do not move the plate 
with hot solution, let it cool first and then move it) 
 After the process is over, test the solution containing the membrane for any residual 
Pt by boiling 2 ml of the solution with 2 ml NaBH4 5%. If the colour of the mixture turns 
black, the addition of reducing agents must continue for a longer time. If no colour 
change is visually detected, the process is complete. (Gloves must be used; Hot plate 
is used to heat the solution, do not move the plate with hot solution, let it cool first 
and then move it) 
 Rinse with pure water 
8. First half, repeat step 7 (put the membrane in 0.5% HCl for 30 min before repeating the 
process) 
9. Use both halves now for the following steps: 
10. Boil with 0.1N HCl solution for 30 min to remove any other cations in the membrane. 
(Gloves must be used; HCl is a highly corrosive acid)  
11. Rinse the membrane again with pure water and then with 0.1 N NaOH solution to replace 
H+ cations in the membrane with Na+ cations overnight.  
12. Clean the membrane in an ultrasonic cleaner for 5 seconds and removed 
13. Store the membrane in pure water at room temperature.  
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 Protocol D 
1. Use sandpaper to rough both sides of the membrane, very gently (ultrafine 600) (2sec/cm2).     
2. Clean the membrane in an ultrasonic water bath cleaner for about 10 minutes.  
3. Rinse the membrane with pure (deionised) water and boil at 80oC in a 2.4N aqueous 
solution of HCl for about 30 minutes. (Gloves must be used; HCl is a highly corrosive acid)  
4. Rinse the membrane again with pure water and boil in pure water for about 30 minutes to 
completely swell the membrane. (Hotplate is used to boil the membrane; carefully deal with 
the boiling water, do not move the plate with hot water, let it cool first and then move it) 
5. platinum-amine complex: primary coating 
 Prepare 0.2% platinum-amine complex (Pt(NH3)4 Cl2) (tetra-amine platinum chloride 
hydrate, 98%) add 1 ml of NH4OH 30% to equalise the PH. Leave the solution for 3 
hours, preferably for the next day. 
 Immerse the membrane in the solution for 8 hours at room temperature slowly 
stirring the solution. The final amount of platinum deposited on the membrane must 
be about 3.75 mg/cm2 for each face of the membrane surface. This produces a pair of 
porous electrodes on the surface of the membrane. (Gloves must be used) 
6. Reducing process: 
Rinse the membrane again with pure water and immerse in a reducing solution consisting of 
180 ml H2O, 0.5 ml NH4OH 30%, and 2 ml NaBH4 5% in a water bath at 40 degrees C while 
stirring at low speed (150 RPM). (Gloves must be used; this process must be done in a fume 
hood) 
 Add 2 ml NaBH4 5% every 30 minutes for about 3 and a half hours while gradually raise 
the temperature to 60 degrees C 
 At which point add 20 ml NaBH4 5% and stir the mixture for an additional one and a 
half hours.  
 Rinse the membrane with pure water and store in a 0.5% solution of HCl for the next 
day.  
7. Secondary coating: 
 Remove the membrane from the storage.  
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 Rinse the membrane again with pure water and immerse in a solution containing 300 
ml H2O, 0.2 grams Pt(NH3)4Cl2, 6 ml H2NOH.HCl 5% (hydroxylamine hydrochloride, 
99%), 3 ml H2NNH2.H2O 20% (hydrazine monohydrate, 98%), and 0.5 ml NH4OH 30% 
(only NH4OH for the first time of the secondary reduction ) at 40 degrees C while 
stirring at low speed (approximately 60 RPM). (Gloves must be used; this process 
must be done in a fume hood) 
 Add reducing agents consisting of 6 ml H2NOH.HCl 5% and 3 ml H2NNH2.H2O 20% every 
30 minutes for 4 hours while gradually increasing the temperature to 60 degrees C 
(Gloves must be used, Hot plate is used to heat the solution, do not move the plate 
with hot solution, let it cool first and then move it) 
 After the process is over, test the solution containing the membrane for any residual 
Pt by boiling 2 ml of the solution with 2 ml NaBH4 5%. If the colour of the mixture turns 
black, the addition of reducing agents must continue for a longer time. If no colour 
change is visually detected, the process is complete. (Gloves must be used; Hot plate 
is used to heat the solution, do not move the plate with hot solution, let it cool first 
and then move it) 
 Rinse with pure water 
8. Repeat step 7 
9. Boil with 0.1N HCl solution for 30 min to remove any other cations in the membrane. 
(Gloves must be used; HCl is a highly corrosive acid)  
10. Rinse the membrane again with pure water and then with 0.1 N NaOH solution to replace 
H+ cations in the membrane with Na+ cations overnight.  
11. Clean the membrane in an ultrasonic cleaner for 5 seconds and removed 
12. Store the membrane in pure water at room temperature.  
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 Protocol E 
1. Use sandpaper to rough both sides of the membrane, very gently (ultrafine 600) (2sec/cm2).     
2. Clean the membrane in an ultrasonic water bath cleaner for about 10 minutes.  
3. Rinse the membrane with pure (deionised) water and boil at 80oC in a 2.4N aqueous 
solution of HCl for about 30 minutes. (Gloves must be used; HCl is a highly corrosive acid)  
4. Rinse the membrane again with pure water and boil in pure water for about 30 minutes to 
completely swell the membrane. (Hotplate is used to boil the membrane; carefully deal with 
the boiling water, do not move the plate with hot water, let it cool first and then move it) 
5. Prepare 0.2 g of tetraamine palladium (II) chloride in 100 ml water and leave the membrane 
there for 2h before immersing the membrane in Pt solution. 
6. platinum-amine complex: primary coating 
 Prepare 0.2% platinum amine complex (Pt(NH3)4 Cl2) (tetraamine platinum chloride 
hydrate, 98%) add 1 ml of NH4OH 30% to equalise the PH. Leave the solution for 3 
hours, preferably for the next day. 
 Immerse the membrane in the solution for 8 hours at room temperature slowly 
stirring the solution. The final amount of platinum deposited on the membrane must 
be about 3.75 mg/cm2 for each face of the membrane surface. This produces a pair of 
porous electrodes on the surface of the membrane. (Gloves must be used) 
7. Reducing process: 
Rinse the membrane again with pure water and immerse in a reducing solution consisting of 
180 ml H2O, 0.5 ml NH4OH 30%, and 2 ml NaBH4 5% in a water bath at 40 degrees C while 
stirring at low speed (150 RPM). (Gloves must be used; this process must be done in a fume 
hood) 
 Add 2 ml NaBH4 5% every 30 minutes for about 3 and a half hours while gradually raise 
the temperature to 60 degrees C 
 At which point add 20 ml NaBH4 5% and stir the mixture for an additional one and a 
half hours.  
 Rinse the membrane with pure water and store in a 0.5% solution of HCl for the next 
day.  
8. Secondary coating: 
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 Remove the membrane from the storage.  
 Rinse the membrane again with pure water and immerse in a solution containing 300 
ml H2O, 0.2 grams Pt(NH3)4Cl2, 6 ml H2NOH.HCl 5% (hydroxylamine hydrochloride, 
99%), 3 ml H2NNH2.H2O 20% (hydrazine monohydrate, 98%), and 0.5 ml NH4OH 30% 
(only NH4OH for the first time of the secondary reduction ) at 40 degrees C while 
stirring at low speed (approximately 60 RPM). (Gloves must be used; this process 
must be done in a fume hood) 
 Add reducing agents consisting of 6 ml H2NOH.HCl 5% and 3 ml H2NNH2.H2O 20% every 
30 minutes for 4 hours while gradually increasing the temperature to 60 degrees C 
(Gloves must be used, Hot plate is used to heat the solution, do not move the plate 
with hot solution, let it cool first and then move it) 
 After the process is over, test the solution containing the membrane for any residual 
Pt by boiling 2 ml of the solution with 2 ml NaBH4 5%. If the colour of the mixture turns 
black, the addition of reducing agents must continue for a longer time. If no colour 
change is visually detected, the process is complete. (Gloves must be used; Hot plate 
is used to heat the solution, do not move the plate with hot solution, let it cool first 
and then move it) 
 Rinse with pure water 
9. Repeat step 7 twice 
10. Boil with 0.1N HCl solution for 30 min to remove any other cations in the membrane. 
(Gloves must be used; HCl is a highly corrosive acid)  
11. Rinse the membrane again with pure water and then with 0.1 N NaOH solution to replace 
H+ cations in the membrane with Na+ cations overnight.  
12. Clean the membrane in an ultrasonic cleaner for 5 seconds and removed 
13. Store the membrane in pure water at room temperature.  
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 Protocol F 
1. Use sandpaper to rough both sides of the membrane, very gently (ultrafine 600) (2sec/cm2).     
2. Clean the membrane in an ultrasonic water bath cleaner for about 10 minutes.  
3. Rinse the membrane with pure (deionised) water and boil at 80oC in a 2.4N aqueous 
solution of HCl for about 30 minutes.  
4. Rinse the membrane again with pure water and boil in pure water for about 30 minutes to 
completely swell the membrane.  
5. platinum-amine complex: primary coating 
 Prepare 0.2% platinum amine complex (Pt(NH3)4 Cl2) (tetraamine platinum chloride 
hydrate, 98%) add 5 ml of NH4OH 30% to equalise the PH. Leave the solution for 3 
hours, preferably for the next day. 
 Immerse the membrane in the solution for 8 hours at room temperature slowly 
stirring the solution. The final amount of platinum deposited on the membrane must 
be about 3.75 mg/cm2 for each face of the membrane surface. This produces a pair of 
porous electrodes on the surface of the membrane.  
6. Reducing process: 
Rinse the membrane again with pure water and immerse in a reducing solution consisting of 
180 ml H2O, 5 ml NH4OH 30%, and 2 ml NaBH4 5% in a water bath at 40 degrees C while stirring 
at low speed (150 RPM). (Gloves must be used; this process must be done in a fume hood) 
 Add 2 ml NaBH4 5% every 30 minutes for about 3 and a half hours while gradually raise 
the temperature to 60 degree  
 At which point add 20 ml NaBH4 5% and stir the mixture for an additional one and a 
half hours.  
 Rinse the membrane with pure water and store in a 0.5% solution of HCl overnight. 
7. Repeat step 6. 
8.  Secondary coating: 
 Remove the membrane from the storage.  
 Rinse the membrane again with pure water and immerse in a solution containing 300 
ml H2O, 0.2 grams Pt(NH3)4Cl2, 6 ml H2NOH.HCl 5% (hydroxylamine hydrochloride, 
99%), 3 ml H2NNH2.H2O 20% (hydrazine monohydrate, 98%), and 5 ml NH4OH 30% 
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(only NH4OH for the first time of the secondary reduction ) at 40 degrees C while 
stirring at low speed (approximately 60 RPM).  
 Add reducing agents consisting of 6 ml H2NOH.HCl 5% and 3 ml H2NNH2.H2O 20% every 
30 minutes for 4 hours while gradually increasing the temperature to 60 degree  
 After the process is over, test the solution containing the membrane for any residual 
Pt by boiling 2 ml of the solution with 2 ml NaBH4 5%. If the colour of the mixture turns 
black, the addition of reducing agents must continue for a longer time. If no colour 
change is visually detected, the process is complete.  
 Rinse with pure water 
9. Repeat step 7 
10. Boil with 0.1N HCl solution for 30 min to remove any other cations in the membrane.  
11. Rinse the membrane again with pure water and then with 0.1 N NaOH solution to replace 
H+ cations in the membrane with Na+ cations overnight.  
12. Clean the membrane in an ultrasonic cleaner for 5 seconds and removed 
13. Store the membrane in pure water at room temperature.  
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 Protocol G 
1. Use sandpaper to rough both sides of the membrane, very gently (ultrafine 600) (2sec/cm2).     
2. Clean the membrane in an ultrasonic water bath cleaner for about 10 minutes.  
3. Rinse the membrane with pure (deionised) water and boil at 80oC in a 2.4N aqueous 
solution of HCl for about 30 minutes.  
4. Rinse the membrane again with pure water and boil in pure water for about 30 minutes to 
completely swell the membrane.  
5. Palladium-amine complex: primary coating 
 Prepare 0.2% Tetraamminepalladium(II) chloride monohydrate add 5 ml of NH4OH 
30% to equalise the PH. Leave the solution for 3 hours, preferably for the next day. 
 Immerse the membrane in the solution for 8 hours at room temperature slowly 
stirring the solution. The final amount of Palladium deposited on the membrane must 
be about 3.75 mg/cm2 for each face of the membrane surface. This produces a pair of 
porous electrodes on the surface of the membrane.  
6. Reducing process: 
Rinse the membrane again with pure water and immerse in a reducing solution consisting of 
180 ml H2O, 5 ml NH4OH 30%, and 2 ml NaBH4 5% in a water bath at 40 degrees C while stirring 
at low speed (150 RPM).  
 Add 2 ml NaBH4 5% every 30 minutes for about 3 and a half hours while gradually raise 
the temperature to 60 degree  
 At which point add 20 ml NaBH4 5% and stir the mixture for an additional one and a 
half hours.  
 Rinse the membrane with pure water and store in a 0.5% solution of HCl for 4 hours, 
and store it in deionised water for the next day.  
7. Repeat steps 5 and 6. 
8.  Secondary coating: 
 Remove the membrane from the storage.  
 Immerse the membrane in 0.5% HCl for 1 hour. 
 Rinse the membrane again with pure water and immerse in a solution containing 300 
ml H2O, 0.2 grams Tetraamminepalladium(II) chloride monohydrate, 6 ml H2NOH.HCl 
240 
 
5% (hydroxylamine hydrochloride, 99%), 3 ml H2NNH2.H2O 20% (hydrazine 
monohydrate, 98%), and 5 ml NH4OH 30% (only NH4OH for the first time of the 
secondary reduction ) at 40 degrees C while stirring at low speed (approximately 60 
RPM).  
 Add reducing agents consisting of 6 ml H2NOH.HCl 5% and 3 ml H2NNH2.H2O 20% every 
30 minutes for 4 hours while gradually increasing the temperature to 60 degree  
 After the process is over, test the solution containing the membrane for any residual 
Pt by boiling 2 ml of the solution with 2 ml NaBH4 5%. If the colour of the mixture turns 
black, the addition of reducing agents must continue for a longer time. If no colour 
change is visually detected, the process is complete.  
 Rinse with pure water 
9. Repeat step 7 
10. Boil with 0.1N HCl solution for 30 min to remove any other cations in the membrane.  
11. Rinse the membrane again with pure water and then with 0.1 N NaOH solution to replace 
H+ cations in the membrane with Na+ cations overnight.  
12. Clean the membrane in an ultrasonic cleaner for 5 seconds and removed 
13. Store the membrane in pure water at room temperature.  
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 Protocol H 
1. Use sandpaper to rough both sides of the membrane, very gently (ultrafine 600) (2sec/cm2).     
2. Clean the membrane in an ultrasonic water bath cleaner for about 10 minutes.  
3. Rinse the membrane with pure (deionised) water and boil at 80oC in a 2.4N aqueous 
solution of HCl for about 30 minutes.  
4. Rinse the membrane again with pure water and boil in pure water for about 30 minutes to 
completely swell the membrane.  
5. platinum-amine complex: primary coating 
 Prepare 0.2% platinum amine complex (Pt(NH3)4 Cl2) (tetraamine platinum chloride 
hydrate, 98%) add 5 ml of NH4OH 30% to equalise the PH. Leave the solution for 3 
hours, preferably for the next day. 
 Immerse the membrane in the solution for 8 hours at room temperature slowly 
stirring the solution. The final amount of platinum deposited on the membrane must 
be about 3.75 mg/cm2 for each face of the membrane surface. This produces a pair of 
porous electrodes on the surface of the membrane.  
6. Reducing process: 
Rinse the membrane again with pure water and immerse in a reducing solution consisting of 
180 ml H2O, 5 ml NH4OH 30%, and 2 ml NaBH4 5% in a water bath at 40 degrees C while stirring 
at low speed (150 RPM). (Gloves must be used; this process must be done in a fume hood) 
 Add 2 ml NaBH4 5% every 30 minutes for about 3 and a half hours while gradually raise 
the temperature to 60 degree  
 At which point add 20 ml NaBH4 5% and stir the mixture for an additional one and a 
half hours.  
 Rinse the membrane with pure water and store in a 0.5% solution of HCl for 4 hours, 
and store it in deionised water for the next day.  
7. Repeat steps 5 and 6. 
8.  Secondary coating: 
 Remove the membrane from the storage.  
 Immerse the membrane in 0.5% HCl for 1 hour. 
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 Rinse the membrane again with pure water and immerse in a solution containing 300 
ml H2O, 0.2 grams Pt(NH3)4Cl2, 6 ml H2NOH.HCl 5% (hydroxylamine hydrochloride, 
99%), 3 ml H2NNH2.H2O 20% (hydrazine monohydrate, 98%), and 5 ml NH4OH 30% 
(only NH4OH for the first time of the secondary reduction ) at 40 degrees C while 
stirring at low speed (approximately 60 RPM).  
 Add reducing agents consisting of 6 ml H2NOH.HCl 5% and 3 ml H2NNH2.H2O 20% every 
30 minutes for 4 hours while gradually increasing the temperature to 60 degree  
 After the process is over, test the solution containing the membrane for any residual 
Pt by boiling 2 ml of the solution with 2 ml NaBH4 5%. If the colour of the mixture turns 
black, the addition of reducing agents must continue for a longer time. If no colour 
change is visually detected, the process is complete.  
 Rinse with pure water 
9. Repeat step 7 
10. Boil with 0.1N HCl solution for 30 min to remove any other cations in the membrane.  
11. Rinse the membrane again with pure water and then with 0.1 N NaOH solution to replace 
H+ cations in the membrane with Na+ cations overnight.  
12. Clean the membrane in an ultrasonic cleaner for 5 seconds and removed 
13. Store the membrane in pure water at room temperature.  
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 Chemical Preparation 
Name Required How to prepare 
HCl (Hydrogen chloride) 36N 2.4N- 100ml Add 20.256 mL of HCl solution to 25 mL 
deionised water. Adjust the final volume of 
solution to 100 mL with deionised water 
HCl (Hydrogen chloride) 36N 0.5% - 100 
ml 
Add 1.38 ml of 36%HCl to 80 ml water and 
then continue adding water to reach 100 
ml 
HCl (Hydrogen chloride) 36N 0.1N   -100 
ml 
Add 0.844 mL of HCl solution to 25 mL 
deionised water. Adjust the final volume of 
solution to 100 mL with deionised water 
NaOH (Sodium hydroxide) 0.1 N -100 
ml 
0.4 g of NaOH per 100 ml 
Pd(NH3)4Cl2·H2O (Tetra 
ammine palladium(II) 
chloride monohydrate) 
99.99% - powder 
0.2% - 100 
ml 
Add 0.2 g Pd(NH3)4Cl2·H2O to 90 ml water 
and then continue adding water to reach 
100 ml 
(Pt(NH3)4 Cl2) (tetra-amine 
platinum chloride hydrate 
0.2% - 100 
ml 
Add 0.2 g Pt(NH3)4Cl2 to 90 ml water and 
then continue adding water to reach 100 
ml 
NH4OH )Ammonium 
hydroxide) 30% Liquid 
30% - 10 ml ready 
NaBH4 (Sodium borohydride) 
Powder 
5% - 50 ml Add 2.5 g NaBH4 to 40 ml water and then 
continue adding water to reach 50 ml 
H2NOH.HCl (Hydroxylamine 
hydrochloride) 99% - 
crystalline 
5% - 100 ml Add 5 g of H2NOH.HCl to 80  ml water and 
then continue adding water to reach 100 
ml 
H2NNH2.H2O (Hydrazine 
monohydrate) 65% - Liquid 
20% - 50 ml Add 15.38 ml of H2NNH2.H2O to 30 ml 
water and then continue adding water to 
50 ml 
Table 11.1 Chemicals preparation  
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 Top Surface Scans  
 Figure 11.1 shows all top surface scanning images of Commercial 1 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.1 SEM images of Commercial 1 
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Figure 11.2 shows all top surface scanning images of Commercial 2 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.2 SEM images of Commercial 2 
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Figure 11.3 shows all top surface scanning images of Commercial 3 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.3 SEM images of Commercial 3 
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Figure 11.4 shows all top surface scanning images of Commercial 4 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.4 SEM images of Commercial 4 
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Figure 11.5 shows all top surface scanning images of Commercial 5 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.5 SEM images of Commercial 5 
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Figure 11.6 shows all top surface scanning images of Commercial 6 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.6 SEM images of Commercial 6 
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Figure 11.7 shows all top surface scanning images of Strathclyde 1 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.7 SEM images of Strathclyde 1 
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Figure 11.8 shows all top surface scanning images of Strathclyde 2 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.8 SEM images of Strathclyde 2 
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Figure 11.9 shows all top surface scanning images of Strathclyde 3 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.9 SEM images of Strathclyde 3 
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Figure 11.10 shows all top surface scanning images of Strathclyde 4 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.10 SEM images of Strathclyde 4 
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Figure 11.11 shows all top surface scanning images of Strathclyde 5 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.11 SEM images of Strathclyde 5 
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Figure 11.12 shows all top surface scanning images of Strathclyde 6 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.12 SEM images of Strathclyde 6 
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Figure 11.13 shows all top surface scanning images of Strathclyde 7 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.13 SEM images of Strathclyde 7 
  
257 
 
Figure 11.14 shows all top surface scanning images of Strathclyde 8 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.14 SEM images of Strathclyde 8 
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Figure 11.15 shows all top surface scanning images of Strathclyde 9 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.15 SEM images of Strathclyde 9 
  
259 
 
Figure 11.16 shows all top surface scanning images of Strathclyde 10 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.16 SEM images of Strathclyde 10 
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Figure 11.17 shows all top surface scanning images of Strathclyde 11 IPMC under 6 different 
magnifications. 
  
  
  
Figure 11.17 SEM images of Strathclyde 11 
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Figure 11.18 shows the top surface scanning images of the fragments of Strathclyde 1 at stage 
4 under 6 different magnifications. 
  
  
  
Figure 11.18 SEM images of Strathclyde 1 Stage 4 
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Figure 11.19 shows the top surface scanning images of the fragments of Strathclyde 1 at stage 
5 under 6 different magnifications 
  
  
  
Figure 11.19 SEM images of Strathclyde 1 Stage 5 
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Figure 11.20 shows the top surface scanning images of the fragments of Strathclyde 1 at stage 
6 under 6 different magnifications. 
  
  
  
Figure 11.20 SEM images of Strathclyde 1 Stage 6 
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Figure 11.21 shows the top surface scanning images of the fragments of Strathclyde 1 at stage 
7 under 6 different magnifications 
  
  
  
Figure 11.21 SEM images of Strathclyde 1 Stage 7 
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Figure 11.22 shows the top surface scanning images of the fragments of Strathclyde 1 at stage 
8 under 6 different magnifications. 
  
  
  
Figure 11.22 SEM images of Strathclyde 1 Stage 8 
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Figure 11.23 shows the top surface scanning images of the fragments of Strathclyde 2 at stage 
1 under 6 different magnifications. 
  
  
  
Figure 11.23 SEM images of Strathclyde 2 Stage 1 
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Figure 11.24 shows the top surface scanning images of the fragments of Strathclyde 2 at stage 
2 under 6 different magnifications. 
  
  
  
  
Figure 11.24 SEM images of Strathclyde 2 Stage 2 
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Figure 11.25 shows the top surface scanning images of the fragments of Strathclyde 2 at stage 
3 under 6 different magnifications. 
  
  
  
Figure 11.25 SEM images of Strathclyde 2 Stage 3 
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Figure 11.26 shows the top surface scanning images of the fragments of Strathclyde 2 at stage 
4 under 6 different magnifications. 
  
  
  
Figure 11.26 SEM images of Strathclyde 2 Stage 4 
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Figure 11.27 shows the top surface scanning images of the fragments of Strathclyde 2 at stage 
5 under 6 different magnifications. 
  
  
  
Figure 11.27 SEM images of Strathclyde 2 Stage 5 
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Figure 11.28 shows the top surface scanning images of the fragments of Strathclyde 2 at stage 
6 under 6 different magnifications. 
  
  
  
Figure 11.28 SEM images of Strathclyde 2 Stage 6 
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Figure 11.29 shows the top surface scanning images of the fragments of Strathclyde 2 at stage 
7 under 6 different magnifications. 
  
  
  
Figure 11.29 SEM images of Strathclyde 2 Stage 7 
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Figure 11.30 shows the top surface scanning images of the fragments of Strathclyde 2 at stage 
8 under 6 different magnifications. 
  
  
  
Figure 11.30 SEM images of Strathclyde 2 Stage 8 
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 Cross Section Scans 
Figure 11.31 shows cross section scanning images of the Commercial IPMC 1, 2, and 3 under 
2 different magnifications. 
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Figure 11.31 Cross Section SEM images of the Commercial IPMC 
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Figure 11.32 shows cross section scanning images of the Commercial IPMC 4, 5, and 6 under 
2 different magnifications. 
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Figure 11.32 Cross Section SEM images of the Commercial IPMC 
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Figure 11.33 shows cross section scanning images of the Strathclyde IPMC 1, 2, and 3 under 
2 different magnifications. 
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Figure 11.33 Cross Section SEM images of the Strathclyde IPMC 
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Figure 11.34 shows cross section scanning images of the Strathclyde IPMC 4, 5, and 6 under 
2 different magnifications. 
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Figure 11.34 Cross Section SEM images of the Strathclyde IPMC 
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Figure 11.35 shows cross section scanning images of the Strathclyde IPMC 7, 8, and 9 under 
2 different magnifications. 
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Figure 11.35 Cross Section SEM images of the Strathclyde IPMC 
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Figure 11.36 shows cross section scanning images of the Strathclyde IPMC 10, and 11 under 
2 different magnifications 
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Figure 11.36 Cross Section SEM images of the Strathclyde IPMC 
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Figure 11.37 shows the cross section scanning images of the Strathclyde IPMC sample 1 at 
stage 4, 5 and 6 of fabrication under 2 different magnifications. 
Figure 11.37 Cross Section images of Strathclyde 1 
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 6
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Figure 11.38 shows the cross section scanning images of the Strathclyde IPMC sample 1 at 
stage  7 and 8 of fabrication under 2 different magnifications. 
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Figure 11.38 Cross Section images of Strathclyde 1 
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 Blocking Force Diagrams 
 Commercial 1 
Figure 11.39 to Figure 11.42 show the blocking force diagram of Commercial 1 IPMC. 
 
Figure 11.39 Blocking Force of Commercial 1 IPMC at 0.05 Hz 
 
 
Figure 11.40 Blocking Force of Commercial 1 IPMC at 0.5 Hz 
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Figure 11.41 Blocking Force of Commercial 1 IPMC at 1 Hz 
 
 
Figure 11.42 Blocking Force of Commercial 1 IPMC at 2 Hz 
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 Commercial 2 
Figure 11.43 to Figure 11.46 show the blocking force diagram of Commercial 2 IPMC. 
 
 
Figure 11.43 Blocking Force of Commercial 2 IPMC at 0.05 Hz 
 
 
Figure 11.44 Blocking Force of Commercial 2 IPMC at 0.5 Hz 
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Figure 11.45 Blocking Force of Commercial 2 IPMC at 1 Hz 
 
 
Figure 11.46 Blocking Force of Commercial 2 IPMC at 2 Hz 
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 Commercial 3 
Figure 11.47 to Figure 11.50 show the blocking force diagram of Commercial 3 IPMC. 
 
Figure 11.47 Blocking Force of Commercial 3 IPMC at 0.05 Hz 
 
 
Figure 11.48 Blocking Force of Commercial 3 IPMC at 0.5 Hz 
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Figure 11.49 Blocking Force of Commercial 3 IPMC at 1 Hz 
 
 
Figure 11.50 Blocking Force of Commercial 3 IPMC at 2 Hz 
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 Commercial 4 
Figure 11.51 to Figure 11.52 show the blocking force diagram of Commercial 4 IPMC. 
 
Figure 11.51 Blocking Force of Commercial 4 IPMC at 0.05 Hz 
 
 
Figure 11.52 Blocking Force of Commercial 4 IPMC at 0.5 Hz 
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 Commercial 5 
Figure 11.53 to Figure 11.56 show the blocking force diagram of Commercial 5 IPMC. 
 
 
Figure 11.53 Blocking Force of Commercial 5 IPMC at 0.05 Hz 
 
 
Figure 11.54 Blocking Force of Commercial 5 IPMC at 0.5 Hz 
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Figure 11.55 Blocking Force of Commercial 5 IPMC at 1 Hz 
 
 
Figure 11.56 Blocking Force of Commercial 5 IPMC at 2 Hz 
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 Commercial 6 
Figure 11.57 to Figure 11.60 show the blocking force diagram of Commercial 6 IPMC. 
 
Figure 11.57 Blocking Force of Commercial 6 IPMC at 0.05 Hz 
 
 
Figure 11.58 Blocking Force of Commercial 6 IPMC at 0.5 Hz 
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Figure 11.59 Blocking Force of Commercial 6 IPMC at 1 Hz 
 
 
Figure 11.60 Blocking Force of Commercial 6 IPMC at 2 Hz 
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 Strathclyde 1 
Figure 11.61 to Figure 11.64 show the blocking force diagram of Strathclyde 1 IPMC. 
 
Figure 11.61 Blocking Force of Strathclyde 1 IPMC at 0.05 Hz 
 
 
Figure 11.62 Blocking Force of Strathclyde 1 IPMC at 0.5 Hz 
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Figure 11.63 Blocking Force of Strathclyde 1 IPMC at 1 Hz 
 
 
Figure 11.64 Blocking Force of Strathclyde 1 IPMC at 2 Hz 
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 Strathclyde 2 
Figure 11.65 to Figure 11.68 show the blocking force diagram of Strathclyde 2 IPMC. 
 
Figure 11.65 Blocking Force of Strathclyde 2 IPMC at 0.05 Hz 
 
 
Figure 11.66 Blocking Force of Strathclyde 2 IPMC at 0.5 Hz 
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Figure 11.67 Blocking Force of Strathclyde 2 IPMC at 1 Hz 
 
 
Figure 11.68 Blocking Force of Strathclyde 2 IPMC at 2 Hz 
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 Strathclyde 3 
Figure 11.69 to Figure 11.72 show the blocking force diagram of Strathclyde 3 IPMC. 
 
Figure 11.69 Blocking Force of Strathclyde 3 IPMC at 0.05 Hz 
 
 
Figure 11.70 Blocking Force of Strathclyde 3 IPMC at 0.5 Hz 
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Figure 11.71 Blocking Force of Strathclyde 3 IPMC at 1 Hz 
 
 
Figure 11.72 Blocking Force of Strathclyde 3 IPMC at 2 Hz 
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 Strathclyde 4 
Figure 11.73 to Figure 11.76 show the blocking force diagram of Strathclyde 4 IPMC. 
 
Figure 11.73 Blocking Force of Strathclyde 4 IPMC at 0.05 Hz 
 
 
Figure 11.74 Blocking Force of Strathclyde 4 IPMC at 0.5 Hz 
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Figure 11.75 Blocking Force of Strathclyde 4 IPMC at 1 Hz 
 
 
Figure 11.76 Blocking Force of Strathclyde 4 IPMC at 2 Hz 
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 Strathclyde 5 
Figure 11.77 to Figure 11.80 show the blocking force diagram of Strathclyde 5 IPMC. 
 
Figure 11.77 Blocking Force of Strathclyde 5 IPMC at 0.05 Hz 
 
 
Figure 11.78 Blocking Force of Strathclyde 5 IPMC at 0.5 Hz 
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Figure 11.79 Blocking Force of Strathclyde 5 IPMC at 1 Hz 
 
 
Figure 11.80 Blocking Force of Strathclyde 5 IPMC at 2 Hz 
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 Strathclyde 6 
Figure 11.81 to Figure 11.84 show the blocking force diagram of Strathclyde 6 IPMC. 
 
Figure 11.81 Blocking Force of Strathclyde 6 IPMC at 0.05 Hz 
 
 
Figure 11.82 Blocking Force of Strathclyde 6 IPMC at 0.5 Hz 
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Figure 11.83 Blocking Force of Strathclyde 6 IPMC at 1 Hz 
 
 
Figure 11.84 Blocking Force of Strathclyde 6 IPMC at 2 Hz 
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 Strathclyde 7 
Figure 11.85 to Figure 11.88 show the blocking force diagram of Strathclyde 7 IPMC. 
 
Figure 11.85 Blocking Force of Strathclyde 7 IPMC at 0.05 Hz 
 
 
Figure 11.86 Blocking Force of Strathclyde 7 IPMC at 0.5 Hz 
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Figure 11.87 Blocking Force of Strathclyde 7 IPMC at 1 Hz 
 
 
Figure 11.88 Blocking Force of Strathclyde 7 IPMC at 2 Hz 
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 Strathclyde 8 
Figure 11.89 to Figure 11.91 show the blocking force diagram of Strathclyde 8 IPMC 
 
Figure 11.89 Blocking Force of Strathclyde 8 IPMC at 0.05 Hz 
 
 
Figure 11.90 Blocking Force of Strathclyde 8 IPMC at 1 Hz 
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Figure 11.91 Blocking Force of Strathclyde 8 IPMC at 2 Hz 
 Strathclyde 9 
Figure 11.92 to Figure 11.95 show the blocking force diagram of Strathclyde 9 IPMC. 
 
Figure 11.92 Blocking Force of Strathclyde 9 IPMC at 0.05 Hz 
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Figure 11.93 Blocking Force of Strathclyde 9 IPMC at 0.5 Hz 
 
Figure 11.94 Blocking Force of Strathclyde 9 IPMC at 1 Hz 
 
Figure 11.95 Blocking Force of Strathclyde 9 IPMC at 2 Hz 
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 Strathclyde 10 
Figure 11.96 to Figure 11.99 show the blocking force diagram of Strathclyde 10 IPMC. 
 
Figure 11.96 Blocking Force of Strathclyde 10 IPMC at 0.05 Hz 
 
 
Figure 11.97 Blocking Force of Strathclyde 10 IPMC at 0.5 Hz 
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Figure 11.98 Blocking Force of Strathclyde 10 IPMC at 1 Hz 
 
 
Figure 11.99 Blocking Force of Strathclyde 10 IPMC at 2 Hz 
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 Strathclyde 11 
Figure 11.100 to Figure 11.103 show the blocking force diagram of Strathclyde 11 IPMC. 
 
Figure 11.100 Blocking Force of Strathclyde 11 IPMC at 0.05 Hz 
 
 
Figure 11.101 Blocking Force of Strathclyde 11 IPMC at 0.5 Hz 
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Figure 11.102 Blocking Force of Strathclyde 11 IPMC at 1 Hz 
 
 
Figure 11.103 Blocking Force of Strathclyde 11 IPMC at 2 Hz 
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 Power Harvesting Diagrams 
Figure 11.104 shows the generated voltage from IPMC Commercial 1. 
 
Figure 11.104 Voltage generated from Commercial 1 
Figure 11.105 shows the generated voltage from IPMC Commercial 2. 
 
Figure 11.105 Voltage generated from Commercial 2 
 
Figure 11.106 shows the generated voltage from IPMC Commercial 3. 
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Figure 11.106 Voltage generated from Commercial 3 
Figure 11.107 shows the generated voltage from IPMC Commercial 4. 
 
Figure 11.107 Voltage generated from Commercial 4 
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Figure 11.108 shows the generated voltage from IPMC Commercial 5. 
 
Figure 11.108 Voltage generated from Commercial 5 
Figure 11.109 shows the generated voltage from IPMC Commercial 6. 
 
Figure 11.109 Voltage generated from Commercial 6 
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Figure 11.110 shows the generated voltage from IPMC Strathclyde 1. 
 
Figure 11.110 Voltage generated from Strathclyde 1 
Figure 11.111 shows the generated voltage from IPMC Strathclyde 2. 
 
Figure 11.111 Voltage generated from Strathclyde 2 
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Figure 11.112 shows the generated voltage from IPMC Strathclyde 3. 
 
Figure 11.112 Voltage generated from Strathclyde 3 
Figure 11.113 shows the generated voltage from IPMC Strathclyde 4. 
 
Figure 11.113 Voltage generated from Strathclyde 4 
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Figure 11.114 shows the generated voltage from IPMC Strathclyde 5. 
 
Figure 11.114 Voltage generated from Strathclyde 5 
Figure 11.115 shows the generated voltage from IPMC Strathclyde 6. 
 
Figure 11.115 Voltage generated from Strathclyde 6 
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Figure 11.116 shows the generated voltage from IPMC Strathclyde 7. 
 
Figure 11.116 Voltage generated from Strathclyde 7 
Figure 11.117 shows the generated voltage from IPMC Strathclyde 8. 
 
Figure 11.117 Voltage generated from Strathclyde 8 
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Figure 11.118 shows the generated voltage from IPMC Strathclyde 9. 
 
Figure 11.118 Voltage generated from Strathclyde 9 
Figure 11.119 shows the generated voltage from IPMC Strathclyde 10. 
 
Figure 11.119 Voltage generated from Strathclyde 10 
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Figure 11.120 shows the generated voltage from IPMC Strathclyde 11. 
 
Figure 11.120 Voltage generated from Strathclyde 11 
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 Power Balance 
Table 11.2 showed a comparison between the generated and consumed current, voltage, and 
power of all IPMC samples 
 
Current 
generated 
(µA) 
Current 
consumed 
(mA) 
Vrms 
Generated 
(mV) 
Voltage 
Consumed 
(V) 
Power 
Generated 
(mW) 
Power 
consumed 
(mW) 
Commercial 
1 2 100 56.56 6 0.113 600 
Commercial 
2 5 100 14.14 6 0.070 600 
Commercial 
3 12 110 1.41 6 0.016 660 
Commercial 
4 14 200 17.68 6 0.247 1200 
Commercial 
5 56 150 56.56 6 3.167 900 
Commercial 
6 100 500 353.50 6 35.350 3000 
Strathclyde 
1 15 200 28.28 6 0.424 1200 
Strathclyde 
2 65 100 42.42 6 2.757 600 
Strathclyde 
3 65 60 49.49 6 3.216 360 
Strathclyde 
4 74 40 141.40 6 10.46 240 
Strathclyde 
5 72 180 21.21 6 1.527 1080 
Strathclyde 
6 32 200 3.54 6 0.113 1200 
Strathclyde 
7 20 120 127.26 6 2.545 720 
Strathclyde 
8 4 150 2.12 6 0.008 900 
Strathclyde 
9 52 200 10.61 6 0.551 1200 
Strathclyde 
10 21 50 1.41 6 0.029 300 
Strathclyde 
11 15 300 1.41 6 0.021 1800 
Table 11.2 Comparison between the generated and consumed electrical parameters 
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